var title_f19_54_20320="Complete vaginal vault prolapse";
var content_f19_54_20320=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Complete vaginal vault prolapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 277px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20320=[""].join("\n");
var outline_f19_54_20320=null;
var title_f19_54_20321="Fixed drug hyperpigment";
var content_f19_54_20321=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fixed drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 293px; height: 508px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fixed drug eruptions (A) typically resolve with postinflammatory hyperpigmentation (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Chris Ha, MD, DermAtlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20321=[""].join("\n");
var outline_f19_54_20321=null;
var title_f19_54_20322="Ultrasound image of membrane separation";
var content_f19_54_20322=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70493&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound image of membrane separation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal midline sagittal ultrasound image of the uterine cervix showing cervical funneling, membrane separation from the decidua (along the anterior lip of the cervix), and debris (the diffuse area of echodensity resting within the amniotic fluid of the funnel on the posterior cervix).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jay D Iams, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20322=[""].join("\n");
var outline_f19_54_20322=null;
var title_f19_54_20323="Molluscum and eczema";
var content_f19_54_20323=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Molluscum contagiosum in a patient with atopic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lesions are present on a background of atopic dermatitis of the flexural creases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20323=[""].join("\n");
var outline_f19_54_20323=null;
var title_f19_54_20324="Diverticular colitis";
var content_f19_54_20324=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diverticular colitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20324/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20324/contributors\">",
"     Tonia Young-Fadok, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20324/contributors\">",
"     John H Pemberton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20324/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20324/contributors\">",
"     Lawrence S Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20324/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20324/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/54/20324/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infrequently, patients with diverticular disease develop a segmental colitis most commonly in the sigmoid colon. The endoscopic and histologic features vary, ranging from mild inflammatory changes with submucosal hemorrhages (peridiverticular red spots on colonoscopy sometimes referred to as \"Fawaz spots\") to florid, chronic active inflammation resembling (histologically and endoscopically) inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/1-8\">",
"     1-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will focus on the pathogenesis, clinical manifestations, diagnosis, and treatment of diverticular colitis. The epidemiology, clinical manifestations and diagnosis of symptomatic diverticular disease, the treatment of diverticulitis, and diverticular bleeding are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36854?source=see_link\">",
"     \"Epidemiology and pathophysiology of colonic diverticular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34919?source=see_link\">",
"     \"Clinical manifestations and diagnosis of colonic diverticular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/8/13450?source=see_link\">",
"     \"Treatment of acute diverticulitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38679?source=see_link\">",
"     \"Colonic diverticular bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99665329\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of diverticular colitis is incompletely understood. The cause may be multifactorial, related to mucosal prolapse, fecal stasis, or localized ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may be asymptomatic or have features resembling those seen in patients with segmental colitis including hematochezia and abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In a systematic review of 18 studies, the average age of onset was 64 [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/9\">",
"     9",
"    </a>",
"    ]. Typical symptoms included diarrhea, hematochezia, and tenesmus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of diverticular colitis is made endoscopically and histologically.",
"   </p>",
"   <p>",
"    On endoscopy, diverticular colitis is characterized by inflammation in the interdiverticular mucosa without involvement of the diverticular orifices. In contrast, the inflammation in acute uncomplicated diverticulitis primarily affects the diverticular orifices and peridiverticular mucosa, while in patients with inflammatory bowel disease (IBD) and diverticulosis the inflammation involves the colonic area harboring diverticula, as well as the diverticular orifices [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The distribution of the colitis (ie, limitation to a segment of diverticular disease, sparing the rectum, terminal ileum, and other portions of the colon) may also assist in differentiating diverticular colitis from other causes of colitis (see",
"    <a class=\"local\" href=\"#H13138981\">",
"     'Differential diagnosis'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The endoscopic features of diverticular colitis vary in severity, ranging from mild inflammatory changes with submucosal hemorrhages (peridiverticular red spots on colonoscopy referred to as \"Fawaz spots\") to florid, chronic active inflammation resembling inflammatory bowel disease. The histological appearance of diverticular colitis also varies &ndash; from modest inflammatory changes with vascular ectasia, through classical mucosal prolapse changes, to florid active chronic inflammation (with neutrophilic cryptitis, crypt abscesses, and distorted crypt architecture) that closely mimics chronic inflammatory bowel disease, especially ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Evidence of IBD elsewhere in the gastrointestinal tract suggests that as an alternative diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=see_link&amp;anchor=H12689106#H12689106\">",
"     \"Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13138981\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis includes inflammatory bowel disease (IBD), infectious colitis, nonsteroidal antiinflammatory drug (NSAID)-induced colitis, and ischemic colitis, which can usually be distinguished based upon the clinical context and the distribution of the colitis (ie, limitation to a segment of diverticular disease with sparing the rectum and terminal ileum are suggestive of diverticular colitis rather than IBD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of diverticular colitis is incompletely understood. One report suggested that affected patients appear to be at increased risk for complications related to diverticulosis (such as the development of a stricture) that may ultimately require a sigmoid resection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/4\">",
"     4",
"    </a>",
"    ]. Case series have suggested that some patients eventually develop more classic features of either ulcerative colitis or Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/12\">",
"     12",
"    </a>",
"    ]. However, in most patients the disease appears to be distinct from inflammatory bowel disease, a point illustrated in a report of 25 patients of whom 23 remained free of Crohn's disease during a median of six year follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal treatment of diverticular colitis has not been well defined.",
"   </p>",
"   <p>",
"    Our approach in patients who have an initial attack is a trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    500 mg orally twice daily and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two or three divided doses for 10 to 14 days. In patients who do not respond adequately, we add oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"     mesalamine",
"    </a>",
"    started at 800 mg PO three times daily for 7 to 10 days and if the response is inadequate in two to four weeks, we increase the dose to 1600 mg PO three times daily. In patients who fail to respond to antibiotics and mesalamine, we use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    40 mg daily for one week and then gradually reduce the dose and discontinue prednisone over six weeks.&nbsp;We discontinue treatment after achieving remission, as there is no evidence of benefit of maintenance therapy. In patients who relapse after successful treatment with antibiotics, we suggest repeating the same regimen for one month.",
"   </p>",
"   <p>",
"    In those with chronic disease, we suggest long-term treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    and not",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    , because of its better tolerance and fewer long-term side effects. These recommendations are based mainly upon experience with long-term treatment with antibiotics for treatment of pouchitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32759?source=see_link&amp;anchor=H11#H11\">",
"     \"Pouchitis\", section on 'Antibiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A high fiber diet, antibiotics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aminosalicylates were helpful for symptomatic patients in case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Combination therapy with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    dipropionate (10",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    in divided doses for four weeks followed by 5",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    for an additional four weeks) plus the probiotic preparation VSL#3 (1",
"    <span class=\"nowrap\">",
"     bag/day",
"    </span>",
"    for 15 days followed by 1",
"    <span class=\"nowrap\">",
"     bag/day",
"    </span>",
"    for 15 days each month) improved symptoms and histology in an open label trial involving 12 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20324/abstract/13\">",
"     13",
"    </a>",
"    ]. Oral beclomethasone dipropionate is a corticosteroid with limited systemic activity that is not available in the United States.",
"   </p>",
"   <p>",
"    Segmental resection should be considered in patients with chronic disease who fail to respond to medication or with frequent relapses and in whom the diagnosis of diverticular colitis is certain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/6/1122?source=see_link\">",
"       \"Patient information: Diverticulitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/32/17922?source=see_link\">",
"       \"Patient information: Diverticular disease (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infrequently, patients with diverticular disease develop a segmental colitis most commonly in the sigmoid colon. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients may be asymptomatic or have features resembling those seen in patients with segmental colitis including hematochezia, diarrhea, tenesmus, and abdominal pain. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of diverticular colitis is made histologically and endoscopically. On endoscopy, diverticular colitis is characterized by inflammation in the interdiverticular mucosa without involvement of the diverticular orifices. In contrast, the inflammation affects primarily diverticular orifices and peridiverticular mucosa in acute uncomplicated diverticulitis, while in patients with inflammatory bowel disease and diverticulosis the inflammation involves the colonic area harboring diverticula, as well as the diverticular orifices. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal treatment for diverticular colitis has not been well defined. A high fiber diet, antibiotics",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      aminosalicylates were helpful for symptomatic patients in case reports. There is little evidence to suggest which is more helpful.",
"      <br/>",
"      <br/>",
"      In patients who have an initial attack, we suggest is a trial of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      500 mg orally twice daily and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two or three divided doses for 10 to 14 days (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In patients who do not respond adequately, we add oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"       mesalamine",
"      </a>",
"      started at 800 mg PO three times daily for 7 to 10 days and if the response is inadequate in two to four weeks we increase the dose to 1600 mg PO three times daily. In patients who fail to respond to antibiotics and mesalamine, we use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      40 mg daily for one week and then gradually reduce the dose and discontinue prednisone over six weeks.&nbsp;We discontinue treatment after achieving remission, as there is no evidence of benefit of maintenance therapy. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who relapse after successful treatment with antibiotics, we repeat the same regimen for one month. In those with chronic disease, we suggest long-term treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (but not",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/1\">",
"      Goldstein NS, Leon-Armin C, Mani A. Crohn's colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn's colitis. Am J Surg Pathol 2000; 24:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/2\">",
"      Ludeman L, Shepherd NA. What is diverticular colitis? Pathology 2002; 34:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/3\">",
"      Rampton DS. Diverticular colitis: diagnosis and management. Colorectal Dis 2001; 3:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/4\">",
"      Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol 1996; 20:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/5\">",
"      Evans JP, Cooper J, Roediger WE. Diverticular colitis - therapeutic and aetiological considerations. Colorectal Dis 2002; 4:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/6\">",
"      Sladen GE, Filipe MI. Is segmental colitis a complication of diverticular disease? Dis Colon Rectum 1984; 27:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/7\">",
"      Guslandi M. Segmental colitis: so what? Eur J Gastroenterol Hepatol 2003; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/8\">",
"      Van Rosendaal GM, Andersen MA. Segmental colitis complicating diverticular disease. Can J Gastroenterol 1996; 10:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/9\">",
"      Mulhall AM, Mahid SS, Petras RE, Galandiuk S. Diverticular disease associated with inflammatory bowel disease-like colitis: a systematic review. Dis Colon Rectum 2009; 52:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/10\">",
"      Tursi A, Elisei W, Giorgetti GM, et al. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther 2011; 33:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/11\">",
"      Lamps LW, Knapple WL. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 2007; 5:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/12\">",
"      Hokama A, Kinjo F, Tomiyama R, et al. Progression of diverticular colitis to ulcerative colitis. Inflamm Bowel Dis 2005; 11:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20324/abstract/13\">",
"      Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Beclomethasone dipropionate plus VSL#3 for the treatment of mild to moderate diverticular colitis: an open, pilot study. J Clin Gastroenterol 2005; 39:644.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2601 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-41.196.66.12-562CF1C545-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20324=[""].join("\n");
var outline_f19_54_20324=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99665329\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13138981\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/6/34919?source=related_link\">",
"      Clinical manifestations and diagnosis of colonic diverticular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20490?source=related_link\">",
"      Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38679?source=related_link\">",
"      Colonic diverticular bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36854?source=related_link\">",
"      Epidemiology and pathophysiology of colonic diverticular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/32/17922?source=related_link\">",
"      Patient information: Diverticular disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/6/1122?source=related_link\">",
"      Patient information: Diverticulitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32759?source=related_link\">",
"      Pouchitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/8/13450?source=related_link\">",
"      Treatment of acute diverticulitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_54_20325="Zafirlukast: Drug information";
var content_f19_54_20325=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Zafirlukast: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?36/57/37780?source=see_link\">",
"    see \"Zafirlukast: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/22/41316?source=see_link\">",
"    see \"Zafirlukast: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F235421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Accolate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F235422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Accolate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F235452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Leukotriene Receptor Antagonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F235426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Asthma:",
"     </b>",
"     Oral: 20 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F235440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/22/41316?source=see_link\">",
"      see \"Zafirlukast: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Asthma:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      U.S. labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 5-11 years: 10 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F235427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F803894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F235428\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F235399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 10 mg, 20 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Accolate&reg;: 10 mg, 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F235384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F235403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer at least 1 hour before or 2 hours after a meal.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F235402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis and chronic treatment of asthma",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F235459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Accolate&reg; may be confused with Accupril&reg;, Accutane&reg;, Aclovate&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F235450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Incidence reported in children &ge;12 years and adults unless otherwise specified.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache (13%; children 5-11 years: 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (2%), pain (2%), fever (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (3%), diarrhea (3%), abdominal pain (2%; children 5-11 years: 3%), vomiting (2%), dyspepsia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: ALT increased (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (2%), myalgia (2%), weakness (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Infection (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Agranulocytosis, angioedema, arthralgia, bleeding, bruising, depression, edema, eosinophilia (systemic), eosinophilic pneumonia, hepatic failure, hepatitis, hyperbilirubinemia, hypersensitivity reactions, insomnia, malaise, pruritus, rash, urticaria, vasculitis with clinical features of Churg-Strauss syndrome (rare)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F235406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to zafirlukast or any component of the formulation; hepatic impairment (including hepatic cirrhosis)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Patients in whom zafirlukast was discontinued due to treatment related hepatotoxicity",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F235388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Eosinophilia and vasculitis: In rare cases, patients may present with systemic eosinophilia, sometimes presenting with clinical features of vasculitis consistent with Churg-Strauss syndrome, a condition which is often treated with systemic corticosteroid therapy. Healthcare providers should be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients. A causal association between zafirlukast and these underlying conditions has not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity: Serious hepatic adverse events (including hepatitis, hyperbilirubinemia, and hepatic failure) have been reported with use; female patients may be at greater risk. Periodic testing of liver function may be considered (early detection coupled with therapy discontinuation is generally believed to improve the likelihood of recovery). Advise patients to be alert for and to immediately report symptoms (eg, anorexia, right upper quadrant abdominal pain, nausea). If hepatic dysfunction is suspected (due to clinical signs/symptoms), discontinue use immediately and measure liver function tests (particularly ALT); resolution observed in most but not all cases upon discontinuation of therapy. Do not resume or restart if hepatic function studies indicate dysfunction. Use in patients with hepatic impairment (including hepatic cirrhosis) is contraindicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infections: An increased proportion of patients &gt;55 years of age reported infections as compared to placebo-treated patients. These infections were mostly mild or moderate in intensity and predominantly affected the respiratory tract. Infections occurred equally in both sexes, were dose-proportional to total milligrams of zafirlukast exposure, and were associated with coadministration of inhaled corticosteroids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuropsychiatric events: Postmarketing reports of behavioral changes (ie, depression, insomnia) have been noted. Instruct patients to report neuropsychiatric symptoms/events during therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Warfarin: Concomitant use with warfarin results in a clinically significant increase in INR; closely  monitor INR with concurrent use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Clearance is decreased in elderly patients; C",
"     <sub>",
"      max",
"     </sub>",
"     and AUC are increased approximately two- to threefold in adults &ge;65 years compared to younger adults; however, no dosage adjustments are recommended in this age group.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Reversal of bronchospasm: Not approved for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus; therapy can be continued during acute exacerbations of asthma.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F235446\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C9 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (weak), CYP2C8 (weak), CYP2C9 (moderate), CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F235393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carvedilol: CYP2C9 Inhibitors (Moderate) may increase the serum concentration of Carvedilol. Specifically, concentrations of the S-carvedilol enantiomer may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inducers (Strong): May increase the metabolism of CYP2C9 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Moderate): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Inhibitors (Strong): May decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C9 Substrates: CYP2C9 Inhibitors (Moderate) may decrease the metabolism of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erythromycin (Systemic): May decrease the serum concentration of Zafirlukast.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C9 Substrates. Management: Use CYP2C9 substrates at the lowest recommended dose, and monitor closely for adverse effects, during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: May decrease the serum concentration of Zafirlukast. Zafirlukast may increase the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Zafirlukast may increase the serum concentration of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F235418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Food decreases bioavailability of zafirlukast by 40%. Management: Take on an empty stomach 1 hour before or 2 hours after meals.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F235395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F235408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have not been observed in animal reproduction studies. Based on available information, zafirlukast may be considered for use in women who had a favorable response prior to becoming pregnant; however, it is not a preferred option in new patients (NAEPP, 2004).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F235432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F803893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Zafirlukast is excreted into breast milk; breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F235409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be taken on an empty stomach (1 hour before or 2 hours after meals).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F235407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Accolate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (60): $136.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (60): $136.55",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Zafirlukast Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (60): $107.36",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg (60): $107.36",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F235397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for improvements in air flow; monitor closely for sign/symptoms of hepatic injury; periodic monitoring of LFTs may be considered (not proved to prevent serious injury, but early detection may enhance recovery)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F235410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Accolate (AR, AU, BB, BE, BF, BJ, BM, BR, BS, BZ, CH, CI, CL, CN, CZ, ES, ET, FI, GB, GH, GM, GN, GY, HK, HN, HU, ID, IE, IL, JM, KE, KP, LR, MA, ML, MR, MU, MW, MX, NE, NG, NL, NO, PE, PH, PK, PL, PT, RU, SC, SD, SG, SL, SN, SR, TN, TR, TT, TW, TZ, UG, UY, VE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Accoleit (IT);",
"     </li>",
"     <li>",
"      Zuvair (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F235387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Zafirlukast is a selectively and competitive leukotriene-receptor antagonist (LTRA) of leukotriene D4 and E4 (LTD4 and LTE4), components of slow-reacting substance of anaphylaxis (SRSA). Cysteinyl leukotriene production and receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle constriction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F235405\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : ~70 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;99%, primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic via CYP2C9",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Reduced 40% with food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~10 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (~90%); Urine (~10%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program Asthma and Pregnancy Working Group, &ldquo;NAEPP Expert Panel Report. Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment - 2004 Update,&rdquo;",
"      <i>",
"       J Allergy Clin Immunol",
"      </i>",
"      ,  2005, 115(1):34-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/54/20325/abstract-text/15637545/pubmed\" id=\"15637545\" target=\"_blank\">",
"        15637545",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reinus JF, Persky S, Burkiewicz JS, et al, &ldquo;Severe Liver Injury After Treatment With the Leukotriene Receptor Antagonist Zafirlukast,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2000, 133(12):964-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/54/20325/abstract-text/11119397/pubmed\" id=\"11119397\" target=\"_blank\">",
"        11119397",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10052 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-A6750C7309-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20325=[""].join("\n");
var outline_f19_54_20325=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235421\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235422\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235452\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235426\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235440\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235427\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803894\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235428\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235399\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235384\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235403\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235402\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235459\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235450\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235406\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235388\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235446\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235393\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235418\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235395\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235408\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235432\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803893\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235409\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235407\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235397\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235410\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235387\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235405\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10052\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10052|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?36/57/37780?source=related_link\">",
"      Zafirlukast: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/22/41316?source=related_link\">",
"      Zafirlukast: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_54_20326="Ultrasound and Doppler images of placenta accreta";
var content_f19_54_20326=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Ultrasound and Doppler images of placenta accreta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 485px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHlAkgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3n4ofEDSvhxoFvq+uW99PbTXS2irZojOHZHYEhmUYwh7+leYf8NV+B/8AoFeJP/AeD/49R+2t/wAks0r/ALDUX/oievKfgN8HvC3jr4f6p4h8TajqtmbK8lhY2ssaRrEkUbliGjY5+du/QDigD1b/AIar8D/9ArxJ/wCA8H/x6j/hqvwP/wBArxJ/4Dwf/Hq4r4XfBz4W/EnTLy80HUfGEItJhDLDdy2ySDK5VsLGw2nnHP8ACeK+X6APtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqKAPtX/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqKAPtZf2qfBLMFXSvEpJ4A+zwf8Ax6p/+GnvB+cHR/EgP/XC3/8Aj1fF2mQtJPvCsVQZJUdPStIysjlMcHuy80AfXUn7U3guM4k0fxMp97aD/wCPUz/hqvwR/wBArxL/AOA8H/x6vkZ2CEFSc9M9vyp8X2VwRcQRk9dxBXP0oA+tv+Gq/A//AECvEn/gPB/8eo/4ar8D/wDQK8Sf+A8H/wAer5OXT9OljBEM4Y/3JRgfXIpDoEDBfLunTnnegP8AI0AfWX/DVfgf/oFeJP8AwHg/+PUf8NV+B/8AoFeJP/AeD/49XybP4XeNFZLyF93QYIJqnNokkRwZkJ9gaAPr7/hqvwP/ANArxJ/4Dwf/AB6j/hqvwP8A9ArxJ/4Dwf8Ax6vkGPRiwJNwgXOPunNKmlwAsJLh9w4wsff65oA+vf8AhqvwP/0CvEn/AIDwf/HqP+Gq/A//AECvEn/gPB/8er5J/su0jUM7ybSOrnH5AVUmgt0yEwQO/XmgD7BH7VXgg9NK8S/+A8H/AMep/wDw1L4LwT/ZPiTA5J+zwcf+Rq+LWDiTJTB69MUxmJOeBQB9pH9qrwQP+YV4k/8AAeD/AOPUf8NV+B/+gV4k/wDAeD/49XxWTmkoA+1f+Gq/A/8A0CvEn/gPB/8AHqP+Gq/A/wD0CvEn/gPB/wDHq+KqKAPtX/hqvwP/ANArxJ/4Dwf/AB6j/hqvwP8A9ArxJ/4Dwf8Ax6viqigD7V/4ar8D/wDQK8Sf+A8H/wAeo/4ar8D/APQK8Sf+A8H/AMer4qooA+1f+Gq/A/8A0CvEn/gPB/8AHqt6h+0z4V077N/aHh7xdafaYVuYPPsoo/NibO2Rcy/MpwcMODivh+igD7V/4ar8D/8AQK8Sf+A8H/x6j/hqvwP/ANArxJ/4Dwf/AB6viqigD7V/4ar8D/8AQK8Sf+A8H/x6vT9c+IGlaN8NI/HF1b3z6TJa292Io0Qz7JigQYLBcjzBn5vXGa/NuvtX4l/8mbWf/YF0n/0O3oAP+Gq/A/8A0CvEn/gPB/8AHqP+Gq/A/wD0CvEn/gPB/wDHq8I+BPw78PeNtG8Y6n4nuNWhg0K3iuQunPGrOpWZnHzqQTiIY5HXn27jwh8Jfhp4m1fTdOjPjuwm1OxOo2bXctkVmhBxnMauVPswFAHf/wDDVfgf/oFeJP8AwHg/+PUf8NV+B/8AoFeJP/AeD/49XyL430qDQfGmv6RZvK9tp+oXFpE0pBcpHIygsQAM4AzgCsSgD7V/4ar8D/8AQK8Sf+A8H/x6j/hqvwP/ANArxJ/4Dwf/AB6viqigD7V/4ar8D/8AQK8Sf+A8H/x6j/hqvwP/ANArxJ/4Dwf/AB6viqigD7V/4ar8D/8AQK8Sf+A8H/x6j/hqvwR/0CvEn/gPB/8AHq+N9JsX1G+jtkdI9wZmkfO1FAJLHHYAGr7+GtQaMyWQhv4x1azlEhB9No+b9KBXSPrn/hqvwP8A9ArxJ/4Dwf8Ax6j/AIar8D/9ArxJ/wCA8H/x6vi6aGSGRo5o3jkXgqwwR+FMoGfan/DVfgf/AKBXiT/wHg/+PUf8NV+B/wDoFeJP/AeD/wCPV8V4ooA+1P8AhqvwP/0CvEn/AIDwf/HqP+Gq/A//AECvEn/gPB/8er4qpaAPtT/hqvwP/wBArxJ/4Dwf/HqP+Gq/A/8A0CvEn/gPB/8AHq+KqWgD7U/4ar8D/wDQK8Sf+A8H/wAeo/4ar8D/APQK8Sf+A8H/AMer4rooA+1P+Gq/A/8A0CvEn/gPB/8AHqP+Gq/A/wD0CvEn/gPB/wDHq+OtO0fUdSI+w2c8yk43qh2A+7dB+JrWk8JXUEU7XN3ZCeKJpWto5hJKAuM5A44znr2NBLklufV//DVfgj/oFeJf/AeD/wCPUf8ADVfgf/oFeJP/AAHg/wDj1fFZ44NJQUfav/DVfgf/AKBXiT/wHg/+PUf8NV+B/wDoFeJP/AeD/wCPV8VUUAfav/DVfgf/AKBXiT/wHg/+PUf8NV+B/wDoFeJP/AeD/wCPV8VUUAfav/DVfgf/AKBXiT/wHg/+PUf8NV+B/wDoFeJP/AeD/wCPV8VUUAfav/DVfgf/AKBXiT/wHg/+PUf8NV+B/wDoFeJP/AeD/wCPV8VVb1Wwm0y/ltLl7Z5Y8bmtrmO4jOQDxJGzK3XsTg8HkGgD7K/4ar8D/wDQK8Sf+A8H/wAeo/4ar8D/APQK8Sf+A8H/AMer4qooA+1f+Gq/A/8A0CvEn/gPB/8AHqP+Gq/A/wD0CvEn/gPB/wDHq+KqKAP0k+F/xA0r4j6BcavodvfQW0N01oy3iIrl1RGJAVmGMOO/rRXmH7FP/JLNV/7DUv8A6IgooAP21v8Aklmlf9hqL/0RPXH/AAE0HWfFH7N/ifQ/DtxaWt3f6w8Ek1yzKqwmG38zG1SSSuRj3PNdh+2t/wAks0r/ALDUX/oieviqgD7/APAnwy1DwP8AEKXUtK1Rbvw/d6ZFZ3UV1sScSwgLEyrFGqFQgC888knNfAFFFABRRRQAUUU+NDJIqL1Y4oA0dNuWtIyu0qHO4knG4dqsTnzgGUZLdqsL5XlJHJADgbCQ3I9xVG5tWtW3ICMHg9cigCGVnjkBZGUDjB6Uu5jg54/rWqnl3ltk7tw6+30rInDIxJAx60AXYZhs2B9tPWd14I3EcZBrLimbOcADPU1cjmygIZsexoA0Y7uAMFIYP/EwbgU4usrtsl5J4DdKy5HaQkbcgDOaiyryYODgeuKANhWMRJkYMCcHHP5+lRvdGJGEIBB698CsvzdvCDBbqScCr1pFFJZXVzKSCq4jwerZGT+AI/OpnNQV2b4fDyxEnGPRN/JK/wDXmOe9lkICwjZjq46VSkl8piQoZep560jzhmURzS7gOfSmPJFKcEmMDA6ZyaowGqstwSUSV2PQdfwq0dPlmG6SDyQBg9uaLQywfvEMhYH92OnFLeandu2y5TC+hHSgCs+lzrC0p2hB3J6/Ss+r0t55sQEgLYPAJ4FU3xuO3p2oAbRRRQAUUUUAFFFFABW3c6NYw6ML2PxLpE9yURjYRx3QnBOMrloRHlcnPz44OCeM4lFAHoHjzw8dH8G+G7i88NvpOo3ILNNEs/lywlFKGRpCy+ax3ttQjapAIzwPP6kkmlkRUeR2VeFDMSB9KjoAK+1fiX/yZtZ/9gXSf/Q7eviqvtX4l/8AJm1n/wBgXSf/AEO3oA8//ZE06bWPCvxP0y2aNZ72ygto2kJChnS5UEkAnGT6GvU/hv8ACnWPDviDwrfTxaFpUejWUtteNpUrvJqzsu0NNmKMAKfmGd5z37j4XooA6v4sf8lT8Zf9hq9/9HvXKUUUAFFFFABS0lKKAOh0RxZeHtUuiAJLorZRseyn55P0Cj/gVUoreSOMSKuAQdrk5Az6e9at0sNsNN06VgjW0QlfjkyyYYg/Rdg/CrerQwPAtzEFKoOQBgE+4rNztJLudNDCOrTlUT26GVb6/qYj8qa7W6jHHlXaCYAevzA07+1LCYEXui2TsDjdAzQNjueCV/THtWdebpp2kCoqkbvlxVQFiACMt1Ga0as7HLyo2D/wj8wz5Op20hPRGSZR7AHaT9c0o03RZSPL1mWJmPCTWjfLz/EVJH5ZrMbmQPFtQdcD+Go5ECO2X3epXvQFjai0GxmlZYtdtCA2BmGb/wCIqdfDFk8u2PX7Vl/v+RLj/wBBrB3hPkwVAPY5Iq5BeKiRpLnYTuYdCw9qCbPubMvhfSYGZJPEIdwN2YbKRlA9ySKhfR9Cij51DUJjxho7RVBz2AZ80OySYkRmCZDEHowHb605ZVjukO7dbqQ+NuCc8AfhQPlfcWzg0UBnj0u5uY1bG64utpyO21F6fiDUI1qOKRV0zTtPtArYSRoTK4PX7zk8574qpeIvmDypU3yZ3Lg4bJ6VXwYwVc7CoK/NySfwoDlRs3GrXV6QtzNJLExIfczBQfTb0H4CpLW7jtdRtLlonMatiTfwuwja2B/uk1zsjyo8UkcpLn5+D90981PLdySwrI+wogwy9CxoHyq1ivrVidN1W6s2bd5MhUH1GeD+Iwao1t+ID9qttO1LjdPF5UpzyZI8KSfquw/jWJQgWwUUUUDCiiigBaSiigAoore1S08PLHCNA1XVLu7aVVKX+nQ2sYU553i4k744IAwSSRjkAwaK9A+L9v8AZb/SYZF0WS6jtNs93pRtliuH3k8RwHChQVQFgrNtyR0A8/oAKKKKAPtX9in/AJJZqv8A2Gpf/REFFH7FP/JLNV/7DUv/AKIgooAP21v+SWaV/wBhqL/0RPXxVX2r+2t/ySzSv+w1F/6Inr4qoAKKKKACiiigAqa2YpIHC5I6VDWjHp03kRSgH94M4xjj1oAne9DI0bwNuHQg8rTIppg6sX3D/a7UtvBLA7K0ZJIxT4LR9wK5x3PpQA4yx7lYK0bnqVPX8KsbVmyo+cFeu3GT71H5UawseC1RsZIAcg84IIHGKAKl5aiLkYwew5FVkkKA7OK2rdw/yllVSOQwyCKq32mGLEkIJQ9s5NAFKJwOG+8e/tSrKd+M/QVDIArEYI9RUeaAJ4d73CpGu93IVQO5Nacsqhb6OIgxW9uIlI6M3mpuP4nd+GKqaf8A6Pbz3h+8v7qL/fYdfwGT9cU2040+/PqqL/49n+lYT9537W/M9TDfuoW6zUn8lF2+96/JMgFwQzEAcjFXLC9aOdMJFnpnHWsylBwc1ueWdKl1NIyl9qL09/ypsmnx3dzH585gQj5mPP6VhRSPniQg9q1bQ+XbEsMlurEUAal9ZeHLS3EVvPNc3OOW6j6YrA1G2VYI54gApO0gdvTNdBYaefKM+MJjvyaSz0cTWuqRzKzTGMvFjorDn/61AHH0UUUAFFFFABRRRQAVb1CSxf7N/Z9vcwbYVWfz51l3y/xMuEXap4wp3Ef3jVSigAoro9b8Ky6X4a0zW11CzurW+YoqxLKjI4UEj94ih8ZwShYBuCemecoAK+1fiX/yZtZ/9gXSf/Q7eviqvtX4l/8AJm1n/wBgXSf/AEO3oA+KqKKKACiiigAooooAK0/Dlml9rNtFNgQBvMmJ6CNRub9AazRW/pEUkHh/UbqJW8y5ZbKMj0PzP+gA/wCBUCew6CeO+1Se+uXKXDzGTZjjB7Z7Yq8k5g3ywkTRM2HGcjPr9faudaSezkdAfvYDbh1NWNNuhvxKDsJ/ekfxDsKTSaszSlUlSlzRZ091o6X1r+6hSOQjggYxXKalZtazmMxkMBhtxzz612ul3lqkqxvcMHYcRsCfLHoTS6zBbTukrAlSpR2UAFfQ1y06jjPklsfQYzB0q+H+sUviW6PO1bDBgcGpHmYhgoUBj6YNW7yzdRLMgJjDH5jgcVndumcV1nzgvfr9Km819uWYE425PcelRbz0/A0KdpyOcc47UAWo5plD+W2VHzNjgH2qS2uZIiZOGXcOp6e1U1wzAZPPOAKU8ltxH4dqANO7nBy7rHIrZBUDkVVkkRgirIyHoVJPH41BCPnByCQM4z/WpVXe4cqoXI6k9f60AIQ7EpuJUNktjj6mnSRPLIVAVQeAB396s206WzynbujYd+eexH41HcX0rNny0jYddvQk96ALOnq11omp2L5MkGLyIem35XH/AHyQf+A1h1r6Hdi11u0luDmHd5c27oUb5W/QmqOpWrWV/cWz53QyNGc98HGaBdSrRRRQMKKKKACiiigAooq3ql1De38txbWFtp8T4221s0jRpgAcGR3bnGeWPJOMDAoAqV3F58Pr3T/CeleILqW1nt7md1mt7e+t2kEY8rbsw7F3bzTlQpK4BYc1w9XYtUvoobOKK8njjs5muLYI5UwyNty6kcg/InI/uigD2LSvht4Wv7+0neW8h0u9t7YRFb9Hj86aeWLCzeSN7ARMQjIgLBhvAwTyvws+Hi+LdfvLfU7h7W0sz5bxq6JPJI24KqhjgAFSWPOMYGSRXd/s96Vc/EPV/Ed/4g8U+KLe/ijt7cXFjqHlvJG/mZVyysSBtGAMY5qH4eeBrDxB4U0HXL/WNfj1COKSKFoLxVECLLIAseUJUdTjPVj61hiMTTw0eepsdGGw1TEz5Ka1PXf2LkaL4YaujgBl1uZTg55EEHeitH9lKwh0vwj4r0+1MjW9p4lu4IzIQWKpHCoyQACcD0FFbRakk0YSTi7MzP21v+SWaV/2Gov/AERPXxVX2r+2t/ySzSv+w1F/6Inr4qpiCiiigAooooAmtLd7q6igj+/IwUZrtZGvIIVtrog4AROhAA9MVieELE3N1NNtDLCnQ+p9PwzW7cpFAUIdmGMjdzj2oAiTTmmkXcWOB3PWrD2kUER8sBUyNwPrT7ciSLEYkO/kkY6irM8QMKRsrISO3O6gCvcxxJAVSAAnkE/w1kzW25cYy3XGa15lMbRFyXGMYb+GoLcrliysUJxg9aAMV7dkAfacD1HI+lEVzPEi5KFO2eOPcVu3FuNmyMKWzgqe1VW0udFBdE2McfN0oAx76zt50aW3BXAy2TkKf8KxGjYSBANxJwMc5rpr2xS0hZonbA++owVq1oWnWcuny3ksixvDMWSY4+T5BjP0Jzj1FZVqyox5mehlmXzzGv7GDS0vr2W5zWqMI2js4zlLcbWPYufvH8+PoBSQcaRdn1liX9HP9Kr3QiW4cQSNJHnh2XaT74qwnGjS/wC1cJ+OFb/H9aGrQS9PzBTc8ROT6KS76crSV+ttNSjRRRWp55LAcSDlfx6VpW7qxKhTkHOc8n/CsuMZbAODWnbB0ZpDsEYGCxOMUAbunSf6M0ZZ9vf0NSPdWtrA7NbPI+PlDybVX+pqjb3UJt2E0uw9iuST+FUr1vMjDOHEQ4LFsZ/CgDHmwZWICgEkgKcgVHT3wWJUYGfWmUAFFFFABRRRQAVt3PizxHdaMNIutf1ebSQiRiykvJGgCJjYvlltuBtGBjjA9KxKt6hYTWH2bz3tm+0QrcJ5FzHNhWzgNsY7G45RsMO4FAGxrniqTU9AstHh06zsLK2k84rbtK3mSYwW/eO23jPCbQSSSOmOcoooAK+1fiX/AMmbWf8A2BdJ/wDQ7eviqvtX4l/8mbWf/YF0n/0O3oA+KqKKKACiiigAooooAUDJwO9dvq1tLaadp+mxL5rW0IklHTbJJ8xB9wNn5Vz/AIVsF1DW7eKbAt1bfMScAIvLZ/AGrb3U95qU1yw2s0hkbeThcnIP9KCHrL0IZrCS6kMalAQxyxXDbu4IrOhBin8uQbQGwfqDXRoskNwquwSSSQuXI5YY4IFVL7TW2GWNJFYNwCeeerUFk6S28sBmyxmifbnGSo7n3ratZI5owJM+Yy5IPAI9qxtF0y7vvNgNuUTgNMeBt/qTVrU4H04uYt4H3OuQR7g10xy2eIhzXsdWDzH6rNrddUQ38i22pDYwWBo/L2t8x69hWHqliIpBJBuMLnCkjBJ+lXCZWVC427SSJAOee30rQtoZXkkLBBtUjax37+M5x2NZ1MNPD2jMyq1FWm6kVZHJEYyDjPfmnhjE4xtO3n1rW1DTGaET2cQe2A3GVPXPIx7VjspjYZ4YdjWTVjIkhJZlVRg5zmmuAX4Iwe+MUmWXnJz65pC2e3tz2oAVsnGSB29KBlGPzEY4yDStyueDxgkinROMAMx2j7w9RQBOqkqVGHA5yxx+GKfI37so6oP4hzg5/oKSExgkqhdv7oH8P/1qlUxPC0sisuzjAGQfegCuvlqok4cAHK4xitDxK32yLT9TA+a6hCSnOf3kfyN+YCn8aqEZHybQOo7mtO3thc+Hr+2BH7hlvIu+QMJJz9Ch/Cgl6anM0UtJQUFFFFABRVm+srmwn8i+t5bebYr7JUKttZQynB7EEEexqtSTTV0AUoGSASAD3Pakre1Xxf4i1qKGHXdc1TVrWKUTC3vryWaPcMjO1m64JGRzgmmBL4v8LS+Gl053v7S+gv4TNDJbrKmVBxnbKiNtJ6NjDdjwcc5XQ+K/E8viGPT4BY2thZWMZjgt7dpXC7jk/NI7tjgYGcADgDnPPUAfQP7J1z9nn8Sc9WtP5y1f+E135Xw80hPQTd/+mz1zH7N0/kS69z1a2/nJVz4b3Rj8E6YgPQS/+jXrzM1hz0UvP/M9vIdcS/R/mj3r9mBt/h7xm3r4pvT/AOORUVF+yq2/wr4tb18TXZ/8hw0V6FPSC9DyK38SXqzK/bW/5JZpX/Yai/8ARE9fFVfav7a3/JLNK/7DUX/oieviqrMwooooAKKKt6VaG+1K2tRx5sgUn0Hc/lQB23hKwWHSYnziaTMhU8ZB6fpT/ENvKiwqfn3/AE49sit+a1cbBGuBGMLkY49Kpz2y4HmCRcNnD9KAKlrb/wCjhVQIVHUNz+FTQu+doaWJF/vcgUqWxWTeA00B6hDytSTsiKVik/d+jjNAFdkyWV38xPXHNQPa7VYvC7Rno3p7gVciKOCm8x55zjn8KZMzJFm3eTcv39vJPvg0AQwh4toZyFPAdQQaW9WTYvmyM6dicc1XDEuGBdnb35P4VdYebGqKA3sScLQBliKPJGcKOGKisnWLaVI/KilItmcvsAwCcAZP5V0sVqUJyo5OMh+BVHWLaJo9kEgKDqM4pNJ7lRnKF+V2vocRcW7wgFgMHuKmPGjJ/tXDfoo/xrUe1gKEMc54wB/WqF/EYNOt4mBUieU49tsf+FTPdepvh9I1H2j+qX6mbRRRVnMKpwc1YjuXDZ+Ukf3ulVqfGm9wpZV9yaALCXjIxZVG8nOaLm5kuCDM/T/PSocqhGFDYPUjrVy1vVDZnVCoHTbQBn0lWbuVJWzGu0emMVWoAKKKKACiiigAoorbubbw4ujLLa6rq8mrbEJtpNMjSAOcbx5ouC2Bzg+XzgcDPABiUV6V8SB4PHgjwwnhGeOSWC4uYp2aAR3E3yQEvL8xI+bcFHTBIH3ST5rQAV9q/Ev/AJM2s/8AsC6T/wCh29fFVfavxL/5M2s/+wLpP/odvQB8VUUUUAFFFFABSikpyAswA6k4oA7TwrbG18M394QEkvGFpFL1Kg8tx6YGM+9WJYLiG2LIAszHEsigMGPbHpWhcagulWenabEwUw24eVHXJDPg4/752/nU4uPOt4Y7NVLFuQD8pwOmfX2oIhrqZYtY7iRfOVllHLyFsnp1yPp0qvqMFzc3sNq5W3ScBkyfm2ev41cvriCS3jgjintXQlWDDALeoPf6VhYuBdu1y5MjHc8wBLD8O1dOFhTcr1XZIcm+h6ZLqAXQodPghWe4hixFcO4XYR2IHJGP1ryu+urueWQTSSNKH5GeMfStezjvZFcwyp5Qz8zHke2O9EkMUcAkSKeaWTIkJA5A9MeldbnQw8LUpN9SXzTlzT3MxILiZhC5SMk7QM5OfTirbtbxG3NxG32hc+YyrkSHsB6/Wke0tILeQebLLM3zExjIz2zVpY5Jb6B0tZCPL25I+UAd19M1Kp1cZNe1uka063sU+UdA0rLPJGHFvjEkZ7A96yde0mO1WFoZoXQgnC8bfY+tdDqFlax6dJdwakiSMPmjA+Zz6e1Z2nC3d5I7osyS4RS45jPeufEYZ0W7vToU61OvZwVn1OS2BZFWRhtHXFNGCGBzgHjFdD4h0E2KJJCqsudpKNnPoaw8FRkJhcY+bj865SBh+eONVU7hnp3p8YJAII3BvmyOMe9OiZnh2EqcdyOR7CjaCnl7ctv54wCKAHKAsxAY+X1YAf0q088bnEW3G4DkHp6n1pUszMjSxBCOhHPGO2aW4g8iJWdwiOOVGOD7UAQ+TsgdkZjk8MG6/hWlodysGoWpuXAgJMMqdQEcFTntgZz+FZuAbdAVKndu3Y59qgYOYzGR8oOeBzQJq+gzUbZ7S8mglOZI3ZGP+0Dg/qKq1u+JUa5FnqXzYuoR5mf+eifI/wDIH/gVYVAJ3QV3WnWVt4KsYNX1uCO416dBLp2myrlYFP3bidf1SM9ep4wGNOsrbwVYwavrcEdxr06CXTtNlXKwKfu3E6/qkZ69TxgNx2oXt1qV9PeX88lxdTuZJZZGyzsepJrgbeMfLH+H1f8AN5Ly7vrsi/h9Q1C9utSvp7y/nkuLqdzJLLI2Wdj1JNVqKK7klFWWxIVb1Wwm0y/ltLl7Z5Y8bmtrmO4jOQDxJGzK3XsTg8HkGqlFMAooooA9W+BM3kyaxzjJg/m9SeCLny/CtimcY3/+jGqh8GUmZtWMKbgphLfMBj7/AKms7w5eeVolsm4DG7/0I1y4uPNC3mexkdSMMS2+36o+q/2S23eC/E7eviO6P/kOGiof2P23+APELf3vEFwf/IUNFdEdkeXV1qS9WVf21v8Aklmlf9hqL/0RPXxVX2r+2t/ySzSv+w1F/wCiJ6+KqozCiiigArsvhtpj3N9cXm4xpAoQPkcM3/1ga46vZvCekDSfC9mWkC3c4+0sgG7IYcA+hAxxQBf+yPGHM1w8h+o5qpdRJE485VMUn3WPVatuyyRhpcgL0KqSKgu44Z8eZJH5ijchbv7elAGGZ1t53YqjIp4bON31AqNy0xMoXCkEgK3IFU7qP7TdFoz5aA8jNdB9hMcaSITtkT6igDFI3hQokGOrHt9Kt26nYRvQN0yw5IpxRraQBIhKxHpyRU9oImi2zW7IAfvBjkfhQBn/AGTLcJGij+Idakdkj2hQ5HZmer5iKvuCyPGOjbccVIiwzu21EcN1XigClA6ylxKAXxjAOM/SobiP5iGUdOflwx9vetMW265RYiMJ/CRn9afOYVDI6jJ/hJ4B+tAHB3iFZSY0CJuxyelV54HurcKgWRsSMAc5PIHH/fP6Vr63brsLpLHuXsOapabKkcttJKxCeWWYr15lkHH5VEt4+v6M6aH8Or/h/wDbonKOpRirAgjgg02uh8SPZTXHmQTZJHQLjPtXP1ZzCUtJRQA5mZjknNJSUUAFLR2pKACiiigAooooAKKKt6hdQ3X2byLC2s/KhWJ/IaQ+cwzmRt7thj3C7V44UUAVKKKKACvtX4l/8mbWf/YF0n/0O3r4qr7V+Jf/ACZtZ/8AYF0n/wBDt6APiqiiigAooooAK2fCdql3rtqs3+oVt8h7BRyST24BrHrpdDT7HoF/eNnNyVs0A7huX/8AHR/49TUXJ2RM3ZBfX8d5q8125Y/aJWbIBBQk8D8BgfhXY6FajCtG+FjUsoAGFI6kD+YriIkQzAxFjnnBGcen0rvNKRvIkNuzSSuAzKG2vx1Izx+FDTi7MaVkVPELwXIWWFcscbVIwM+vpXL38txIVyj4Y7cKD0+tdfM73VtNJDaySWy5yxHSsdYJPIaSEFNuXc53bmpDILHzopUZ2MglTlkHQD1WtR7O6ltpILCTzFZNq5XAKk/MNx6e1ZGmXsy3SW9yPMhfoxAyh9M/yrq7O78u21C1jISdSCUfqc9ce9VGXK1LsHSxz0umuCpvV8m2QAFEcMWJ6ZA7VYvtPs47OWR5lt0Eg2qpZgQeg46Vp2tqkO4ysPs8vJTGJEPYmkknt4oZoDGki7Noib5gwJ/hNdEsVUnLmk/uJUUjl5dOie8i+zIZMJyYV+83UED0xV+yUOZBcxPcTZ2gFcEAf3gO9aumWbRlJYRujhYhI2G5hnryO/NZ/iPTY0c3duxMUZCSwsduWPQr/wDXp831pKjN28+p0Uqyw8/aU1fTqZ0gjkYBQTtcgljyw9D7Vk6tbHzZJVHD42AnIwK2tOg8wSRmVmXGM9efTPfFXZdPEsMgZ5ZHxje+CcDoK46yWHm4Slex6EcHLF01VpRtf+tjhFCjJPySg9OwFTIQ/wAu0MOm48Z9APepr+OS3u9jqEJGDgdaYZIhNxE5RO3oaad9Ty5RcW4vcW2k+zswjkwr/LtYED8/WnTneIkhTKxg7mIHPvTJwgIZC5Y9Pl6CoXOwBWl3xnqBwTQSSyOxk+Z5GfqFwMfWmyeYAflZc8gsadaKI5ibh3SNRzjHP40y9lEhPlA7SO55AoA0rNluvDt9DIpMlq4ukyeSrYR/12H8K2dPsrbwVYwavrcEdxr06CXTtNlXKwKeVuJ1/VIz16njAazoWnW3hRbK/wBbWJtcvdn2GwmGUgRiNtxcL6dCsZ64DHjAPFa3Ne3GrXkuqzST37ysZ5JG3Mz5IOT9a4G3jG4x/h9X/N5Ly7vrshpcvqQ6je3WpX097fzyXF1O5kllkbLOx6kmq1FFdySirLYQUUUUwCujurPwmstmLLWtalR7hFuDcaVHCI4T951K3EhZhxhcDPqO/OUUAehfGBvDElx4ck8Htbiz/s3Y0cUe1gVnmCtKckmQrjOeeAeAQB57RRQB2/w0cI9/kDrF/wCzVy9vc3scKrCxEYzjgetbvgOTy2vPcx/+zVW0q18zT4W2g5z/ADNdWEw8cRPkntYPaSp6xdj60/YvZm+GOrtJ9863MW+vkQUVJ+xuu34ca4vprs4/8gwUVzyVpNIL31If21v+SWaV/wBhqL/0RPXxVX2r+2t/ySzSv+w1F/6Inr4qqQCiiigC7o9m1/qdvbKM+Y4z7Dqf0r3W0hE9mgs8wzoMEHODXlnw8toXvLi4nnELKvlxe5PX9B+tew+BYNXudcistMsFvrhgXWN3UI6jk8sQBx70AZkiSC2ZLl0ZjyNrYI/CsXUJF37YUKtjBB5z9K9Q8W+BvFMiXN/N4cNlABukFtMkvA5yArFq46DwhqV54budfsbZJNMtmKSzGUcHj+EnP8Q6DvQBydjaRNIRM4T1DVt3T+TbRWpCbeqEE81kW0vlyFGePcT92QnH4VsGPftlh2ylBuKg8Ae3rQALAkZDSxSR4HOD29QagE0aPsWUS7zweQa0ZpnlgE8Mkgx1jBBqpDaedMBFZhn+9+9bH5UAOkdbUKHlKMRnjofbmo/3Er5tEj3t1QH5j9DVbVdGe+OJw5kXoI0OR7Z6VHounJBO0bh4gOpcZ/KgCSRZImYR4UjgxFgT+dTiRmtWLQqdvABI5/OrskMcFwrS+ZIrdN6bQfxqhqF2xcwBkZO+GHFAHNaqivtRI0DOwU5XAGTiue1bS7i1hhluMJFGojPzfeJZjwAfQ5rf1uNnVgrR47EZArL1XU1vfKMhZDGgH3eC/wDEf6VhU9p7SPLt1PVwjwiwdb21/aaKNno7vrp0tf8AAyb+3j+yo6+WMDqFOaxj1OK0tRuiyhA7N7nj9KzK3PKCiivSdG+B/wAQ9Z0mz1PTfD3nWV5Es8En223XejDKnBkBHB6EZoA82orptU8CeJtK8V2nhrUdJmttau5Ejt7eRlAlLttXa+dpBPGc496peLPDWreEtbm0jxDafZNRiVWeLzEkwGAI5QkdCO9AGNRRRQAUUUUAFFFFABRRW3c+LPEd1ow0i61/V5tJCJGLKS8kaAImNi+WW24G0YGOMD0oA0fGXgq48K6fpdxeXsUsl/DHOkSW86gK8auCJHQI+AwB2McHg1yddJrviuXVdCtNJi0+zsLOBxM4gaVjLIE2Bj5jtt+UdFwOenTHN0AFfavxL/5M2s/+wLpP/odvXxVX2r8S/wDkzaz/AOwLpP8A6Hb0AfFVFFFABRRRQBJBG00yRRjLuwUD3NdvrkUdnDpmkwKXe2hE0q453vhiCB3ChRWV4A0r+09ejMgBt7cebLn+6Ov6Z/Ku9mAk1SW+tba0aW6O/wA5uTg9snpxx+Fb4esqM+Zq5nJczsVdH8Pwas091p0a2Nmu0tFI5LJ/eIz29j0retoEtpStpb78H5bkfex9f6Uq2slrObfZA7NHvZUYj5D2Y96Zb2TgBFuDGLfloV6YPp6Gspy55OTNERRDzJJEM821t2+NMJg561DLpNpCga5C/Lyqp/EP9phxVi5WK3kmeBXESKuGLAlWPUP9ag1O2+wwHyo5RG/LuWyqk+g6ipAztajtG+zyWUMKuxCnyyTgdee1RxRiUQtJIgkL4ckDcfQkehrTRrOGE2cdoJZGwxZXLoM/xVn3OnG2hea5VZtx+UxucAf40AX2uEMgWOJnziPzV6DHqKluSlrI3nqqJtAjYRj5jnkjFVNGvljS+MLCTeAEjdCGLd+PT0NWre5mmsrSCO3eOSNCHc/NtHfI9fagChhppnQwgXW0MrxkqCPbHU/WhrKddO+YMLgsXck7gAOmQep9qim8tbjCfbZzEQGkPy4z0qzqjT3Jkj817MR43BPmOAM/MOu36HNVFXfYDAt4hdW8quY7dXIdLhV4jHUg49asaRbXAs5ArOOTsZ+FbP8AFjrVWeWXV3eQWoiklJaVID8oI77eoFa2mXtlbwO5kjlcsAkSSbtij3PU/wAq9DC0NZQqrm/rc6cVinThGWH0fr+Bz3imxuoo4bmRA4Q4ZkOccf41zMkuxGVAME+n9a9V8V3UMnh5ogEBmKooGBgk9a8t1OyOn3bwFlkx2zyK58TQjSS5VY8+hi6uLTqVVZlZpQ5AJ+uKRSFUjA+U/jUbEk+5pSCuCCoB49cVym5LHJhzjbz97d3rtLO0tvB1pDq+tQpca9cIJdO02YblhU8rcTqfzSM9fvHjALNPsrbwZZQatrUEdxr86CXTtNmG5YFP3bidT+aRnr1PGA3PXTanqF1cX99JJJcTMZJZpWyzk9Se9cDbxj5Y/wAPq/5vJeXd9dkV8PqUNRvbnUb6e8vriS4u52MkssjZZmPUk1oeJh9oltdSHS+hEjnGP3q/K/6jP41ntHGN3JLD7uBkNWjb/wCleFrqI/6yymWZf9x/lYfTIQ/jXckopJbEPuYdFKaSmMKKKKACreqXUN7fy3FtYW2nxPjbbWzSNGmABwZHducZ5Y8k4wMCqlSQRmaaOJSAzsFGemSaAI6K6n4g+Dp/BWsjTLy8jubkbt4S3niC4OODKi7wccMuVPrXLUAdD4Sk8trn3Kf1rf8ADFp5mhWr467v/QzXK6C+wze+3+teg+CoA/hexbA5D/8Aoxq7sBNQqtvsc+KqqlDmZ9E/shLs8BeIl9PEFyP/ACFDRUn7JQ2+CvE49PEd0P8AyHDRXHPWTN4u6TKH7a3/ACSzSv8AsNRf+iJ6+Kq+1f21v+SWaV/2Gov/AERPXxVUjClpK0vDuntqmtWloq7g7jcP9kcn9AaAOq8KaqmnWa6dqWnSGIkyFwdj89x+GK9v/Z9uVPxJs47O6lnsnt5SFlXlTt6Zrz3V7a0ljL3cDQuB8pJ5X6GpfCHiS/8ACGpJrOhGyubiFHQJdAlSGGDkKQf1oA9Z8M3Hh34XeNvH/ijX/FuhzSXt7dsmm6ffGa4O6besckPG2RSGXocFjlgKwNFuLm7/AGRPF1zdp5bTXTyIn91DLDtH0x09sV439qkv9c1TVNWsbCe81G8lvJNiHEbSNuIXdyACTjk/WvVtA8Y65YeD5NC0nTPDeo21xN5s0OrwvLG4IHG0MAeVXqKAOSXToZ9OWR0iyFBBP0pNMZ4JArIip/eGCK29b13xHrC28eo6J4P06ziYmT+y7WWJ2GOh5IOKzhbRFRtyY88GM5A+qmgCU3EaSOibZAe8f+Bp8iMUDlZdvqYzx+IqawscyMpi3bvukNitEW8bWrpFMTKn8DMefyoAg02dclQyS7eVK5OPrWdfyZ1FWjRiSfmMbYFMQ3trI5RFEZ+8MGptPEV5dKiOpcH7uMUAXpCssDRx7yjj5g4zsrn5oIoZyEXeAMLhsAV0lzEIQTNchQP4ABkfjmsKeeO5lCou/b/EQOBQBzWsyuI2VgMdzjmuRmhWaXLXLyeoY4xXXa7cwpMYkmG7sGGa5y8hUAs9xA4xkqBzQBzuoRiOUgAf99ZNVKsXSqrnaAB7VXoAK+t/Hkvg+D4JfC2XxwPEBgjtIGtxo5iDFxChO8uRgY/ukGvkivW7X46awnhrSND1Dwx4Q1ay0qBILb+0tPedlCqFDcyY3EDkgCgD1/4uQ3mpfGT4S+KI7uKbQtSubUWUQiMckQLxud+Sd24ODnjGMY7nyb9rH/ktur/9cLf/ANFLWB4i+LfibxB4w0TxDqLWbS6NMs1jZxxFLaEqwbaFB3EHaActnAAzW/q3x41DWb57zV/A/gG/vHADT3WkNLIwAwAWaQk4FAHj1FS3Mvn3Es3lxx+Y5bZGMKuTnAHYVFQAtJRRQAUUUUAFW9QsJrD7N572zfaIVuE8i5jmwrZwG2Mdjcco2GHcCqlFABRRRQAV9q/Ev/kzaz/7Auk/+h29fFVfavxL/wCTNrP/ALAuk/8AodvQB8VUUUUAFLSVLbxNPNHEgyzsFH40AekeAPslj4Tv5bhZRc3j+RGyDBAI5H0wD/31WsllJHLa266fA5ds/u5NrHHf6Vh6jsMml6bPMbOOzgDcL8xkfB2k9AduwZNbJgntZYbiG8Ayn+qbGQD1GAcg/StZ0nBJvqRDW8jamltNNZp2mY3cg5iI3KmOmD6Vny6gHLR2F0d8jb5EkGMnuM0XBNtdQWoic28q/LFvDEgcnDelPj+zWl4l2bWR4mbAYRkFPfPSsizQNnb3CJvMtu4ALh0I3/U9DWHdXKJcyLO7z2g/5ZPlSo6ceore1G7WO4ImjlaKUZR2G3B9MVzXiG7iIAhnBC9i5BAPUEYoAx7y7htb1WtGlUpgbYgTkf1rfZbm4BZ1n88D5kGCpU9SQK4GJ5HuDHZFt2SxkR8EAAkgZIHSuttJXIsZIriWcxhSzgn5h6fWuirQdOEZPqK92WpLn7FPtRGL8KUGBx0HPX8asTT3DREMhIjYAvE/z5PHHrj1qSW6txqMsrxqxlGMkZ247balCxoJRNbM0L8tOBtIzxxjpXOhnK3919qijtLd3aOORhNOTt83nAGPQHvUGtWdxosoSWYL5i+YWRt27tkmtePR7ixnji0e2nuowBifYvU+2ePqap3YuJde09bzdPNFJiWPGRGg756Y569q92mqShaFnG3zMrtO4eH9XgsZpS9o1rcMpDTLFv685KHnmo9VkiurgrBevqm4GTCW/l+Rn+E/57Vf1bTrgat9tCvNZ3DIjSRgOYgMD5getWbK2t9OeeS4E960+HcQ24VXC/3VFYe2pUrVKfxPoOzejOR3SyyKs6P5kRIRSMAen41V122llCykMT0AOM/pXT6ncjW5o4tP03yRuxib7wHrx0q7Po0GnJALoC4eViPNRjuGBnoeAPpXFzKvX5KkrSfQ6vq9VUPaxj7q6nmsVpPJcw26xs00rBI0A5ZicAfnXvni/wCFK/DrS4/EtnYNq89taRDyWAaG3uQv7y4kBOWUEAqgBGSd3AwfNbmSXQNds9b0a1iaa0fzUE48wBx91sDHIOCPcDr0rE8U+KfEHiqc3PiDVri9ZTlUd8In+6gwq/gK8jNsuxrxNONOajSXxb3lfppa229+pnSnHlu1qZOoXtzqGoT3l9O9zdzOZJZpG3M7HqSana7aRAYxIzqOWJ6fgKz1GTjt61KkpjZkjdkQ9cV2pKKstiRryFmJPBJzjFaXhiVF1ZLeY7YLxGtZD6BxgH8DtP4VlybS3BJpgJByOtMGSTxPBNJDKpSSNirKexHBFRVteJgJrqDUFA230KztgceZ92T/AMeBP41i0AgooooAK3tV8X+Itaihh13XNU1a1ilEwt768lmj3DIztZuuCRkc4JrBq3qthNpl/LaXL2zyx43NbXMdxGcgHiSNmVuvYnB4PINAGt4s8UTeIlsojZW1jaWauIre3eVwGdtzsWld2OT2zgY4HXPPUVJbwvcXEUMQXzJGCLuYKMk4GSeB9TQBNZSeXv8AfFevfD+EP4P05sDkSdv+mjVxNv8ADjxJPerbW0FlN5kSSxTRahA0M25zGqpIH2M5dWQKCTkHit/4da/qU8Nr4d0jw9LqF7AkrttuRHhQzOxbK4UDOOT+pxWlOfI7nmZtQrV6CjQV3f8AzPpb9lAY8IeKh6eJbv8A9Fw0VX/ZAu/7Q8A+IbwR+WLjxBcTbN27buihOM9+tFQ9WehTTUEnvYq/trf8ks0r/sNRf+iJ6+Kq+1f21v8Aklmlf9hqL/0RPXxVSLCvSvg7YpHcXWrXllJcWo/0ZXUfcY4JP5Y/OvNa+gvCGh3Gn+FbC3jMgcR+dMI/mwz/ADfMv0wOPSgDWlGlBtitKwPIjk+6fbHauZ8RabZbPMs7GSBj1KklWro9QtZpbYieNUlUcblA3fTNZNtNPCCkjSNGeCmckfSgDlrCwNwwW2ZnfPKbeRXVaVZskLLck/L1XZzUds0VveGSNXdu5I2sKvLcRSK7RYL9wc7vyoAZFHNDKxt4pGyOjDfxVuPTRNFuZ4opT3iO0/ipqp5ZvU2Lc7SvO1V+YVXt5pbR2UkzL33KTj65oAfe6jPpS+XdKJYOzYwR71CmpRZEqXK46hUbH6Vj+KLkyxjFr5Q/vRsSp/wrkluvsu4yjKHo27laAPSpJZtRTNuYzjqXfJ/LFVGsb6WQFZIYmHGVXGfqK4KDX5bW4VreTcB1wxBNdjpnitJIla4iZB+LH86AC/s7uIZcl8feMZz/ADrKvrvbCQEVCo/h6n61uahI11C1zZGZFPUnofwrl9YiuxCJWMar9eTQByV/eSLcNKJCCeOuaitS0qs0iFlI67s/pTpN01yv7hyuepHFdA7xR2ikRxI4H3gOaAOOu8+Z9zYO3GKr1papLuZsqjE/xE5IrNoAKXHFJRQAUUUUAFFWFtmK7iUA9zzTJQFACsG9cCgCKiiigAooooAK27m28OLoyy2uq6vJq2xCbaTTI0gDnG8eaLgtgc4Pl84HAzxiUUAepfFmLw+ugaKfD0tpHChCwwwvbSNLGYlLTOY1EqNuGCsxJznGACK8tors/DHgDUNZ1a40y6k/s68htItQ2TRM+62YKxcbc8hHVguMnlfvYBAOMr7V+Jf/ACZtZ/8AYF0n/wBDt6+LZAgkcRMzRgnazLgkdiRk4/M19pfEv/kzaz/7Auk/+h29AHxVRRRQAV0XgTTTqfiO1jPESNvkbONqjkn8ga56vQfCNlLa+F7y7ihYz3OIUdTyAeW/8dX/AMeoJm9DM1S7kvL69ku4yk8krl06454H4DArrbL7Dpuk2dzb6jFfoQBIAm0o/wDMY6VZstLsdaghuL+HzAV2ZhHlyAjuT/FVe80Cx0+XyLCY+XIhZmyeg7fWu7E4qNanGKVmhQhyu3QmgnikmiadxbxsSd0g+VSewPar1xMLWKCK1u4THu3Rh2Dox747jNcjam1W78i9vdtvtySIy4z6EHp9ahuI3jmjSNoWgz8jqMr/APWrz1K50VaXJqndHYyyyahMDdE2yRNuMbttJ91Pp7Vj+I721g0yZrJlkH3T5nJbPGCeprJvtXSOSKKaUrgZLj5iPp6VSvXm1mWNY28xVOQ4xvx0ziuilFcyc9jFmJ5SNCBtYv0GByTXodrOz+Gba0lX94seDcQR4wOwOO4HGai8K6JBaFri/t5bmXGElTI2fQdj71ry3Nm80qW1uy+SofYGyFHqwFdeOxUa1ow2RMI23KtqkAs0leORposeWZGPzj04rR0CdpJ7mNzMkQIIRxnBPUVRkW3chnjF0nLK2wx7B9B1HvRCZbTZFFIoEh3bwrjA+prziyzqN9NZSH7HPFI6gp5yIU8sn1HQkVltHZXdpFbDyZxC2+RnUs0rHqWI6/Sn6g4uj5UwaNSNo+bO71yferOi6EdOKMrujyn/AFcADhR6sewqoylHZhYclylyfMmPlSA4ghTKqccZqndSTWVuW1BczIC29W6L3JHatiZYrTUkaKYS7BmUMm4DPQ9OKhuboTpLNbMDEx25jCnd65B5pLfUDBsJ4Hu45LB1eO6y3mSZUqw4I55rTvYp7gRBHhHltvEhzgeoPGMVW0uGJLy5LLHK8bbU4x+IFbdyJG06ZZgscGMlWTIOPUV5dWryYjmhpqfbYKk54FRqa3X9I8/8T306QeU97C8L9DboRu/E1xhGWx2rZ8QalJe3TI8hkWM4B2BR+QrGPTI7+9e1Xq+0as2/U+LmkpNJW9AxkHHAHvQgbt370L1FSI6BzuGRjj2rAkjcFeD0oIwoyOveggkEgHbTc8UAbK/6Z4Vdesmnz7x/1zkwD+TKv/fVYtbHhd1OqfZJWxFeo1qxxnBb7p/Btp/CsuWNopHjkUq6EqynqCOtAkR0UUUDCiiuna18Ix3un/ZtX1i6ia6jW6W60yO2VYM/OwZLiQlvbb3PPGCAcxWtpWtSWVpJYSwwT6bcSo9zH5EXnOqsCVSZkZ484x8p/A12Hxpj0oaxYvo72SIY3T7LaPaypDGHPlkSW6qG3A5AfLgfeJyKg8AeK9M0PQb2zvJLu1uJLgTM9tZxXH2uIIV8hy7KUXJzkZ6njIFAG/Y/F63stVFxFpV+0cVvBAkzXyC5lEUjyBZnEWx4zvClQgOETnI5yPDHja48A6qjW+hRxxXkUNxeW11tYyZ3OjRErmOMq6EKd3QHPQjfuPiBoficzaRq7SW1he+ZE072sSiDN8kkb5XkbIBIvHc4AOSaoX3xB0fVPDHiu2vobhLzUruSa0jhtVGyPCLCjy+ZyiKmNvlkjswycAH0B+xc/mfDDV3IVS2tzHCjAH7iDoKKb+xT/wAks1X/ALDUv/oiCigA/bW/5JZpX/Yai/8ARE9fFVfav7a3/JLNK/7DUX/oieviqgDb8GaZ/a3iawtXBMRkDy4HRF5P6DH419GS6lCZ/NZ5opPaPacf1rx/4SWUZe9u5H2SMBDH8ueOrf8AsteizwXBHyl3K8gZoA6KS++124imfzIv4Tjr+BrmZIlLSKjFHBym3kfjVuCWYBW8i5b18sjI+oNSyrHKAG3JKehc8fjQBQksru4Xzrd1WVR8yIwz+RqhI3l4W4UE+rcc+xHStN44PNB2xxzr1xJjdTbuINaviAMvXO+gDDkd1lyrNGv95SSf0qykt7GgWMNJGecvkH/69M0+YCTy2k8pP97n6V0Vu8TFfnVo1HKkYNAHMazKY7H95AmWHQnH6V59esXZ08sLn26V6r4htYLpd0oTy1HBRORXFW9sn2plMQaMngk8GgDkI9MvZ5CI5owB3YYrS0yLVbOQCWJ3Ts6civZ9MS2tdLj+y2ttC56l4w/41UuJY1+W/dZVJ48tAo/A0AcxZXEk0Cm5jdgOvIFVNRgsLhmeQliP4SuMV1My2ccDNbBnDdmHSufvYtPkz5kWxh94q5zQBhtFpKoRbrcm5PQ4+UVmXUGWK8KfU4FaV/J4fglBMlzN67s1WvdQ0GS3K29pKGx1JOaAOQ1WEQy4Mwlb2XGKz6u38lqzEW0brz1Y1Tx70AJRRSigAoHXjrRip7aN3cBEyc/e9KAJVhnkUMyME/vMOKbLCoGMlnPZRwK2Xs5HiV7u4DYHyqTx+QqIWzRhmzx78UAYboUOGGDTKtXmN2Bn3qrQAUUUUAFW9Quobr7N5FhbWflQrE/kNIfOYZzI292wx7hdq8cKKqUUAXtDiE2t6fEbR70PcRr9lR9jT5YDYGwcFumcHGa9h/aE8T6/N4g0a8l0m78OzvYWhMsLPAJ2WGGcLtIBzDLK65zxgDgqa841rwymkeH9O1yy12yvormdoUW3SeKRHRVZiPMRchdyglc8kVb+Kfj3UPiHr1rqepLsa3sobVUByNyr87f8Ccu3sCBzigDj5HaWR5JGLO5LMxOSSepr7S+Jf/Jm1n/2BdJ/9Dt6+Kq+1fiX/wAmbWf/AGBdJ/8AQ7egD4qooooAmtYGuLmKGMEtIwUfjXsNrbRmPT9O3eRHFGHdnflWfBwQOuFCD2rgPh3YpfeIoRI4VU557+v/AI7uNeuaDaXzXNzqVr9neSdzJ5bqCpBPHXvjA/Cgh6yS7Ed3avDaxxJLHPAp3fu8KzY9+KrSyQXymO3DWUsuCFIzyPf3rq577T/7IeK4sY3ukBdp4zgKe+R2rn5tTstUt4VuVj+X7jBeePp1FBZ59q9jcLqLm4UmVRhtnTGeKks9QXSbKSG9shPBJlwCcEn0PpWzNHDJeTRwyAs/G9snd7D0rPv9GSxBlimFxIw/1EyFD+fQ0kkpcxq6zdP2ZzFtKL4uTa7mJ4YHaAewxjmu30DSLaOwV5GlEsRJK/dA/wARWBAkzWxNrtjMbZZMHn29q6HRZxDYx/aY2EpJIZMkg/1rarUU3eKsjFI6TQ7aHUEmMU89ng9eqt74NQSQ29hfzCQCZZQFaSKPr/vc8VnQ3TT3fmTF3QjClV2yfUY4/A1qRm6S4DRo6PjJ6Mx9j6VkMLg7kVCpS3TgOCCSPQ96rtfSQNNEqzCHaMqke8H39qlvbyd4I5J2aSaM8w+VgL757ioZ9QN3KqwO1tIyje6DnH070AQ7bCSN5r5kYsuEgjHLAetXtO1eysLG4msWEZiA3pBKGYZ6fKe9ZJsQWkS0SW4YMPOVVChQe+e2azNBFvaavcskSxXQcs8V2VOwn0I4xj8a6cNQ9s35EylY3JdVDTNc6hczWcTDaklyoVpT6DttHrVG703bL562/lHacMpDhs9+OOayrm6OpaxdXGoEzwWqAJt5QOT90/hziuht4L+7tYjYxYQAbXkOUI9geTWeMVPDu0nY3w9CpiHamrnLpNHa36ifzpsD5TnlPXgdqk8QapKdPdbOdsEcBxyfzrd1LQJ4la6lm/fONp+TCD2ArmrnToIIZ/7Vn8+XG7ZGM7Qen0rzIOlXqc1z6mNPEYbC+yfXrtY4DDF2PO7qSTTXOWJOOfSpbrBuZNgbbnjf1x701YvlJdgo7ZruPkmrOxGCVPGPrSfWl6HsaSgQpYsACelJ2opKAHKxVgykhgcgjtWx4pUPqMd6gCpfQrc4HQMeHH/fQasWts/6Z4VUjmTT58f9spP8GH/j1AmYlFFFAwooq3ql1De38txbWFtp8T4221s0jRpgAcGR3bnGeWPJOMDAoAq0Vq+FrfTLvxDYW+v3kllpckoW4uI03Mi+uP68464PSrXj60sbHxprVrpIjGnw3Tpb+XJ5i+WD8uG78Y570E83vcpz9FFFBR9q/sU/8ks1X/sNS/8AoiCij9in/klmq/8AYal/9EQUUAH7a3/JLNK/7DUX/oieviuvtT9tb/klmlf9hqL/ANET18b6RbtcXyKEZwnzsB6CgD0fwm76daWtsuEkQbmLD+I8nNej2DyXJR2kiiOOVIOfqK8ehv7h7g7wQSema9G8JX8wjGItwAwfmORQB096zWEe8SkSHkPt/wAODWBNdyXEhD3KNI/YcfmKn1syMhZ32jrtOQP8KwoZxMwjaVAM47E/nQBZmZoTturYsB0dOcfhV2K8ee0MYZWTs2OR9RU48lYli2mQ/wAMjdj9RVOeFHDiaRYWHdjj8sdaAMtllW4xKELg/LkcNW5p88ix/vd0ZPGxlGPzqlLbD7MCkn2xT1AccfQ0mmlVkAkEqx+j84oA0z57SlVEYLf3ycfoKfZaCsszGVUjY84QjDVctbra/l+crIRwFPIrRZHKLhyT6MePwNAFSFLSGJoL5owg4UNj+dc/e2Fmpc2t4gUn7gXcK2b6I3EhjYxoB1Hl8n8ao3dj9ktyYrVhzy8bg/mKAOZuIBGpDyLjt8xFYF2ru5WJov8AvrNaetT5Vg4J92JFcdqEsajC7lY90JoAWdU87MoLEHrnip52tGh+WPcCOR1NYBlkmfy/PX/gZAH51M9rJCuWlhP+5IKAIr6KBASsKoPdv6VknrxVu8m3AIOfU7s0yC1MmCSAPrQBXpy8HkZ+hqzJFFHnO8kflSRRNKfkQbR68UAQvliAqY/Dk1t6VYytGrKVRO5cZ/8ArVZ0TR/tDLLheDwGauwGl2gjBu5FJA+6oJA/CgDnna3tx8jiaXH8Iyf8BWbPvZwZIwgPYH+ZNdDqE9kieVYW82f4nYAViqpmZiThR3agDBvgDJtJUqOmz/GqZX2x9a1NQt1Q7klZ29AvT/CsuQktyc0AMooooAK27nxZ4jutGGkXWv6vNpIRIxZSXkjQBExsXyy23A2jAxxgelYlW9QsJrD7N572zfaIVuE8i5jmwrZwG2Mdjcco2GHcCgCzrWszarDpsLxxQ2+n2q2sMUQIUAEsznJ+8zMzE+p9ABWXRRQAV9q/Ev8A5M2s/wDsC6T/AOh29fFVfavxL/5M2s/+wLpP/odvQB8VUUVLawtPcRxL1dgKAO88GwxWvh26nkCLJMfIVznIL9cfRFP/AH1Xonh+W8S3TzJFism+UOp3BvrkV5f4jL21tpumj5PLT7S46EPJjA/BAn5113w61u8mtxZ3dwfKjbMKpGTI+Ou44wy/rXXLCSjRVYzhK7Z0kdrZBrmO41SLKsSI9gz+Rqm4RYBZx2/kFifLmI8tT/hV28je+uZUbT4bm4Ax5nllTH6E1QmKDy7dYZJLmHG9GIdfrz0rkNClaafMusqsl2sbOmDvfekhHbip9cRUcQyIyBFziN8xsfYnofao783UDoVSBI2b7oX5j+VR32+N1eJjGGIDuj7mT8+1AHNTyfYLpWXMcTHds3ZDe2PWtvRGF1dvJsiErDKQSZKD3yKp3MFol06amTP5gyJgcfpV/R4biGdII5UwRmL5QRtoAvFzH5rXloIwGyXtxnB9eOahW9lN5Ip+dEA2TBijge5707VE+zsr3czCVG3YgUjqOMmnwWXnaf5l3tYuMJ5jbc+5x1NAHOa7rN2rlZ7mQhT8hxgkehIrNtNSuIrtD9oGyQ4VSSTz1qxf6MLeOYXU8ac4CyZJb3Ge1cttLSeWrBkQ8HsP60Aem2d07vsRX3EfvFU/e+ozVZf7KTU/ObSWF9CdzeWcRsfdehNZnhVrKSPF1bXMiLyrk4De+a6cwxXEH2i1MjIOkZwFH59aqM5R+F2C1zk9eKWkjXUKCMzN8tk8IHHcgjt359a3/BF3dQWd7PMTFHEN2JAWwntWLrEjy3azzyJGhPlhRzgdyau6fdwz272llcfKq7X2rwRUY3Ee1oeynG/me3k+Haqe1hNJ9i7qHiOymuQZnuCrdCw+QfhmrWjQW0tpNMPKit2G4nYPn/GuXl8OzKHit0QwsQVLMdy/gOtZdzJqkUbCWS4W0jO3BLKrY9iOntWf1ChWivqk9bao9B5jiMPdYunpfRow/FE0E+sztagCMHGQetZRXjI5GKkuZBNOzLGqAn7q1GT8uK0iuVWPmK0/aVJT7sQKcZxxSdaXnpz9KQ8HmmZhSUtBoAStnwwyyag9jKVEd9E1tlhkBjyh/BwtY1Pjdo5FeNirqQQR1BFAMR1KMVYEMDgg9jTa2fFSKdWa6jGIr1Ful/4GMt+Tbh+FY1AIKkgRZJo0eRYkZgDIwJCj1OATgewJqOtvW/FniPXrRLXXNf1fUrZHEixXl7JMgcAgMFZiM4JGfc0AWPFvhpPD8OlzQ6vZ6lBqELTxNbpLGQgYrkrKitgkNg4wdprna0/Emsza9q0l9PHFCCiRRQQgiOGNFCoigk8BQB+vesugAooooA+1f2Kf+SWar/2Gpf8A0RBRR+xT/wAks1X/ALDUv/oiCigA/bV/5JZpX/Yai/8ARE9fNfw10YXNneXjTGKRnEMeOuByx/lX0p+2rz8LNKA6/wBtRf8AoievFPDGhQ2ul20bXDQyKgLjqrMeT9OuPwoAnm8JXUQEk0SXcLch0IDVu6XaRada7oZplGO7htp9COoqxaXSW0RtzOHBH8a4P4GqV/CxVpUuInYdsYYf40ARzut0Srb3J+orFubcxBgu+J/7jdD+lbVnEJYiXuDbs3GSCVb61TeFHmMUzsWH9xzg/TNAGdYardWrgM+VH8Lc/wAqvX2tfaYP39nFKOzhulVr/SnhUSIuYz/EGII/Cq4spNuY0E47gDB/+vQBatr2HaoS2ihY/wAQarZnkjcMshcHs64/UVnmyhSIMI8DuAf6Vas5PkBt2GwcEBgf0zQBoNcTCMvc2UPlH+MEk/WrNlcLIERZISp6EMcirVvNNb24lWdDGRyqMCfyNZ8tzbTM0tuDn+IYC/pQBuTwTQRhpLljnkfvMrVHUrxzaEQQQqR1cyYP5Vjzsk20MptsnGSSQfyp15Jaw2ptxBvnPR1lJB/PpQBymsXoeRhcyibtsOf51zV40bqeWUenJrbvE2TMkjMCe5GcfjWde6NGYvM87n3Lc0AYUUNq0oQrK2T/AHaXUYbaPCxwFT/eK4q5BaShgyMPlPrUeoC4ZhuiZx67SRQBkmBpMbV2j2qxDZvtGxMn15qSOFessb5/2crV2O3mChkcovozFjQBSktWxhlUH86taXbZmAMrHHYDirVtbG5bYZ1J9CuM10mk2aWbAzRQkf73JoAt6f5UcKq2xIx95pI9g/Ok1O6+0OI7FY/JXvGh5/E1srcWkcTSJp6M+OGYFwP6VkyXkbS5cKzf3Adv6CgDEuxPcARFPLXvgcmoHslhXLO30Faeo3m/g24hX03Y/Ss2fLxfKRGvtxQBhamkaglpM+z9vwrGnWIJ8pLOe/QVvyxW2DlCzf32zWXcyxRkokZ+p5oAzKSnOxZiTSdRQAlFFbdzbeHF0ZZbXVdXk1bYhNtJpkaQBzjePNFwWwOcHy+cDgZ4AMSivVfix/YP/CKaCukf2SJo2VVa08gvNF5KZc+X86r5gc7Z8ybmPPBryqgAr7V+Jf8AyZtZ/wDYF0n/ANDt6+Kq+1fiX/yZtZ/9gXSf/Q7egD4qrqfh9p0d9rQ+0MyRgbQwHQnqfwUMa5avVPAdqLfwrcGQNEbj5BKBwWftnsQi/wDj1BM3ZaD9ZHh6S/NzevezXV4xPk2+COeFOD0IGBjvitDwQ99b3V5DFpl1DAu0KgkEe1ufnCv1J74OK4/xEluNTcSXJExUAkjK47Zx0rs/BniiYabDp0mq2UkykLE0qOSE9Dzk+gr05NrDrrfv+hKVmdfp0501bqe8fffXAG95kVd2B2A6D2rnbtPtKTTG6to5GPyyQsS+O4xWnqOtpJIoUn7TCcNIse+M/n2rHa2kuLi5up4n+X+KKJSXHbgfzrzDQ0LW00uKzaYSSRygcmUnP1APWst7WGSB5/tkbREdQpBYe9XhLeJZsBJDLHj/AI92Xay/nyDWdbahG7tvVlyNhaI8r7MOlAFSGeGVlWC3Mqrw27HFadvZsold/s0W47lY7gRVVfsttCwsmWR8fec7fyxT4pFcoLqKSe3PA8t96591oAsQyRS38KveRO45AJL5/E1au71orkSwQRtHnacsfL56n0BrNNwRcJFYacssUZyVVACv09K05dW0tIiGV7a5I+ZUG7P1A4NAGHcSpeJNAXMk7N8kWfkA9s1Tfw1DaP8AaJl82NlAxG4JB98VvyafeXm24YWL2a/MIwQrE9s+la1vqkyWvkwWmmq54VsgYP8AWgDko7COCZYpRdRo3+rRWVlH1IPH41oxac090YoJ28qEfNGZQAD/ADq9Le3Omki/jtJY3GX8kL19h1rMvre3dTNLvt1+8I/LJyPrQBja9pVx5hlg1CHylOWiaTawP+9jn6Vn6I2mWVzI+oSFpByojfcHP44xV6KTRnaV7x5tqHjykO79Ky7iLSy8lzYq7AkKPMPI96udW9P2bWhrQlOFRODszv8ASfE9o2F3CH+6SuDj3qh8QvFtm2kNbLILhz0A5wfrWHaaQtxBuCoOM7mPNZuvafYwWTedJJLP/CAQteLTo0va3Vz7DFTrrD3aW27OEHLdvxpxGwgZ/EVO1nKE3MmB2yagKgLlgQfYV658UGxjnjv360jKOcHmr9pbNJAXSFHHqTzUBEfmYAXj+8/FAFUDr1z9KkWNim9gQg71p6fpd3OWeK13r2djhRUNxY3Su0bKDjkleQKAM75Rngn0pCMGnOuzI6849qaKANqX/TPC0TgEyafMY2wP+WcmSv5MG/76rErZ8MFZbyawkxsvoWgGTwH+8h/76VR+NZDAqSCMEcUCQ2req2E2mX8tpcvbPLHjc1tcx3EZyAeJI2ZW69icHg8g1UooGFFFFABRRRQB9q/sU/8AJLNV/wCw1L/6Igoo/Yp/5JZqv/Yal/8AREFFAG3+1DYDU/Cfhy1LFQdbjfIxn5La4bv/ALteH3ULwRD7TIXJ6sV2nP1HBr1v9sm6msvhro9xayNFMmtRbXXqM284P6GvlrRvH13b/u9TjN1F6o21h+HINAHo9tcgDy2dSh6EkEinywTyMo3pMmflcfI6/Xsa5a08V6LfkBpvsrk/dmXA/MZH8q6jTZY/LJjzImPvxMJFI/CgDRgeSECL9yGP8Mh4P51kapBlz5i7Cf7h3Afh1FWbf52J4dc9Gzio7mIuwIzge/T6UAZyF0Hl+c2D23HH5Gp4Ha3lBjO0eoO6rgkVl8reXYdAEyRTMlyF8pM/7WVagCcW0d22Y5YxKf7w4NQx6LLHc7o2i8zqQAQD+NOit2inDrIq46q5I/8A11rTNF5AMxbpwY8kCgCOdrYWnk3KeVKvcrkn8e9YsclusxEcfHTcj7Sfwqzd30yR/I0E6Y4DLhh+VY7Xe9yZ0CntkEYoA2FklsJBcRQ3JPZiokH5Vg6tqQ1Cc+fC+71VNpp0+qzhfKhuC3bawOKpRh3JJZmY9ecfzoAydQwrFY96gf3m5rMlN4+Nss0iDohcVqX8RMhDl8+m4GqLW00ZDxoyj1//AFUAKgkjjBdHib/aOc/hRK9wyfvBlPTlf608RySN++ldh6hulV7xLSMcXE5f0wP50AZ9xvLEE4X0q7Y26OQJpCo9gTWe+5pNqsCOxc5NaFmqxsDKWb2A4oA6rSNP04OpnlkC92Axj866WafwnbW+0W0l5Mf70mT+QrkLcxeWGIBH90tV+0dQ4KvDGB2wKANG6vg9uRbaV9lgP8bt/IVhSyhAdkQDH+NmA/lVzVbyaZcOEMa9CGwKxjJ5gC7QD2CigB8oaRc4JA6sWGKqPcWqIfNlxj+4wGafcxNEMFAzHoGOazJbeSVsLHEreoGf1NAFC9McrmSNnI9yTWVM4wdoP1NbdzYzopY7n+rVnTRiNN0oz6YFAGbS08kM5J+UfTNNbGflzj3oAbRRVvULqG6+zeRYW1n5UKxP5DSHzmGcyNvdsMe4XavHCigCpRRRQAV9q/Ev/kzaz/7Auk/+h29fFVfavxL/AOTNrP8A7Auk/wDodvQB8ZWFv9qvYYM4DuAT6Dufyr1DW9bl0NdMttMaKK0aMySxMgbDOAVyPUIF/OuL8GWUk11NcRFMwrgK65354IHvjNd1daBHrN/NextLaXUx3MXQTQg+nGGUdsc4rowrpqonU2Mql9Dl9XguLqd7+UwETgE+SBg8dSAcjPvWl4TsBcrJJJi5kjAaGOJg0lswPVlI6fTNdTY6Lq+mNbQta2FzaoxH2zTiDcRqeuUbBZc9VIPFbtvqVgtzNaW1nJZTWe0rN5Pk+aD12qcEgHqPyruxOJUqfJFaChZu9zP1acv9kiuZneUfMqmNY1JHUN/hUMd6XuoXtc74jgiNwu3256/StzW5P7TtsXwt9gGVl2Bj9ecEVhR6QkdssrOJJT0TB2n8BXkmxq+ItYa5t4pL6G1Zo8YZsK349jWba3VukReG1iQyHDbGBXPuO1YmtLO0W02TxBeflfcDWM13Hbyf61w7j7qp0oA6W4tZWYIxitcvuRQMq3tx0rShe7trV5ZI7cqePLVev4iuT0u7d3IkeVioLDLEZFbFrqnmoZI3MijgxuGBU/UUASW969rcjzwYln6Ki/c9vSpoYIhdzq8ckavjy2K7cn6CrNgkl0mb6SRIG6bYg/5mp7aNYJikrPPGDmNlXBT325oApRGaCRoYoR5jnGLlcFvxPSlmt/JthbAxwhWy8RjD4J/2vStGWW4mla4cx3kCjbiWPaazrtyZNyqIvPXmOMFQO2CTxQAzyYpbksNscoTAABKH/wCvWVeXl19zzv8ARh9/CkOnsQegrbuNLMdrFNdsCgUAAKxI/EdPwrB1G7W33+VGs8jnarOPlU++eTUz2Zvhm1VjZX8hG061uLdmtZJRuHLLytZOm6XaySTR3EspSNsLt7mr1lavHblJrmUK3OyM4FUILWKO8maeSOONCNvmt1+gHU1y4bmlPlvc+gzajCFBVIwUWWF1K9tY3t1aFjF8u7AP5VgX8b3rPNOx+Xq7AMfwFbZtbq5dntwIYzxgAKre+OtRQLaWTgX97JOpOGSJASr59c9PXNejTy6cIupseTjMw9vCNO7bX3HPxWald8UYdV6BtxzVOUSu7rkIoPOR0rs5Dp0rSfLM46IUBbI/Oq8em3NwHEduEtxyCeGP1rI845B4ZYYAASIm/WtbQtJiuGRmUsVOTtXn/wCtW3b6XcNOrPMgVf4EjLECtZILl3WO0QRRH77NGQT+XSgCliO3vPKlysIAOC4yfqKyfEd8mBFGWjQ/wxqMtW9qtmtpbs8WXlHP7uLb+prkZ7OSS6852V8/3zyaAMFowzEgERg8nOaSRUYkw7gBxzWjf25yQTHEM8Ad6da6JfXCZtrWZoSNxmbCp/302F/WgLmVbyvb3EU0RAkjYOp9wcitLxRCqaxLNCP3F0ouo/8AdcZx+BJH4VZfTbC3P/Ew1SCN1HMNqrTt24zwgPX+I81W1u+s7q3sbeximCWqsnmzsC7gnOMAYABLY69aBdTHrpZrTwslzYjTtY1O4LXMazjUNLS3iSIn5mJjuJGOOPlAGRnkEDPNUUDPS/jg2kSarpr6PHpsLGKUSRWTW74TzGMRZrfEZyhAAwHAX5s5BrzSiigAooooA+1f2Kf+SWar/wBhqX/0RBRR+xT/AMks1X/sNS/+iIKKAD9tb/klmlf9hqL/ANET18VV9q/trf8AJLNK/wCw1F/6Inr4qoAKmtbqe0k8y1nlhk/vRuVP5ioaKAOksvGmt2o2m6E6H+GZA369a2bLx8u9ft1k4H8RglPP/AWz/OuCooA9X07xT4dmuo3kuJ7XcedyMCPxUkV0ianplyN1lqttMnH3phu56DB5rwSigD6AfFyA0T+Yf7oGQaqzrcxKQ8Uir2I4NeIQ3VxCB5M8seOmxyMVeh8QatDtCahcEDoGbcP1oA9Gu70wNmZse7LVZ9UmcbU3AdiFzXEt4n1J1AmkjkwerIMn8qda+I5IpS0ltFID2DFf1oA7uCS4X/XvhT3KD+lPa1glBZndj/tAgVx0Xi35j5ts4TsqS9frkVo/8JrYbVEelzRH+Jhcbv0IoA1LiAqMQwRn/dest1ljnHnW3ynuGxVO48V28p/49Xx+ANVW8QWzA5iuB9GFAG5MIQQXURj3O6q1wYvLIjlU/gQKxZNYtDykM2f9og1BPq6SKV8klT6nFAExCtOQGRffrWnbIFw2Ek+rYrmhdhf9WjAe7VYj1mWPHlxr77yTmgDtrS5j8vH2Jc/3t+cVqWUtuilmSIP/AA5X+pFefx+KdRiVhAYIsjAKxjI/E1Xn8RarP9+8ccY+UBf5UAei6gt5PGXhRXA7heB+J4rHYSRZ+23cVuehLSKCPwrg5rq4m/108snGPmcnioaAOtutWsICRDKZ2PJcgnP51nTa78pWGJue7NjH4CsKigC8+qXbcCUqPaqkkjyHMjsx9zTKKACiiigAoorbufFniO60YaRda/q82khEjFlJeSNAETGxfLLbcDaMDHGB6UAX/Ffgm+8N6dBd3VzazhpBBPHD5m62lKBwjFlAbKnqhYcEZ6Z5Wuo8S+NNR17QtK0ecCLT9PA8uMTTS7n2hdxMjtt4HCrtUZOBzXL0AFfavxL/AOTNrP8A7Auk/wDodvXxVX2r8S/+TNrP/sC6T/6Hb0AfGthqF3p8gks53iYHPynj8uldbo/xF1GzcfaoYZ07lRsJ/pXD0UAevDxfoeotHMJ54br+KCdtiMPTcOBXYWuuPPCIrG8UptzgsJQo9uSK+cqfBNLA4eGR43HIZTg0CaT3PoKVTGyK9tbajcf6zEGY9w9eOM+2Kamo6dcX8Iu0urDyz8mQHXPplSD+YryTQvHniHRLkTWd+S2NpWVA4I/Guk/4WibwMdV0qJpmHMkLYB5/ukHt70E8i6HpGtRXN+Y0tJbCJxgguzL5o9BkAZ/GuS8R+Grm8aNjY7E3DMtswfn/AIDmsax8cWZUwvc3cUD/APLN+VGfTriprDWbQytFazp5LZA/eLux3OTzigLSXUSGxksMztcSJIpAWKVSu7n3rQa3a9kkYS28RA5Jm6+4xWzBfanHaCG3mF5D1KTHcQPY8jFVb6N4ZY5JLO0Yyclntxlfqy44oC8l0LFsJLWyhDxW9yi8PIXI3D8Kt2l7pd+Xt7v7PbFRhCpJ49OapaZNc6napLLpsJAJAKTtGvHcL2+lSST2Fw8kUiCB4jg4mVmJ9htwaA5n2Itojnkjgu2QEf6wKVxjpnH3qrwSyvtEks08itjcRmNh/Srs0Vu8Hnte3WR14Rio9lBGaSK3hlt2mtNbuPfbakH8gcUBzrsRyQxtBNLdXKxIBkQxOV/OuaubiOfTpZjdxPHKfkjCZwR0wfr3NdFLHYysPt2r8kYG6zdSfqaxb7SbKbP79mtEOfLisnDN78kCk9VYqFVRkmZJvpzAsZkh3nABH+PSk1TT7WCOOS2uFkupGCqQ+due7Hpj2qW403T7uZY7a8vUTqwS3VQPY/PVtrXTFtpYjeyiVmD7RbAEEdMDfToWw8lOOvc76+NeN0qOyS0NOwint0gEiw3DLzIpyof2BHSuH8TqY9Tl2bY5H5MaHKhfY963jfw70DnWbh9w4leOKPHcHAJxT9Q1bS5rV7VtJS6JfezNPsYH0DKBx+denWxcJXS1ujyKMZRTcvyMjS4jIiut75J/uso/kK6I2MktuM3KzjGCq/KPz71R02+mRBEulaZHDjgpG0jfjubBPvitbT9R1ASlBJBZ2/YRRJHz69Cc/Q15hteXY3fDVtGtuYLO9uBOQfljh3/XnFT6pp93puL24uokZe9zOsaH3I6/kKwIHM9+32rxBcxg+sxCD8yBmoL2+8I2TsTqhvLjqZWBk59sD+VAe8N1eaS7iLXWs265PSCJ5U/kMj3zWFKLCXJma9vZF+4CqQIv5bjn8qgu/FGmxyM0az3Zz8o2CNV/mTWNd+KJpJN1va28I7ZG4/4UByvqzQub27tfnsrG1twOkkUe+Uf8DfJ/EYrCvr24vpWkvLiRnB6zSFm/I9OvaobrV7+6GJrlyv8AdX5R+lUScnJ60FJJD3YFie/50zNJRQMKt6pdQ3t/LcW1hbafE+NttbNI0aYAHBkd25xnljyTjAwKqVYsLWW/vre0tlDT3EixRqTjLMQAM/U0AV6K6Pxj4UufDElt513bXkFxvVJrcSKu+NtsiESIrZBxzjBBBB9OcoAKKKKAPtX9in/klmq/9hqX/wBEQUUfsU/8ks1X/sNS/wDoiCigA/bW/wCSWaV/2Gov/RE9fFVfpJ8UPh/pXxH0C30jXLi+gtobpbtWs3RXLqjqASysMYc9vSvMP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+KqK+1f8AhlTwP/0FfEn/AIEQf/GaP+GVPA//AEFfEn/gRB/8ZoA+Kq+1fiX/AMmbWf8A2BdJ/wDQ7ej/AIZU8D/9BXxJ/wCBEH/xmvT9c+H+laz8NI/A91cXyaTHa29oJY3QT7IShU7ipXJ8sZ+X1xigD826K+1f+GVPA/8A0FfEn/gRB/8AGaP+GVPA/wD0FfEn/gRB/wDGaAPiqivtX/hlTwP/ANBXxJ/4EQf/ABmj/hlTwP8A9BXxJ/4EQf8AxmgD4qor7V/4ZU8D/wDQV8Sf+BEH/wAZo/4ZU8D/APQV8Sf+BEH/AMZoA+KqK+1f+GVPA/8A0FfEn/gRB/8AGaP+GVPA/wD0FfEn/gRB/wDGaAPi+GeWEkwyvGT12MRn8q0YvEWsR5xqNy3f5334+mc4r6//AOGVPA//AEFfEn/gRB/8Zo/4ZU8D/wDQV8Sf+BEH/wAZoA+T/wDhNdZdFSeaKZFGArxKPx4wakh8ZXMe5msbIynpIoZGA/A19Wf8MqeB/wDoK+JP/AiD/wCM0f8ADKngf/oK+JP/AAIg/wDjNAHyuPGkrov2qxildTlW3kH8fWrFp48ngLKlsscTdVTBz+Yr6g/4ZU8D/wDQV8Sf+BEH/wAZo/4ZU8D/APQV8Sf+BEH/AMZoA+YZfGltJAYmsrgg85MwyD7cUL46ZLUQCCZx3Z5AW/lX09/wyp4H/wCgr4k/8CIP/jNH/DKngf8A6CviT/wIg/8AjNAHy3F4ugjk3LaTKe+JQc/gRUd74ye5AH2CH5TwxPzY/Cvqj/hlTwP/ANBXxJ/4EQf/ABmj/hlTwP8A9BXxJ/4EQf8AxmgD5LuvE8twQGtozHjG1nYj+dUZNYmeTcsUKjsoU4/nX2F/wyp4H/6CviT/AMCIP/jNH/DKngf/AKCviT/wIg/+M0AfHMerXsRzDO0Z/wBgAUy41K9uP9fdzuM5wXOM/Svsn/hlTwP/ANBXxJ/4EQf/ABmj/hlTwP8A9BXxJ/4EQf8AxmgD4sZixJYkk8kk02vtX/hlTwP/ANBXxJ/4EQf/ABmj/hlTwP8A9BXxJ/4EQf8AxmgD4qor7V/4ZU8D/wDQV8Sf+BEH/wAZo/4ZU8D/APQV8Sf+BEH/AMZoA+KqK+1f+GVPA/8A0FfEn/gRB/8AGaP+GVPA/wD0FfEn/gRB/wDGaAPiqivtX/hlTwP/ANBXxJ/4EQf/ABmj/hlTwP8A9BXxJ/4EQf8AxmgD4qrd1fxd4j1uCKDW9f1bU7aOQTLDeXssqBwCAwDNwcEjI55NfXH/AAyp4H/6CviT/wACIP8A4zR/wyp4H/6CviT/AMCIP/jNAHyh448Zaj4wurR9QAjgtIzFbwiaWbYCckl5Xd2JPqx4AAwBiuZr7V/4ZU8D/wDQV8Sf+BEH/wAZo/4ZU8D/APQV8Sf+BEH/AMZoA+KqK+1f+GVPA/8A0FfEn/gRB/8AGaP+GVPA/wD0FfEn/gRB/wDGaAD9in/klmq/9hqX/wBEQUV6f8L/AIf6V8ONAuNI0O4vp7aa6a7Zrx0Zw7IikAqqjGEHb1ooA7CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPgD9qP/ku3ib/t1/8ASWKj/hnz4n/9Cz/5P2v/AMco/aj/AOS7eJv+3X/0lir6X+Jq2C/Gfw3L43W2Pg3+y50ja/VTZi8L8+bv+QHYFxu7gYoA+SfGvwt8Y+CNKi1LxPo/2GylmFukn2qGXMhVmAwjk9FbnGOK4mvrv9qMaMPgR4fHhjb/AGMNZQW2wsU2+Vcfc3fwZztx8uMbeMV8iUAFFFFABRRRQAUVpeHdO/tbWbazJKpIxLsOoUAliPfANX7nR9OklZbPUGtGz/qdQj2kf8DXKn8QKBXOeorVvNA1K1i817V5IOomhIljI9dy5FZjKykhgQR2NAJ3G0UuKSgYUUtJQAUUtFACUUU4KzEAKST0A70ANorbtvDGsTruNjJDHjJe4IiUD1yxFPv9EGmpbSTyxXCTZYNDIGQ7Thlz6g4zjjkc0E8yva5g0U+UASMF+7nj6UygoKKKKACiiigAooooAKKKt6hYTWH2bz3tm+0QrcJ5FzHNhWzgNsY7G45RsMO4FAFSiiigAooooA9V/Zc/5Lt4Z/7ev/SWWvv+vgD9lz/ku3hn/t6/9JZa+/6ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPgD9qP8A5Lt4m/7df/SWKur/AOGq/HH/AECvDf8A4Dz/APx6uU/aj/5Lt4m/7df/AEliryqgD1D4ofGvxH8R9At9I1yy0iC2gulu1azikVy6o6gEtIwxhz29K8voooAKKKKACiilFAHffCvSJbyS/uYm2SMotYWPIy3Lcf7ox/wKtv4gfD/XrOD7SmnsbcctNH91qr+EtYXw02n2awGV0QTTheP3kmGwfcLsFfUXhrV7DxP4YWAlWkaPDISMivOxeJq4aSmleJ62Gpxlh7Pq9f0Ph1WvtLlLxSz2s3fYxVs/hVxvE2ovGqXUsd2idFuoklz68sM/jnNe5fEXwONMgu5EtBNG4J8xRkivnm+t2t7h0YEYPFdlGrGvHniceKwio2ad0zTOq2Ez5utFsiT1MDyRfgACQPyokm0CRjvsb63PTEFwrqOOvzLk/TNY6spAEnQelD7duAMYHXHWtLHHym3GnhreAz6uxJ6bIgP/AEKrKWfhxvNQHViVGdx8r+W7muaJIBDdKkineI85Oe+eaLBy+Z0hh8MQumIdWkLcESPGm33xg5/MUsUOi7isOmXE+TnNxebCPwRelY3nrPMo8wnAxkjG7/Cp7V7YXGJty4PClsD8T3p2FyeZfjvbaGZo00jTrb+FjOjzZPqCzYFV7rxLqQXyba7EKA4220SQ/iNoGDReMlyWDKABzk9PaspoTAylW3OTnI4wKVh8qLcUlxclpN7PKT8zSHe5A9Ca1gxuNAuRKsbNYzJOiH5mKP8AIw+m4KfxrmERvMIDbCATycVs+GZS2oizlk+S8ja0LZ4G8cH/AL6C0MJbGLchfNYqCATnnioalnLtI3nZEgOCCMY9qiplBRRRQAUUUUAFFFFABRRW3c3PhxtGWK10rV49W2IDcyanG8BcY3nyhbhsHnA8zjI5OOQDGKkAEggMMjI6im16F4+1KKbwX4a06LxLBrrW4Mjl2mMtuWjRfJQOgCRKEAwGJZiSQOAPPaACiiigD1X9lz/ku3hn/t6/9JZa+/6+AP2XP+S7eGf+3r/0llr7/oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA+AP2o/wDku3ib/t1/9JYq8qr1X9qP/ku3ib/t1/8ASWKvKqACiiigAooooAK0vDtpHfazawzsFt93mTN6RqCzfoDWbXRaHE9voWpXinbJcEWMXPPPzSf+Orj/AIFQTJ2RVmupL3WXvPMCtcTFyueVBOQPpjivW/BWvXEX2Y28mzYcEdMivGJbYiMsWRXXqvQ10XgrUoILyOGSRoCSMSls4P0qKtNTg0z0cvrKnPkezPsOOFNc8P4KFXZOcnqf8K+e/iN4XSK3nNssayBv4sD8vWvcfhlrsd5bLazXSTOoxknqPUVP8RvCFnf2rXMcCdMnPSvn8PXeGrOD2PVaWtOezPijUbKTT5jDN5bsf4lbNUxg9TxXoPjPRI7d5d0KI+/ClWyG/wAK4CSMxylHGCDg19EmpK6PDxNH2M+UaeQOtKD0GMjPamnrxSqR3H/1qZzj92Eb5eT/ABZ/pSByNvAG39aQn5duB1zmgEDHX3OaALBuHYLyCeoUUjys5BkO4Z5Pf86r5IORS5yPegCwiJ/rMsyg49ackUsKecvmIQ4Kcc5HQ1ErkIACPl5606a4nnw0jEqOM0AaXiqJf7Xa4iQiK8jW7X/gYyf/AB7cKxK27v8A0rw1Zz4VpLOZrdiOfkb50z+PmCsUg4zjikiY7WG0UUUygooooAKKKKACiireoX81/wDZvPS2X7PCtunkW0cOVXOC2xRvbnl2yx7k0AVKKKKACivXf2Y7DTNS+IV3DrOnWWo2w02ZhDdwLMgYNHhtrAjPJ5969k8D+GvDN18UviPBc+HNFltLeSxFvA9jE0cO6OTdsUrhckAnHXFY4isqFN1Gr2LhBzlyo8T/AGXP+S7eGf8At6/9JZa+/wCvmL+zNM0n9rXwVBo2nWWn27aXK7RWkCwoWMV0CxCgDOABn2FfTtVRqKrBTXUUo8raYUUUVoSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB8AftR/8l28Tf8Abr/6SxV5VXqv7Uf/ACXbxN/26/8ApLFXlVABRRRQAUUUUAFdRqTLbW+maWT5bQQ+ZI4HKyy4Yg/Rdg/Cszwxp/8AaWuWtuy7otxklz/cUbm/QGrmpCbUry4uceVNI7SMGI4BPTj0GB+FBL1lbsVJrY7x9oikkZujq3X61FKv2K5AWNSSNwB5I9q0Ps5hiRpWFwrjC7Xzg/WkttOknmZRhpJMZG3JUU1uaRTbSjueqfCU6g8kU1uoLgg/e6DvX05ZXsVxYeVOAG24K5zXhHw5ez8MabFPdSbmIB2k4zXtHhq+0/XIBPCgGf4T1r5vMnzzcraLqfQzi1BJ9Dy/4l+G7GSFzMotw+TnZ/I182axYBJJ1QMzI5+YjnH+FfdXiPw5b6tZNDsA44OeleH+KvhFcsz3Nve7XAwRjOR6H1rpy/HQUeSbOfEUliKat8SPmp0ZDh1IPuKbiuz8WeGryyugLpQJM7C2cDH0rkJ4jE7I2cg4z617Kaaujx6lOVN8s1Yau0g5bH4UAsV2joOaAAVzkUbiRggUyBPTrSgEjgZpSu0Hc3HbHNKkZIyOfYHkUAEYYEHBIPb1qZ1jX7x+YD+Ed6bEwL5Zs47seBVot+4ZI1EmehC4I9zQBf0VFmtb6wCuWuYGlT/rpH864H0Dj8ax5QWXL5IP3cVZ0i8e01G1nAJEEgk28DcAckZ9xkVY1jTfsWqXdujBY4ZCqtu6qeV/QikTs7GJRTpAA5AORmm0ygooooAKKKKACtu58J+I7XRhq91oGrw6SUSQXslnIsBR8bG8wrtwdwwc85HrWJRQB1mveF7Ox8F6Pr9jf3U63sjQvHNbLGA6rltrLI/AOV+cITjIBGccnW3rPibUtX062sbtrVLSA7xHbWkUAd8bd7+Wo3tjjLZPX1OcSgD1f9myYwePrpgcf8S6Uf8AjyV7T8O7o/8ACzPiM+fvSWHT/rnLXg3wHlMPjO4YHH+gyD/x5K9f+HdyR498eNn7z2X/AKBJXHj1fDyXp+aOnCK9Zf10NN5PN/a38Et6aXKP/IV1X03Xyxp8nm/tYeC29NNlH/kG6r6nrTCK1GK8iMR/FkFFFFdBiFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB8AftR/8AJdvE3/br/wCksVeVV6r+1H/yXbxN/wBuv/pLFXlVABRRRQAUUUooA7HwqP7M8M6nq25BNcOtjCrcbh96TB+gA/Gr9vFDOjmaUwNOuMMen0NRaqy2GiabpWzcIYBLMGONssnznI9htFUdLeS9Oznb0O9srQiIa69zoPC/hObV7k2pOLUvtLL1cev/AOqvbPD/AMOtF0W2EsiZkGAgY/M1cz8Ldd07TI5Itft44vssZZZh/EvqB3/CuY+JXj6XWtUeTQ7yaK0hOVkHy78dgK86sq9eq6cdIo9+HsaFNTj9/VnrOoeFLBzHPqHnrFn5YSwxxVCXxxoPhS522TPGp+8gIIB9BXhsevavqSsf7Q1Cc94y5NX9H8O6nrNyF+zPHGeS7JnP50vqKS/fT0KjiXV0jFv8j3DTfjdp003lzW82w8LIoyK15vFsd5EJoWRo2P3NuWIrgtG+HFrBAHubnkDO4YXH4V0Gl2+mWSBFvMgHnA3H8xXBUpYdO9JHRGEbXe5D4u8NJ4g05prGJSzAnY6YP5186eINCu7S7kt7oKrRglcH096+iNY1n+zFkl0yRpHY4CZPP4V5D42ubibUE/tkMkLHO5IsYr0MBKfwvY58ZRU6XM+mx5XIMNgnPuKkRNp67h7Guo1PS7CZA1jKscJ5Jxn/APVXNywtbylGI2njPTIr0TwSFkJbgDHtUiOY1YJxjuByaYpCswJyo98H8KmjYG3yXcEN09qAI2jUfMXUjvjNXYjGLYGFiHI5UdTUa+U4I3SAE4BwDuPvVgxLFIvmHepH3Rwc/WgCns4BG7zAeh7D61qayRNp2l3wwT5X2WTHI3x8DP1Qqaolld2i3MsIGQGPGff1q9ZD7XoOp2edzW5S8jx7fI/4bSD/AMBpMmXRmC4xg9qZVh4sDLsFIHTNQUyhKKKKACiiigAq3qEdin2b+z7i5n3Qq0/nwLFsl/iVcO25RxhjtJ/uiqlFABRVmaxu4bG3vJraaO0uWdYZmQhJSmNwU9DjcM46ZqtQB3vwZmSHxXO0kfmD7HIMbiv8S+leo+ArjHjLxm64UM9qQCf9mSvIPhg/l+IZSf8An2cfqtejeCLgr4o8VMDjc1t/6C9c+KV6TX9bnVgVevH5/kdZ4bfzP2qPBhyD/oEw/wDINzX1nXyB4Gk839qDwexOf9CnH/kC5r6/qqCtTiiMVpWl6hRRRWxgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB8AftR/wDJdvE3/br/AOksVeVV6r+1H/yXbxN/26/+ksVeVUAFFFFABWv4UsV1DxBZQSY8rfvkyMjavzH9AayRXs37Nnhgax4huL+4jElrboVbv74PseBWdWoqcHN9AtzNRXXQ891uaa61S5uLwv5kkhdkDcDJ6D6dPwq/obAozRtgZ+VWGRXefGzSdJ028xYArKxJaN4sDP8AskdK4fRISYVVEGFORkYJ9ielOlUVWCmup0YigqEuVPQ09XunOmiJkVF/hkUfIPUVzckZSJlhkFxGRyoSuqlibUAImmWGJT80Ywp/Ed6huLWC2tDDps0ZOMFGHzD6VZzmf4WvZtOkWaHYZW4eJl+UD+lewaH8So9Osx/amgK6IPkktm3Y+teJrp09rqCmZWw3zHzFIArpWlhjjERwI3GA8ecE1lVoU63xo6aWLqU1yrY0fFnjifX2le1SaytM4BJJOfw6V0/wl0k3dqJ31Fi3UoWzXE6ZZJa2lwCJHOCSXYBSPb3q7o97c6VZOmnJCTLzuZjvQ+2ODUVcP+69nT0OvD428m6r9D3u2g0iO6jSYrIw65wea6rVvD+marp6xyW0boBkDaK+dPB3ia4vb/yJpEEof0yD+NfRNhdrBaRlnGCBnB68V8/i6M6Elrqd0ndKUWeU+L/hjpEdpNLpiC3u+p2cZP0r5u1u2mjvpYrqUgRMVLla+7bmJb/y2iXn6ZH414f8VvhvLp5k1i1ghubfO6eE8bs9q7svx137Oq99jmxFFVo6fEj5rQc/eyfccU5iFcYA4+8F6Grt/GBcyNEoGG/1ZHT2qlPuMhG0RjH3Qa9o8bYnJeYKg+aMc7emDT1Zo1Co4fb3IyBVKNhgbtpC9ARTy4kTBAAPTaMfnQA8sc+Y7A5PHHBPqRWl4elEeswi6I+zzk27nplJBtOPTrn8Kzo2jWVGdQVHAptzmQkgMF7Fj1+lAmrqw66gewuZYZUUvE5Ri3OWBwce1UmOSTjGa3PE58+8gv8AA230KTHA6OPlcf8AfSt+dY8yjAOVz02jtQCd0RUUUUDCiiigArbudZsZtGFlH4a0iC5CIpv45LozkjGWw0xjy2Dn5McnAHGMSigD0L4heO7HxZ4V0HT7bSV06fTZptscUjNFFCyQqqpk9zGSeOvPJZq89oooA6XwA/l61If+mDD9RXdeEZwuv+IiSRuaDp9Hrz3wc+zVXP8A0xb+YrrfDkwGsa0T3MP8mrOqrwaOzL/94jfz/I7/AOGcgk/aY8IEZP8Aok45/wCuFxX2XXxT8IHEn7SHhIj/AJ97gf8AkvcV9rU6atFIjF/x5eoUUUVZzBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfAH7Uf8AyXbxN/26/wDpLFXlVeq/tR/8l28Tf9uv/pLFXlVABRRRQAo5NfTPw71Ox+H/AIDlVp4/7QuEVnVuGBI3EA/iPyrwPwTpsep+IreK4V2togZ5gv8AcQbiPxxj8a9D8QzoWgvnjKzht0kLHKkt3HuKwr01VSpy2Z1YOF5yqWvyq/zf9Mj1XVZtfvmvdWlaWOTIjUpkKOxOOhqzZTJo1oiRGO6Rz8xl6KD3wajsJrdr4mS4MSOn7vYQokPp9adFYz3t0JLqExRqDtaQhj9MdxW6SiuWKMalSVSXNIikdLi5IlghmT+9HHgD3zVW5jt4bh2ghJcDGGIwfp1q+LqcTLEZVSFRjAhIFVtVtYEgM1o0UJc8liBk+x6g0GZSlukmspGaS5RlGDHIMpWba3tuIhC8JQRncmORn8a2LmeeS3MFpung2/vmZemPRsc1FBp9olsZbeXEjAHbPjNUrWNXTcY3kty3aLdai8TBFeBD8y7utQX1tLaNJcW0UESKcMOV/U0aJeXhlaFUtbWTPDF/lI+nWrGs2cyw4vLpJYmOQ8WWbPoOxqTJK+iM7Tb2G31VLm2cJG3DGNuA1e+fDy/i1MiO5vGdgBhWPSvJ9D+Gut63crJZWJsrBl5aRApPvivSvDPgjUfDF80rXCyw7MKQO9eZmE6M1ZS9493CKcaXJU0PYo/J0+DPmDZj8hXI+Ptas7jQriEXEAV15yeav6HeS3peKZFfA/GvMviB4fv5NYuE8tltJiFB7CvGw1KLqe+9janBc2p4Br9hJO88luodVkb952xnsa5aTIcCQYI4yK9O8X+HD4eCK8rTWrE5C4DKa85vgsUzm2bMbevJr6uMlNKUdjxMTTlCo+ZbldmywOQeMcLSbwBwo/EUzoc96Pfg5pnOOZixzgD6Cg/Pj5izHgCk/iG01dgtFf5riUAY6CgC2w+1eFsdZLC459o5B/Rl/wDHqxTjtW94eEU2oXGnoR5d7C0A3Ho4+ZD/AN9Kv51hN1560kJb2G0UUUxhRRRQAVb1DUr7Ufs39oXtzd/ZoVtoPPlaTyolztjXJ+VRk4UcDNVK27nw1fW2jDVJJ9INsUSQJHq1rJPhsY/crIZM8jI25HOQMHABiUV3vjnw/odh4Z0rUfDhe4R/Kiu7hrwsVnMKu0bQmJNmDuwQzjA5weBwVAGr4bfZfsf+mZ/mK6LRJ9uo6mf7xj/k1ctpL7LljnHyH+la2mTlbu9II+Yp/I0WvodGFly1Uz1D4HSeZ+0T4UP/AExuB/5Lz19wV8K/s/SeZ+0H4WY4/wBXcjj/AK9pq+6qLW0IrvmqNhRRRQZBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfAH7Uf/JdvE3/br/6SxV5VXqv7Uf8AyXbxN/26/wDpLFXlVABS0lKKAPUPgz4buNYTU3gfyzJG0XmZxtVcM35nYv4mkltbhtSlt7yZN9qxxubk+9eq/C7Rrjw38PpL1YctKojbnJGPmfj/AHiB/wABrzbUguta7ey5ReQhULjP+Brmo1XUrSS2R3U4OOEc/wCZ/h/wwNHHFabjai5fOUfkFfyqwNQmkgSV9hhQ4dMkOKbY27WSS2+8LKRwskpGPwP9Kkja5RBt8l3PBI+cH2NdJwlx4IT5TTQtJGw3Kyy7WA96m8H6A3i7WCZFCWdvJhNo3BvqT1rLubSS2057mFCr4IaMyjaM+h7V6x8A54zoQjaCHcxJ3KpB4/Q1y42tKjRco7nfgYJycn0H+OfD1poWgzS+XahTGcgggD6V4po0EUltueeFEZz5a4y3tzXtfx5eWPRnAjLQkBcg9K+fLctZSobUQgjGcn7+fr0rLLLyouTe50Y5ucIr5mtqkd07iCG3QRqwJcAFh9RXY/CbTLPUtfddVfzWt2ISNuAvuB0rjNSndUjnt5XjklGJRu3Kv+FanhzVZ/DM9vqNlNG+5gJ1c5DgnqD611V4SnTlGG5x4OcYVPePqzVrm10XSGdQERVO3aO+K888NeJZ/EuoS2is6qozxjpXW6JrcHiDS4pJI43yMlV5xXm/jvVYPCetNfWMG0kgOgQjj8K+aw9K7dNr3j2IK109zviq6BdB2mkZXIXa3rVrxcZ59OV4drEngGvLtR+LdtqMUEd5ZTWqll2yhckn6V6n4XmOo2EckkkUsbAEZQk9PeirRqUbTqLUlNNcydzwL4mi4t7JxeRK0jdwp7145rWCi7LYQEAcHrX2F8RrCOaIsoE8mBthWPlvpXinxF8P3j6YZl0a4hAUEuYsAV7GBxUZQUWZYqh9Yjzp6pHhp/GlxgZqa7gMEzIcY7VAQRwa9I8MU47dane4leEIdoTpwOtQdunNBPagCa1na0uobiEgyROsi59QcirviaBINZnaH/UT4uIuMfI43D+ePwrMALHgZrZ1L/SvD+mXfV4C1nKT14O5P0JH/AaLdRPdMxKKKKBhRRRQAUUVb1COxT7N/Z9xcz7oVafz4Fi2S/xKuHbco4wx2k/3RQBY1fX9X1mC1h1bVL6+htF2QJcTtIsS8cKCeOg/IelZlFFAEtu+xyfbFXLObEkzA9cf1rrLH4by3GpQ6bN4g0a21Xy2mubJ/PMlsiwtMS22MqxCqcqhYgkDHXEV98NtXtNP1u8NxYyQaZHDMMOyvdRyIsgaNGUN8sbqzBgpAPTPFNOzuOL5Xc6f9mx/M+Pnhc5/huR/5LTV9618Afsuf8l28M/9vX/pLLX3/Q3dg3d3CiiikIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD4A/aj/5Lt4m/wC3X/0liryqvVf2o/8Aku3ib/t1/wDSWKvKqACtrwjZfbddtxIoaCHM8277uxBk59jjH41jCuz8NwpZ+EdQvZdo+2yraKxGdqD5nz7HCj8aCZ7WPsbwZaWc3guwtI5YZ0WHDbW3DeeW5H+0TXmWufCm5u/EzTWF2LaFxhyAG715FoWrSWUOyz1O5gtnwWS2cqDjv7V1mifEHU9Hv4WttQubqKRgrrOAxx9e9eSsFXoylOlPc9ijXpTSpd+jG+OPButeGXEuoML21HKyQKQwHoeorCu4PtWnLNY6dqC7hksISPxyK+hp1uPEWhLdqpcyR5wDwR7ivOPD3ibVPDd/daZqapcJIf3ZwU2D3GMVVDG1JQaaTkjR4CnPbRnmV1LNcxR2PlsZ+AdqsrY/2h3r6G+EWji004GcxAlB90bSPqKik0DR78Q6hNbRrdSjO+M8iqWv+L08PWjwvBFMV6MrBTWGJxEsXFU4I2o0FSi4w6mP8edeeKCPTLaQgyOckKCMDrXkkTwy2qJILVIgAu9W5NXYL291rXZdQLKvJCJJn7p9PWrepm43kNHGif3woOfqK9TDUPYUlDqeXjK3PPljsjMKy20JjkhX5h+7Zk4I/lTtKaASlbqWH5uqyKAF+lWxFd3Efl24CxHrIsuV/I1Aul3EL+dBHC9uv+vZmJYfQVucZ1vwn8TW2iapf293cIINxESPLgAexqP4veMLfU53tLPaRnlkO4fnXD6ra2gfz1DRRseW6lh9KbcaQxiD2dvdeQejyjGfwrneFp+19s9z1qGJnUjyxjrtcZezxGaEwyLKI1UhlycMPrX078NPEa6noUPzKXjVVIGB29q+YrH/AEG9SSeAxqODjkH2NaGla7caNqIm0+eS3tWYFlyCPwFTjcKsVCy3QqMo0n7KS36n0lf3TvrkDKNoVsELzmj4iSMfCl5ksMxNjIry+fxLqcliLq0FxLwTuMeK8x8U/ETX71mtb65mS3Gf3XTdXmUcBOck77HbWlGglKRwuryxy3DFQdwOCT3rPqxeXLXMm5gB6cYwKr17zPnm7u4UUlLnmkIsWk/lNydqkckAE1p6UwutO1ayGCTH9qiDHndGct+OwvWITk1f0G8FhrNpcvjy0kG8HoUPDfoTTbbVgk21YoGkq3qtobDUrq0Y58mVkB9QDwfxqpSAKKKKACiitu51mxm0YWUfhrSILkIim/jkujOSMZbDTGPLYOfkxycAcYAKl7o2p2Gn2d9e6fd29leAm2nliZUmAxkoSMMOR0rPr0L4meLtG8UWFi9jZlNRBVpHNnHAYEWJU8nejEzDK5DMAQABjrjz2gDvLX4k3lrfR6pBpOmJr4ieKTVV84TvuhaHdxJsVgGzuVQSVBPfMemfEzX7CzitM21zblp2uxdR+a16ZhtkMrtlslAF+UjhRXD0UAeq/suf8l28M/8Ab1/6Sy19/wBfAH7Ln/JdvDP/AG9f+kstff8AQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB8AftR/8l28Tf8Abr/6SxV5VXqv7Uf/ACXbxN/26/8ApLFXlVADkUu4VQSxOABXpM8a2kmnaTLbbGtIFVt6nDSPhnBx9VH4VyvgayS78RW7TkrbW2biVscBUG7n64x+Ndvp0d7qmpG8klkdnYuwR+Rk5/Sgh6yt2Oi0jSbNICwt0Rx1RxyPp61WvDHPNJBPb28DAfuZk+XD9jx0NdBpF5Lp9xs1BEnjcYUyY4/Ef1rI1e+I1sRwGKJTyQQCDQaJtO6PSPhD4ngudPfTtVvkj1CEhDFK4yw9Qe4rpNT0jS7q7e6JR3AxnH9a8D1w2EzrOVie8A27lBVh+IqfwTrU9vJJp+qPfyR3DkRMjlivtg15VfL/AHnUpv5HsYbFqrLlejOy8Z+LNM0h5LNVOQOqHkfhXl+v3lvc3EFx5zzoxy0c2QB70/xjor2erG48uaWOX7onUqcfj1rI865u7y3hnSMxIRkYzxXbhaEYJSiaYmq4xlCSO106a3ltV81oDanjeM8fjU7hbaVEt1Myt91Zmyv4H/GsJJZLOYGyBMbnHlg7B/gasXN1cW10sTNbmNhloy+XH0roPCNHUrW6x5jJjPWFVG0e/Ws65t9QndYldI1I/hUj9elJdyzwqr29w8kTfw7gNn51mnWAJjb3F0JEPOFzn9KdgLNgmo3OsW+luIrpPNUnC8qAe5r33xBp9nbeGVWa1RXAOAB3xXgXh3UJdM1g6hav58K4DIoJcD6HrXb+LPHreIbSCyshKspboQUyPxrzcbSqVKkeX4Ue3geX2aSevU4ae8vLaWRZI41jLkeYQdq/WqdlZNe6kltbsbkyODL5afd57GvVIvhXd6npQLTvH5gD/M27mtb4feC7fw/q0v2uRpphxvbGPwpvHUoQly/EbVabnNNu8UbGlaF9m0FbfZMFCnl/pXzT8VrGSz1obyMNnGK+yPE12tvpT/Z9pbHAH0r49+KQu5tRaW7jKruO0k1z5XUlOcpMyxTcqEmzgDT3jKAElee2aRSVYbTzSsrKMnv717B4YyilwQOlIDigAAyaMEGkooA2vEP+kw6dqAOftFuI3PfzI/kOfwCn8axa2bb/AErwzdw5UyWcy3CA9djfI+Px8usakhLsFFFFMYUUVb1DUr7Ufs39oXlzdfZoVtoPPlaTyolztjXJ+VRk4UcDNAFSlIqS2eOO4ieaITRK4Lxliu8Z5GRyM9M11fxP1vSvEHiGC90G3+yWIsoIVtdu3yCqYKD1APfv1oJcnzJW+Zx9FFFBR6r+y5/yXbwz/wBvX/pLLX3/AF8Afsuf8l28M/8Ab1/6Sy19/wBABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHwB+1H/yXbxN/wBuv/pLFXldeqftR/8AJdvE3/br/wCksVeWxqZJFRerHFAHceDrCVPDeo3MNm9zPdEQjy+WSJfmkJ9j8o/GtzwtJcs26BMpnB2gq6/hXs3wW8NHTdGuJRCJR5S2ocrggj55B9NzKP8AgNcB8QtOGgeLUmtIJY5J2wyp0OfTHeuSniozrOj2OqlhOej7VPXf5F1IoDKsup3aNERj96MfnUGr2FhqFlmweJ4oucK+SPp3q0biaePyfsskhIxmdR196xtRsvs0BV7SSylY/fh5U/l0rrOUwmttt0mJ3ZF9ODWlfWT3VqpSfzAOUIGGU/nV42CSaeBcXEu9RuySMn/Gs43MV0FCTx2sqcfLwJPqRQNNp3RT1TW9WfTvs2oW0crwjCNLw1Y3h13nv2+1RsFbkgKQfwNaN3Z/6aJzFNcSr1VyGUj2NFk0Ek5MUElu+fmGSNv58UopR+FG1TE1KqtJmxcCRrVxDBGyKORKg3H6GqVtZxvbiYqyzA8M3zsK07uJ7az84ytcr2wVFR6fDbIxuJXktmcfKJB976HoaZgcr4kjmSEmGSJsj5mDEH8q46zna3m3q7GQH7yjNd3rURJeUyylVP3GAXP4Ec1ysytNLutk2P8A3Su0fnQgOv0K7W7s3ZboW5UfMSAC34d6dc3crRQr9oLqrEwSLHht3t3qtoM8dpbNFfW4eRvusNjflmptOt5brWYIoX8sbyyBuo/pRe177HfSw8W4uM9WfS3gP7Q3h+AzSyeaY1+8+cVJ/YE0mptcz3DMhOcZ4qfwvaTW2kwiWQn5ByKdLqEEN95UZkef0zxXyUpPnlynqNu7sad/aRrabmCkqO9fKXxjkUancDergNwgHAr6U8ReI7Gx0uZ7+cRfIcBm5NfJHxKvJdR1iS6hR1tn6bxg16WUwkpOb2OfET5KLv1OLJLZ4/Km0pPHXmkr2zxAJ+tLsbGccUoAH3waQ98A4oAbRS0YPpQBseFZFGsJbSvtivEa1c4/vjA/8e2n8KyZUaORkcFXUlSD2IpEYo4ZCVZTkEdQa2PFaq2rG7QAR3saXSgdtw+Yf99bqXUXUxaKUmkpjCtu58NX1tow1SSfSDbFEkCR6tayT4bGP3KyGTPIyNuRzkDBxiUUAdl4s0/QbTwnod5Y2N/Y6rfl5TFPeLOGt1+USYEaFdzh9o54UnuK42rF5eXN68b3k8s7RxJChkYttRFCqo9AAAAKr0AFFFFAHqv7Ln/JdvDP/b1/6Sy19/18Afsuf8l28M/9vX/pLLX3/QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB8AftR/wDJdvE3/br/AOksVcj8O9Pjv/FFsbkgWtuDPKzHACqM81137Uf/ACXbxN/26/8ApLFWZ4U0trfwbe3oR2ur9xbRKB1jHLfgcAfjQJpy92O70PqD4Xawv/COW0Uh8t8FjuBGckkn8zXGfGvAmsbyECeRZhJsXBDHPAz1FZPwr1KWO3W0vLV4wflRhIVA+qtx+VRfF20hW3MoMsYJ2lVbKt7V4dOlyYu/mfR+zjGLS2t+gzSjqKTtcXswW3lXcsQbO0+lU9VvpnR/9Lg2r0WRcGqGnaqYbURJDPIpHyrKxVl9vQ1HPeXM/wC6kuIWhY8RSEq6n617r3PnmSQXYltT9r8uRezqMD8x0qO6sdPlh3fawjnoHAY/nVmDT9QtY972ccCY+WcjII9yOKpXq3IBYspB7Rx71b8R0pCMQ3htne3k3q3RA2QDVjSYDLC/9oTNHk/dypBFSzZmtC8I/wBJTokrbsfgat2FzePbr5ttG03cOnymgCmDb28u2yaSUjqoG0gfWtOazE8UZWdi3ULKcbT7dqbGbxpMRqkLHg7RkVc8ybTLeQSESM3O0gEGgDCvYbl5RbTq0sv8Mjx5TH1BqdfDDGEO6Swt13Qx5U1OnnXqblhMCf3rfk/981JYXd+GaKBroqOGKvgke4NAFT+x5lZTNGZAvRkjB/MZq1cWtqbdXkNwJ48mPYgTYfXrTLqV47lREk0ch7MoIJ9zRJqoUmKa9ghn7jZvFBUW07x3NKH4n63p2nCyuDu2oEWQDOf8KvaDqniLUYvtMlrO6d2j4Nebyz266miyGEQSuPMkTktzngdq990nxfoWn6KsNnKG+UcYxzivOxVONFL2cLtnuYSrOcW5bnm3in7RrO63KzRPGOQVya8q8R210JSLmR8qOA4xkV9A3fiPSS0lzm2R3ByW5P5V4Z4y1CK/v2dJgEBPzY6+wrfCSk04tWROYwg6fM9GcevPG3Jp7DaB8gB9zmpxFM5+WAkdjjFMMD78FM/7KHNdR4ZGEdwSAaTGV5J47Yqy0UgT5wyL6ZoggmYjag2noStAFfYQm4FT7d6QjA+b8ga6OHRpFjDXXlop5C5yT+AqC+0xljLBCkY/icYoAwOM1s3JF14XtJcjfZztA2Rztcbl59ir/nWTKMNgEECtfw5/pA1DTyT/AKVbsUUDrInzr/Ij/gVJil3MSil470lMYVb1COxT7N/Z9xcz7oVafz4Fi2S/xKuHbco4wx2k/wB0VUooAKK0dR0TVNMtLO61LTby0trxPMtpZ4WRZl9UJGCOQeOxHqKzqACiiigD1X9lz/ku3hn/ALev/SWWvv8Ar4A/Zc/5Lt4Z/wC3r/0llr7/AKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPgP8AadQy/HvxHGOrG1H/AJLQ13Pgzw+L25tLeSNPsljAsIUHq5AZz7EZUfhXOfHhYB+0X4kmuZfLWEWzqQQCW+ywgY9fX8KuaZ461fSQs1s9pcqTuxcW+A57ksuDk+vNY4iM5Qahua0KipVVUava/wB/9XPe/wDhHbCLSwPssUmFyQ/rXgfxQjhguPsqpLCxOFRZdyt+fSu/s/ikdRsVW605tOuGH+tD+dC3sP4h+IrLmFtqMMlxrFvb3EjvnbCRKEx0ZcfMP/rV52Bw1anUvVPSlj6apt31ZyltbixsYo7pb6M7BtfqM/XGKy7u+EsqJeRpPtPyybdv5128010sTQ26xNbN90iQo49sc/qKwDaNdzNDdrEE7OFXeP8AGvXZ5F76g/ie4tbEiFiyAYa1JWRWH17Vn22p6dOn2m1H2Gc/eh3Ac/TpU17pSwRECSCeNejIpR1+tcXr0e1lMQK8/e3ZzQB081yzzeZNe28iHoANrL+Iq7Zq0qsVv8Y5AA2n/A1xVtMpeMrsBH3gRya6W2udOkZDHboJB3+6c/SgA1COaeZX8uSbb/H5mz8wKtWg2kTzvwODEjbj+tJHNcvqa5bzLbvGYyM/iK0rm3toHF1BpywSf89Y2LN+NAET6fGji8TfCsnQ7sGo9QjtrTbtDztIOWYFNv4jrUim1ny7XUwk7BJOp9xnio57xWQwahFKzniNt/H40AVoLeGCRZZEV4s5LEMxH41Y8AQ2t7rNzuhaRWkYhgM8ZqqudOiOYi2efLXO0/XqK2/hSsbXL3BgnDO5JCY2DnoKwxT5aLZ6OW/xG/I2vGHhmyktkaG2VSB2AzXl1xotzbXbrDaPNGe2cbTX0Jqkj3MIig2R54bf6fhXMyaLFYzKYpklDHc4Brz8Ni5QVmerKnGrG0jxOaynsrrfcWxVM4xIcgfWsq+R4SWjeOUZ4RcHFe1+KJ7aOF1FtF+Irxy5liGozhYsMzZyqV6VGs6sbtWPNx1D2cE09BsUbPBl5UZiP9WE6flWY9ldSOSltIoHRj8grtdNnuDCEhMCe8nWqXiOOXy0aW8ty2ei5/pWp5Zyq2cu4eZLv/2VxXS6Vphjh8+QqijpvP8ATrU2maJdXwWV4UCAZDySBfyA5re03SknZooJUd16hFJ/z+dAHPfapreV3OZE7bYtoH4msjX7oXQQ43yemeBXUeKNPfT4is6hCRwXPP5Vw7RwsjM0zBz0AU5NAGZPAwO52Gfc07TLl7LULe7TkwSLJjPXBzirdvpj3jYtYZ7lz2hUv/KrbeHbmEYu5bTTxjP+kzqG/wC+Fy36UCbWzM/xBaLZa1eQRnMQfdGfVG+ZT+RFZ+PxrZ8Qz2ztYra3P2qSG3EMspiKKSpO3GeT8u0ZIHSsY9M55oQR2G1t3Os2M2jCyj8NaRBchEU38cl0ZyRjLYaYx5bBz8mOTgDjGKaSgZ6L8R/GeleI/D+m2enR3SzRyiZ/MhWMR4hSLazK5M7fIP3jBTjjHJx51RRQAUUUUAeq/suf8l28M/8Ab1/6Sy19/wBfAH7Ln/JdvDP/AG9f+kstff8AQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB8AftR/8l28Tf8Abr/6SxV57p+u6jYKEt7lvKzny3+dfyNehftR/wDJdvE3/br/AOksVeVUAdtpXjqS2G25tF5+8YTgH/gByPyxXU6P460u5/dXrLH/AHGdNmz8RXkFFAH0bp139viMTywXY6xYCyg/U8n9arXV2bacR32npbkHB2mRAR7cEV4BBcTW8ge3lkicHIZGKkH6iumtPiB4mt4VhfVJbmBRtEdyBKMYx35/Wgj2cT16eGzmCNbX06RHq0yrIq/gMH8qwdZ0hHDJaX9grP2ZSiv9CRj9a4UeN5ZB/pFhAXP3mjdlz+ByKs23inTlYMUu4s9VXBX69aA5X0Zr2fhGaNg95p00yZ+9bMJlYevykkCrq2dhCQVnvLVCcBJbckZ9sis+y1zRhKJre++zzNyW2lT/AMCzxXSprtzLGGW+ik3LkSx3gJI9SucigPfXYpWtvIz7tN1ydXHO0Rgj/GrseqXyuqPPK7A4ZnGQ34Y4ptjdXF0zNcTw3UQ5x5Ct+J+Xn86dda1bQERx2sEgPDFUMLfmCMfgKAvLqh+u3sKrFts4Gdh8xOFJqlBLZS20kTRwRyN0ErE1LFd2Mz4l0iaUt3W8LAfof50+Q6bFcLGuk7WPrdkD8itAcz7MoNJFp1skSw20kkr7Q4lyq/Uda67whot1p9ik0N9bYJJxzXOXdjpslwkj6dPHIpz/AKLNu3exDLiuj0rxdZaciwLpMkm3+Ce8Cn8gtc+KU5x5YI9PB4mlRi3JO5HqR1a/mMVvKWKnkxy4zWloGh6lbo73Oc9Rlqzz8SdGS6aOHwyqz/xGK6BP6rVO9+KLxZEWjADtvuCOPwFcnsazXKopHY8zpdE/uHeMWugG3xHOP4VNeRX6TfapG2Sb+/PSu+fx5dag0gmsNPEZ/hMsmcfXd/SubutakMkpj03RpQ3DfunPHv8APXbQjKnG0kcWMxka8Uop/h/mUtFjSUhnjmkx1bzMKPwrd+xiaTZBExAwT8u/H4CsrS9SvHlBtLSytNp/1kNkgZfoSP510cuoyRxZvNUdQo3ENIEGPoCOPatjzby7G3Z28zWqW62FxGFOGncCNSfT5iK0J/tVvaCO2ks7JR/FCN7t65wOP881xC+KNMt3/e3heNRgrDlcj0GB/WornxxoSljb2F478gMXxn8zx+VAWl1ZPqflXM7fari9vZF6usYhQ+258t9cD6VlXCR26+ZFpVlDGf8AlpPmdj9C/H5LVG98cySAiz0+CLnhpWMrfrgfpWFqHiDUtQGLi5OzsqqFA/KgfLfc2Ndv9QFqouL24aJv4Ffap/4CMD9K5jepJJGO+OtRszOcsxY+5zTaBpJbEjSE9h+VMNJRQMKt6hqV9qP2b+0L25u/s0K20HnytJ5US52xrk/KoycKOBmqlbdz4avrbRhqkk+kG2KJIEj1a1knw2MfuVkMmeRkbcjnIGDgAxKK9C8d+EdG0nwppur6HefaI5ZxbGT7ZHOLg+UHLhFUGEqTgxtk8rz6+e0AFFFFAHqv7Ln/ACXbwz/29f8ApLLX3/XwB+y5/wAl28M/9vX/AKSy19/0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfAH7Uf/ACXbxN/26/8ApLFXlVeq/tR/8l28Tf8Abr/6SxV5VQAUUUUAFFFFABRRRQAUtJRQB6PYeCmi8G2+vjV9XQvayXIksdOee0tyrMBFNOsmYnJXpsIG4ZPUi8vhLxLFonh660zXZ7jU9Xmgt5rE5BtftBJtizEnIdVZs4GOOua5jSPG8mkWSJY6FosWoLavZjUlSZZ/LdSrZAkEbMVYjcUJ565ANaFz8WfFdxc3zy3xa2uPLaCzLyNBYNHIjxPboWIRkKAA88Eg5zQBq65Z3mmaFe6tpfiDXr1LScW7XMuitHZyvu2sI597A4PZ1Qn0zxXFP4r1eWUST3KzHGMPGuP0FaOteOJdT0zUrSLQ9F09tTeOS9ns0mVpmRtwO1pGROSSQir1rkKAPSlGqi58GQJqUaf8JEiPuFsP9H3XMkGPvfP/AKvd264960PDulajrU16smr2VubbWINKMs9qCGEgmO/O7gjycBe5YDIrlIvHEqaTo9q+i6TLd6REYrHUWNwJ4f3rSg4WURkh3YjKH3zVm9+IlxcthfD/AIfgtpLw391bJBK0V3NsdA0geRsACR8BCoBbIGcUAXfHC3fha4s/La/Es4cvb6ton2CWPBGCF3urKc8EN25A4zyc3iXU5JCwljjz2SJQP5VP4k8Ty61p2n6dFp9jpmm2DSyQWtn5pUPJt3sWld3JOxf4sccAc1z9AF+fV72cYkmz9EUfyFVvtM+ciVwfY4qGigB7SO2dzsQeTk9aZRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGhqms6nqyWqapqF3eJaxiG3WeVnESAABVBPA4HArPoooAKKKKAPVf2XP+S7eGf+3r/wBJZa+/6+AP2XP+S7eGf+3r/wBJZa+/6ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transpelvic ultrasound is from a pregnant 33-year-old female.",
"    <br>",
"     (A) Lower uterine segment reflecting the placenta (PL) abutting the urinary bladder (BL). A sonolucent region is noted between the placenta and the bladder (red arrows).",
"     <br>",
"      (B) Doppler study in the same projection shows a series of vascular structures with turbulent flow filling up the lucent space described in image A. There is a focal bulge created by a vascular lake on the urinary bladder (yellow arrow).",
"      <br>",
"       (C) The power Doppler study accentuates the finding of the vascular structures in the space between the placenta and the urinary bladder wall.",
"       <br>",
"        These findings are consistent with the diagnosis of placenta accreta.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20326=[""].join("\n");
var outline_f19_54_20326=null;
var title_f19_54_20327="Pyoderma gangrenosum - histopathology dermis";
var content_f19_54_20327=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyoderma gangrenosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A dense neutrophil-predominant inflammatory infiltrate is present in the dermis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20327=[""].join("\n");
var outline_f19_54_20327=null;
var title_f19_54_20328="Meningioma: Epidemiology, risk factors, and pathology";
var content_f19_54_20328=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Meningioma: Epidemiology, risk factors, and pathology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20328/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20328/contributors\">",
"     John K Park, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20328/contributors\">",
"     Peter McLaren Black, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20328/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20328/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20328/contributors\">",
"     Patrick Y Wen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20328/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20328/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/54/20328/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H627075193\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most meningiomas are benign, but their location in the central nervous system can cause serious morbidity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mortality. &nbsp;",
"   </p>",
"   <p>",
"    The epidemiology, risk factors, and pathologic classification of meningiomas will be reviewed here. Other topics on meningioma include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical presentation and diagnosis of meningioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25540?source=see_link\">",
"       \"Meningioma: Clinical presentation and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Treatment of benign (WHO grade I) meningioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44616?source=see_link\">",
"       \"Treatment of benign (WHO grade I) meningioma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Treatment of atypical (WHO grade II) and malignant (WHO grade III) meningioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42389?source=see_link\">",
"       \"Atypical and malignant meningiomas\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Systemic treatment of recurrent meningioma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4133?source=see_link\">",
"       \"Systemic treatment of recurrent meningioma\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075200\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningiomas account for about one-third of all primary brain and central nervous system tumors (",
"    <a class=\"graphic graphic_table graphicRef81566 \" href=\"UTD.htm?6/44/6862\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef72275 \" href=\"UTD.htm?28/44/29391\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2997?source=see_link\">",
"     \"Incidence of primary brain tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    According to the Central Brain Tumor Registry in the United States (CBTRUS), there were approximately 18,000 new cases of meningioma diagnosed annually from 2004 to 2006. Currently, the estimated prevalence in the United States is that there are 170,000 people with meningioma, because of the prolonged natural history of meningiomas and because asymptomatic elderly patients and those with significant comorbidity are often managed without active intervention. &nbsp;",
"   </p>",
"   <p>",
"    The incidence of meningioma increases progressively with age, with most cases occurring in older individuals. Meningiomas are rare in children [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/3\">",
"     3",
"    </a>",
"    ], except in those with hereditary syndromes such as neurofibromatosis type 2 (NF-2) or antecedent therapeutic radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H627075214\">",
"     'Ionizing radiation'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H703809303\">",
"     'Genetic factors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Overall, meningiomas are more common in women, with a female to male ratio of about two or three to one [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/4,6,7\">",
"     4,6,7",
"    </a>",
"    ]. For spinal meningiomas, which comprise about 10 percent of all meningiomas, the female to male ratio is even higher, approximately nine to one. This female predominance is less pronounced or absent in those with atypical or anaplastic meningiomas, children, and those with radiation-induced meningiomas.",
"   </p>",
"   <p>",
"    Older studies estimated that more than 90 percent of meningiomas were WHO grade I, approximately 5 percent were grade II, and 1 to 3 percent were grade III [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/6\">",
"     6",
"    </a>",
"    ]. However, contemporary studies have found that the incidence of grade II lesions of 20 to 35 percent based upon application of the 2000 and 2007 World Health Organization classification system [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Grade III meningiomas remain rare. (See",
"    <a class=\"local\" href=\"#H627075368\">",
"     'Pathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075207\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of factors have been studied for a possible relationship to the development of meningiomas and other brain tumors. The factors most intensively investigated as having a potential etiologic role in meningioma are discussed here. Factors associated with other types of brain tumors are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/42/8874?source=see_link\">",
"     \"Risk factors for brain tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075214\">",
"    <span class=\"h2\">",
"     Ionizing radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple lines of evidence have linked exposure to ionizing radiation and the subsequent development of meningiomas after both low-dose and high-dose irradiation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/7,10\">",
"     7,10",
"    </a>",
"    ]. Radiation-induced meningiomas have a higher incidence of multiplicity and atypia compared to sporadic meningiomas. An increased risk of meningioma following a lengthy latency period has been established in a variety of situations.",
"   </p>",
"   <p>",
"    The most important implication of this relationship is for patients who received radiation therapy for the treatment of malignancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075221\">",
"    <span class=\"h3\">",
"     Radiation therapy for malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation is frequently used therapeutically, and thus results in exposure of the central nervous system either as a direct consequence of treatment or by incidental exposure. Clinical situations where this is particularly important include the radiation therapy (RT) for primary malignancies of the central nervous system (CNS) or the head and neck region, as well as prophylactic craniospinal irradiation to prevent CNS relapse as a component of treatment for acute leukemia or other malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/22/37226?source=see_link&amp;anchor=H41#H41\">",
"     \"Complications of cranial irradiation\", section on 'Radiation-induced tumors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/32/2566?source=see_link&amp;anchor=H9#H9\">",
"     \"Complications of cranial stereotactic radiosurgery\", section on 'Second tumors after SRS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the absolute risk associated with RT is not known, the latency period is more than 20 years in many cases. Long-term follow-up of epidemiologic studies has observed that the incidence continues to rise even after several decades.",
"   </p>",
"   <p>",
"    The potential clinical implications of the relationship between meningioma and therapeutic radiation are illustrated by several studies: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Childhood Cancer Survivor Study of over 14,300 patients who survived at least five years after their initial diagnosis of cancer, meningiomas have developed in 170 patients (1.2 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/11\">",
"       11",
"      </a>",
"      ]. Patients had been variably treated with surgery, chemotherapy, radiation, or a combined modality approach. In the most recent report from this study, the median time to diagnosis of meningioma was 23 years and the incidence appeared to be rising for at least 30 years after the original diagnosis. The association with meningioma was specifically linked to antecedent radiation rather than other forms of treatment, and the risk was directly related to the dose of cranial irradiation. A similar increased risk of meningioma was observed in the British Childhood Cancer Survivor Study [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The risk of developing a meningioma appears to be highest for those treated at a young age. Furthermore, the incidence may be substantially higher if asymptomatic individuals are systematically screened with imaging techniques. In a study of 49 childhood survivors of leukemia who were evaluated using MRI, treatment with craniospinal irradiation between the ages of one and eight years was associated with the development of meningioma in 11 (22 percent) at a mean latency period of 25 years [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/5\">",
"       5",
"      </a>",
"      ]. Three of the 11 cases had multiple meningiomas. There was no evidence of a plateau in the development of meningioma, and the incidence may have been even higher in those studied more than 20 years after the original diagnosis. Additional study is required to determine whether MRI screening should be used routinely in patients who received craniospinal irradiation in childhood.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075228\">",
"    <span class=\"h3\">",
"     Incidental radiation exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association between radiation and the subsequent development of meningioma has been observed in a number of other clinical settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Tinea capitis",
"      </strong>",
"      &ndash; Until the 1950s, low doses of irradiation were used to treat tinea capitis. Epidemiologic studies on these patients provided the first evidence of the causal relationship between radiation and the subsequent development of meningioma.",
"      <br/>",
"      <br/>",
"      An analysis of over 11,000 children treated for tinea capitis found a sevenfold increase in the incidence of meningioma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/13\">",
"       13",
"      </a>",
"      ]. The mean latency period was 36 years, but latency was shorter in those who received higher doses of radiation [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/7\">",
"       7",
"      </a>",
"      ]. Multiple meningiomas were more common in patients who had received radiation than in those with sporadic tumors. In addition, recurrence rates were higher in those with radiation-induced meningiomas.",
"     </li>",
"     <li>",
"      <strong>",
"       Medical imaging",
"      </strong>",
"      &ndash; Dental x-rays cause a much lower level of radiation exposure to the brain compared to that used in treating tinea capitis. However, several studies have reported an increased risk of meningioma associated with frequent dental x-rays [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/14-18\">",
"       14-18",
"      </a>",
"      ]. In a population-based case-control study of over 2500 patients, meningioma cases were twice as likely as controls to report ever having had a bitewing dental x-ray [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/18\">",
"       18",
"      </a>",
"      ]. Patients who reported having at least one panorex film before the age of ten had a 4.9 times increased risk of meningioma (95% CI, 1.8-13.2). Across multiple studies, the reported risk has been highest for multiple x-ray examinations and childhood exposure, primarily in an era when the dose of dental x-rays was higher than with current technology [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/14,17-19\">",
"       14,17-19",
"      </a>",
"      ]. It is also important to recognize that recall bias can influence associations found in case-control studies such as these, and validation of dental records was not performed in most of these studies [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/20\">",
"       20",
"      </a>",
"      ]. &nbsp;",
"      <br/>",
"      <br/>",
"      Childhood exposure to diagnostic head CTs may also be associated with an increased risk of brain tumors, including meningiomas [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=see_link&amp;anchor=H244757#H244757\">",
"       \"Radiation-related risks of imaging studies\", section on 'Pediatrics'",
"      </a>",
"      .) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Atomic bomb exposure",
"      </strong>",
"      - An increased incidence of meningiomas has been observed in survivors of the atomic explosions in Japan [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]. The increased incidence of meningioma was more pronounced in those who received higher radiation doses and those who were younger at the time of exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703809303\">",
"    <span class=\"h2\">",
"     Genetic factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703809339\">",
"    <span class=\"h3\">",
"     Neurofibromatosis type 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder predisposing to multiple neoplastic lesions. This disorder is due to a mutation in the NF2 gene, a tumor suppressor gene on chromosome 22 which encodes a membrane cytoskeletal protein called merlin or schwannomin [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/26\">",
"     26",
"    </a>",
"    ] that appears to be involved in actin-cytoskeleton organization [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/27\">",
"     27",
"    </a>",
"    ]. Other modifier genes may also be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link&amp;anchor=H2#H2\">",
"     \"Neurofibromatosis type 2\", section on 'Molecular pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately one-half of individuals with NF2 have meningiomas, and multiple meningiomas are often present [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/29\">",
"     29",
"    </a>",
"    ]. Most meningiomas are intracranial, although intradural, extramedullary spinal meningiomas are also seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link&amp;anchor=H8#H8\">",
"     \"Neurofibromatosis type 2\", section on 'Meningiomas'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence increases with age, and lifetime risk of developing a meningioma may be as high as 75 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/30\">",
"     30",
"    </a>",
"    ]. Patients with NF2 tend to develop meningiomas at an earlier age than those with sporadic meningiomas. The meningiomas seen in patients with NF2 are more frequently atypical or anaplastic compared with sporadic tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, many sporadic meningiomas are associated with mutations in or inactivation of merlin [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. Evaluation of these mutations in sporadic meningiomas has corroborated the hypothesis that the formation of aggressive meningiomas follows a multistep tumor progression model [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703809346\">",
"    <span class=\"h3\">",
"     Other hereditary syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial meningioma distinct from neurofibromatosis type 2 is a rare disorder with less than 20 families described in the literature. Since the NF II gene is not deleted in these tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/37\">",
"     37",
"    </a>",
"    ], there must be a second tumor suppressor gene locus contributing to meningioma development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075249\">",
"    <span class=\"h2\">",
"     Hormonal factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of lines of evidence suggest that hormonal factors have a role in the development of meningioma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A higher incidence of meningioma in post-pubertal women compared with men.",
"     </li>",
"     <li>",
"      The female:male ratio is highest during the peak reproductive years and decreases in elderly individuals.",
"     </li>",
"     <li>",
"      Progesterone and androgen receptors are present in approximately two-thirds of patients, while estrogen receptors have been identified in approximately 10 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/38-40\">",
"       38-40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The possible relationship between either hormone replacement therapy or oral contraceptive use and the risk of meningioma has been evaluated in several studies [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1,41-46\">",
"     1,41-46",
"    </a>",
"    ]. These studies have yielded conflicting results about the role of exogenous hormones, and no definitive conclusions can be drawn. Some but not all of these studies have also suggested a protective effect of smoking and an increased risk with higher body mass index (BMI), both of which could potentially be mediated through their effects on endogenous estrogen levels [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/41,44-46\">",
"     41,44-46",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The possible relationship between meningiomas and hormonal factors has led to the evaluation of treatment with systemic oral progestational agents and other hormonal treatments in patients with recurrent meningioma not amenable to surgery",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiation therapy. However, inhibition of these receptors has not been demonstrated to alter the natural history of recurrent meningiomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4133?source=see_link&amp;anchor=H444763147#H444763147\">",
"     \"Systemic treatment of recurrent meningioma\", section on 'Hormonal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H703808909\">",
"    <span class=\"h2\">",
"     Breast cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;A moderately increased risk of meningioma has been reported in women with breast cancer, and a similar increase in the incidence of breast cancer has been observed in women with a history of meningioma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1,47\">",
"     1,47",
"    </a>",
"    ]. Whether this relationship is due to shared hormonal risk factors, other risk factors causing both diseases, or an underlying genetic predisposition is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075263\">",
"    <span class=\"h2\">",
"     Head trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head trauma was originally suggested as a cause of meningioma in 1922 [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/48\">",
"     48",
"    </a>",
"    ], and a number of subsequent studies have analyzed the role of head trauma as an etiologic factor for brain tumors, with conflicting results [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/19,49-51\">",
"     19,49-51",
"    </a>",
"    ]. Improved recall in patients with meningioma may have contributed to a detection bias in some of these studies.",
"   </p>",
"   <p>",
"    The possible etiologic relationship with trauma is illustrated by two large studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A cohort of over 228,000 individuals from Denmark who had been hospitalized for skull fracture, concussion, or other head trauma was analyzed for the risk of subsequently developing meningioma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/50\">",
"       50",
"      </a>",
"      ]. Although the risk of meningioma was increased after a median follow-up of eight years, the difference was not statistically significant (standardized incidence ratio 1.2, 95% CI 0.8-1.7).",
"     </li>",
"     <li>",
"      An international, case-control study investigated the role of head trauma as a cause of brain tumors and included 330 patients with meningioma [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/49\">",
"       49",
"      </a>",
"      ]. There was an increased risk of meningioma among men with head injuries at least five years before the diagnosis of meningioma (odds ratio [OR] = 1.5). The risk was more pronounced for those whose injury occurred 15 to 24 years prior to diagnosis (OR = 5.4).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075270\">",
"    <span class=\"h2\">",
"     Cell phone use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have looked at a possible link between cell phone usage and the subsequent development of brain tumors. At present, there is no conclusive evidence supporting a causal relationship. However, the prolonged latency period seen with ionizing radiation suggests that longer follow-up is required [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/42/8874?source=see_link&amp;anchor=H11#H11\">",
"     \"Risk factors for brain tumors\", section on 'Cellular telephones and radiofrequency radiation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075368\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075376\">",
"    <span class=\"h2\">",
"     WHO classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningiomas are classified according to the World Health Organization (WHO) schema, which is based upon morphologic criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/52\">",
"     52",
"    </a>",
"    ]. The 2000 and 2007 versions of the WHO classification system divides meningiomas into three groups (",
"    <a class=\"graphic graphic_table graphicRef72593 \" href=\"UTD.htm?20/19/20796\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       WHO grade I",
"      </strong>",
"      &ndash; Benign meningiomas (WHO grade I) (",
"      <a class=\"graphic graphic_picture graphicRef60534 \" href=\"UTD.htm?39/26/40355\">",
"       picture 1",
"      </a>",
"      ) are subdivided into a number of subtypes (",
"      <a class=\"graphic graphic_table graphicRef72593 \" href=\"UTD.htm?20/19/20796\">",
"       table 2",
"      </a>",
"      ). WHO grade I meningiomas do not meet any of the criteria for a higher grade lesion based upon morphologic criteria. The treatment approach is the same for all of the subtypes of benign meningiomas.",
"     </li>",
"     <li>",
"      <strong>",
"       WHO grade II",
"      </strong>",
"      &ndash; WHO grade II meningiomas have increased mitotic activity (&ge;4 mitoses per ten high powered fields) and three or more of the following features: increased cellularity, small cells with a high nuclear:cytoplasmic ratio, prominent nucleoli, uninterrupted patternless or sheet-like growth, or foci of spontaneous or geographic necrosis (",
"      <a class=\"graphic graphic_picture graphicRef60534 \" href=\"UTD.htm?39/26/40355\">",
"       picture 1",
"      </a>",
"      ). Chordoid, clear cell, and atypical meningiomas are classified as WHO grade II.",
"     </li>",
"     <li>",
"      <strong>",
"       WHO grade III",
"      </strong>",
"      &ndash; WHO grade III meningiomas have &ge;20 mitoses per ten high powered fields",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      malignant characteristics resembling carcinoma, sarcoma, or melanoma. Features that support the diagnosis of malignant meningioma include the loss of usual meningioma growth patterns, infiltration of underlying brain, abundant mitoses with atypical forms, and multifocal microscopic foci of necrosis (",
"      <a class=\"graphic graphic_picture graphicRef60534 \" href=\"UTD.htm?39/26/40355\">",
"       picture 1",
"      </a>",
"      ). Papillary, rhabdoid, and anaplastic meningiomas are classified as WHO grade III.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The WHO 2000 grading system represented a significant change from the 1993 version, with more objective and reproducible definitions of grade II and grade III lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/1\">",
"     1",
"    </a>",
"    ]. This has resulted in a substantial shift with increasing numbers of patients with WHO grade II tumors. In two large studies that utilized the WHO criteria published in 2000, the incidence of grade II meningiomas increased from 5 to 7 percent prior to 2000 to 20 to 38 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/8,53\">",
"     8,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to increasing the percentage of patients with atypical meningiomas, the refined WHO criteria appear to be more accurate prognostically. A study in patients with atypical or malignant meningiomas compared the",
"    <span class=\"nowrap\">",
"     2000/2007",
"    </span>",
"    classification system with the 1993 system [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/54\">",
"     54",
"    </a>",
"    ]. Using the revised system, the differences in progression-free survival between histologic groups were statistically significant whereas they were not based upon the older schema.",
"   </p>",
"   <p>",
"    The major difference between the 2007 and 2000 WHO versions is that brain invasion is now a criterion for classifying a meningioma as grade II or grade III in a lesion that would otherwise be considered grade I.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075383\">",
"    <span class=\"h2\">",
"     Impact of grade on prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WHO grading system correlates with outcome and thus has a major impact on treatment planning.",
"   </p>",
"   <p>",
"    Patients with WHO grade II or grade III meningiomas are significantly more likely to have invasive disease, a local recurrence following the initial treatment, and ultimately to have a shorter overall survival compared to patients with a WHO grade I meningioma. Overall reported rates of recurrence for patients with grade I, II, and III meningiomas are 7 to 25, 29 to 52, and 50 to 94 percent in various series [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/52,55-58\">",
"     52,55-58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The progressive worsening of prognosis with WHO grade III (anaplastic) meningiomas compared to grade II (atypical) meningiomas is illustrated in by a single-institution series of 1098 patients who were treated surgically between 1986 and 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/55\">",
"     55",
"    </a>",
"    ]. In this series, 74 cases (7 percent) were classified as either atypical (40 cases) or anaplastic (24 cases); the mean follow-up was over five years. The five-year recurrence-free survival rate was significantly better for grade II compared with grade III meningiomas (87 versus 29 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075390\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis and molecular genetics of meningioma are not well understood, and a variety of chromosomal, signalling pathway and growth factor alterations have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most well characterized genetic alteration is loss of chromosome 22, which in many cases is associated with mutations in the neurofibromatosis type 2 (",
"    <em>",
"     NF2",
"    </em>",
"    ) gene located on the long arm of chromosome 22. Meningiomas occur in approximately 50 percent of patients with neurofibromatosis type 2, an autosomal dominant tumor suppressor syndrome caused by germline mutations in the",
"    <em>",
"     NF2",
"    </em>",
"    gene [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. The product of the",
"    <em>",
"     NF2",
"    </em>",
"    gene is a membrane cytoskeletal protein called merlin, which is also known as schwannomin. Merlin is thought to act as a tumor suppressor gene, the absence of which promotes cell growth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=see_link\">",
"     \"Neurofibromatosis type 2\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <em>",
"     NF2",
"    </em>",
"    mutations are also present in approximately one-half of sporadic meningiomas, more commonly in those with transitional or fibroblastic histologic subtypes and in higher grade tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another tumor suppression gene,",
"    <em>",
"     DAL1",
"    </em>",
"    , and its gene product, protein 4.1B, have been implicated in the initiation of meningiomas that do not contain mutations in the",
"    <em>",
"     NF2",
"    </em>",
"    gene.",
"    <em>",
"     DAL1",
"    </em>",
"    loss was demonstrated in approximately 60 percent of sporadic meningiomas in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/62\">",
"     62",
"    </a>",
"    ], although subsequent studies have found a much lower frequency of inactivation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mutation, calling its importance into question [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/63,64\">",
"     63,64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genomic sequencing efforts have identified several oncogenic mutations in a small subset of non-NF2 mutant meningiomas that have potential therapeutic implications. In two separate studies, mutations in Smoothened (",
"    <em>",
"     SMO",
"    </em>",
"    ), an activator of the Hedgehog pathway that is mutated in many basal cell carcinomas, were found in approximately 5 percent of tumors, and mutations in v-akt murine thymoma viral oncogene homolog 1 (",
"    <em>",
"     AKT1",
"    </em>",
"    ), an activator of the phosphatidylinositol 3-kinase (PI3K) pathway that is known to be mutated in a variety of cancer types, were found in up to 13 percent of tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Mutations in",
"    <em>",
"     TRAF7",
"    </em>",
"    , a proapoptotic ubiquitin ligase, were also identified in approximately one-quarter of tumors in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20328/abstract/66\">",
"     66",
"    </a>",
"    ]. The role of these mutations in the pathogenesis of meningioma, however, is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H627075404\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meningiomas account for approximately one-third of primary central nervous system tumors, occurring primarily in older individuals with a female predominance (",
"      <a class=\"graphic graphic_table graphicRef81566 \" href=\"UTD.htm?6/44/6862\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef72275 \" href=\"UTD.htm?28/44/29391\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H627075200\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of meningioma is not known in most cases. However, there is a clear association with antecedent radiation exposure, which is associated with a latency period that may exceed 30 years. Meningiomas are a frequent manifestation of neurofibromatosis type 2 (NF2), and somatic mutations in the NF2 may also contribute to the development of sporadic meningiomas. (See",
"      <a class=\"local\" href=\"#H627075207\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Meningiomas are classified according to the World Health Organization (WHO) grading system. WHO grade I lesions are benign and generally have a favorable prognosis, while atypical (grade II) and malignant (grade III) meningiomas are substantially more likely to recur. (See",
"      <a class=\"local\" href=\"#H627075376\">",
"       'WHO classification'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16501454\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like acknowledge Dr. Margaret Wrensch, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/1\">",
"      Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010; 99:307.",
"     </a>",
"    </li>",
"    <li>",
"     Central Brain Tumor Registry of the United States. Reports and tables 2010. file://www.cbtrus.org/reports/reports.html (Accessed on October 12, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/3\">",
"      Liu Y, Li F, Zhu S, et al. Clinical features and treatment of meningiomas in children: report of 12 cases and literature review. Pediatr Neurosurg 2008; 44:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/4\">",
"      Marosi C, Hassler M, Roessler K, et al. Meningioma. Crit Rev Oncol Hematol 2008; 67:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/5\">",
"      Banerjee J, P&auml;&auml;kk&ouml; E, Harila M, et al. Radiation-induced meningiomas: a shadow in the success story of childhood leukemia. Neuro Oncol 2009; 11:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/6\">",
"      Claus EB, Bondy ML, Schildkraut JM, et al. Epidemiology of intracranial meningioma. Neurosurgery 2005; 57:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/7\">",
"      Umansky F, Shoshan Y, Rosenthal G, et al. Radiation-induced meningioma. Neurosurg Focus 2008; 24:E7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/8\">",
"      Willis J, Smith C, Ironside JW, et al. The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 2005; 31:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/9\">",
"      Pearson BE, Markert JM, Fisher WS, et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 2008; 24:E3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/10\">",
"      Braganza MZ, Kitahara CM, Berrington de Gonz&aacute;lez A, et al. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol 2012; 14:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/11\">",
"      Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/12\">",
"      Taylor AJ, Little MP, Winter DL, et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 2010; 28:5287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/13\">",
"      Ron E, Modan B, Boice JD Jr, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/14\">",
"      Preston-Martin S, Yu MC, Henderson BE, Roberts C. Risk factors for meningiomas in men in Los Angeles County. J Natl Cancer Inst 1983; 70:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/15\">",
"      Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 1989; 49:6137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/16\">",
"      Ryan P, Lee MW, North B, McMichael AJ. Amalgam fillings, diagnostic dental x-rays and tumours of the brain and meninges. Eur J Cancer B Oral Oncol 1992; 28B:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/17\">",
"      Longstreth WT Jr, Phillips LE, Drangsholt M, et al. Dental X-rays and the risk of intracranial meningioma: a population-based case-control study. Cancer 2004; 100:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/18\">",
"      Claus EB, Calvocoressi L, Bondy ML, et al. Dental x-rays and risk of meningioma. Cancer 2012; 118:4530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/19\">",
"      Preston-Martin S, Paganini-Hill A, Henderson BE, et al. Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst 1980; 65:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/20\">",
"      Calnon WR. Shortcomings of study on dental x-rays and risk of meningioma. Cancer 2013; 119:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/21\">",
"      Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/22\">",
"      Davis F, Il'yasova D, Rankin K, et al. Medical diagnostic radiation exposures and risk of gliomas. Radiat Res 2011; 175:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/23\">",
"      Grant IS. Necrotising fasciitis. Lancet 1994; 344:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/24\">",
"      Plyusnin A, Vapalahti O, Vasilenko V, et al. Dobrava hantavirus in Estonia: does the virus exist throughout Europe? Lancet 1997; 349:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/25\">",
"      Preston DL, Ron E, Yonehara S, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002; 94:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/26\">",
"      Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/27\">",
"      Scoles DR, Huynh DP, Morcos PA, et al. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat Genet 1998; 18:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/28\">",
"      Bruder CE, Ichimura K, Blennow E, et al. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene? Genes Chromosomes Cancer 1999; 25:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/29\">",
"      Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol 2010; 99:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/30\">",
"      Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med 1992; 84:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/31\">",
"      Perry A, Giannini C, Raghavan R, et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 2001; 60:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/32\">",
"      Larson JJ, van Loveren HR, Balko MG, Tew JM Jr. Evidence of meningioma infiltration into cranial nerves: clinical implications for cavernous sinus meningiomas. J Neurosurg 1995; 83:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/33\">",
"      Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994; 6:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/34\">",
"      Gutmann DH, Giordano MJ, Fishback AS, Guha A. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 1997; 49:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/35\">",
"      Kimura Y, Koga H, Araki N, et al. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Nat Med 1998; 4:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/36\">",
"      Leone PE, Bello MJ, de Campos JM, et al. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 1999; 18:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/37\">",
"      Maxwell M, Shih SD, Galanopoulos T, et al. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases. J Neurosurg 1998; 88:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/38\">",
"      Carroll RS, Zhang J, Dashner K, et al. Androgen receptor expression in meningiomas. J Neurosurg 1995; 82:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/39\">",
"      Blankenstein MA, Verheijen FM, Jacobs JM, et al. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000; 65:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/40\">",
"      Carroll RS, Zhang J, Black PM. Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol 1999; 42:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/41\">",
"      Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J Neurosurg 2003; 99:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/42\">",
"      Wigertz A, L&ouml;nn S, Mathiesen T, et al. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006; 164:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/43\">",
"      Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 2008; 26:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/44\">",
"      Benson VS, Pirie K, Green J, et al. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 2008; 99:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/45\">",
"      Lee E, Grutsch J, Persky V, et al. Association of meningioma with reproductive factors. Int J Cancer 2006; 119:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/46\">",
"      Claus EB, Calvocoressi L, Bondy ML, et al. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 2013; 118:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/47\">",
"      Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women. Cancer 2002; 94:1626.",
"     </a>",
"    </li>",
"    <li>",
"     Cushing, H, Eisenhardt, L. Meningiomas: Their Classification, Regional Behavior, Life History and Surgical End Results, Thomas, Springfield 1938.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/49\">",
"      Preston-Martin S, Pogoda JM, Schlehofer B, et al. An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol 1998; 27:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/50\">",
"      Inskip PD, Mellemkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 1998; 9:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/51\">",
"      Preston-Martin, S, Henderson, BE, Yu, MC. Epidemiology of intracranial meningiomas: Los Angeles Country, California. Neuroepidemiology 1983; 2:164.",
"     </a>",
"    </li>",
"    <li>",
"     Perry, A, Louis, DN, Scheithauer, BW, et, al. Meningiomas. In: WHO Classification of Tumours of the Central Nervous System, Louis, DN, Ohgaki, H, Wiestler, OD, Cavenee, WK (Eds), IARC Press, Lyon 2007. p.164.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/53\">",
"      Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD. Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys 2003; 56:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/54\">",
"      Combs SE, Schulz-Ertner D, Debus J, et al. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys 2011; 81:1415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/55\">",
"      Yang SY, Park CK, Park SH, et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 2008; 79:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/56\">",
"      Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2008; 71:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/57\">",
"      Palma L, Celli P, Franco C, et al. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 1997; 86:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/58\">",
"      Perry A, Scheithauer BW, Stafford SL, et al. \"Malignancy\" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/59\">",
"      Choy W, Kim W, Nagasawa D, et al. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus 2011; 30:E6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/60\">",
"      Norden AD, Drappatz J, Wen PY. Advances in meningioma therapy. Curr Neurol Neurosci Rep 2009; 9:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/61\">",
"      Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol 2006; 5:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/62\">",
"      Gutmann DH, Donahoe J, Perry A, et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 2000; 9:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/63\">",
"      Nunes F, Shen Y, Niida Y, et al. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma. Cancer Genet Cytogenet 2005; 162:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/64\">",
"      Martinez-Glez V, Bello MJ, Franco-Hernandez C, et al. Mutational analysis of the DAL-1/4.1B tumour-suppressor gene locus in meningiomas. Int J Mol Med 2005; 16:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/65\">",
"      Brastianos PK, Horowitz PM, Santagata S, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 2013; 45:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20328/abstract/66\">",
"      Clark VE, Erson-Omay EZ, Serin A, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013; 339:1077.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15667 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-6C4A8C19E1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20328=[""].join("\n");
var outline_f19_54_20328=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H627075404\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H627075193\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H627075200\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H627075207\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075214\">",
"      Ionizing radiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H627075221\">",
"      - Radiation therapy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H627075228\">",
"      - Incidental radiation exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H703809303\">",
"      Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H703809339\">",
"      - Neurofibromatosis type 2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H703809346\">",
"      - Other hereditary syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075249\">",
"      Hormonal factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H703808909\">",
"      Breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075263\">",
"      Head trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075270\">",
"      Cell phone use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H627075368\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075376\">",
"      WHO classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075383\">",
"      Impact of grade on prognosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H627075390\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H627075404\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16501454\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/15667\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/15667|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/44/29391\" title=\"figure 1\">",
"      Incidence rates of primary brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/15667|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/26/40355\" title=\"picture 1\">",
"      Histologic appearance of meningioma grades I-III",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/15667|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/44/6862\" title=\"table 1\">",
"      CBTRUS incidence of primary CNS tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/19/20796\" title=\"table 2\">",
"      Meningioma subtypes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42389?source=related_link\">",
"      Atypical and malignant meningiomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/22/37226?source=related_link\">",
"      Complications of cranial irradiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/32/2566?source=related_link\">",
"      Complications of cranial stereotactic radiosurgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/59/2997?source=related_link\">",
"      Incidence of primary brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25540?source=related_link\">",
"      Meningioma: Clinical presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20712?source=related_link\">",
"      Neurofibromatosis type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/42/8874?source=related_link\">",
"      Risk factors for brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4133?source=related_link\">",
"      Systemic treatment of recurrent meningioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44616?source=related_link\">",
"      Treatment of benign (WHO grade I) meningioma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_54_20329="Emergency airway management in the morbidly obese patient";
var content_f19_54_20329=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergency airway management in the morbidly obese patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Christian Arbelaez, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Susan Bartels, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Calvin A Brown, III, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Ron M Walls, MD, FRCPC, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/54/20329/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/54/20329/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients presenting with acute respiratory or ventilatory failure, the emergency clinician's first responsibilities are to ensure oxygenation and secure the airway. Obesity-related anatomic and physiologic changes make airway management more difficult, and studies have shown a correlation between obesity and difficulty with endotracheal intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review airway management in obese and morbidly obese patients. Other aspects of airway management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"     \"Advanced emergency airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OBESITY'S EFFECTS ON THE AIRWAY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Definitions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation and classification of obesity is discussed in detail separately. A brief overview and aspects of obesity of particular relevance to airway management are reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link&amp;anchor=H4#H4\">",
"     \"Screening for and clinical evaluation of obesity in adults\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overweight is defined as weight above the normal range. Obesity is defined as an abnormally high percentage of body weight as fat. Body mass index (BMI) is used to distinguish between the two terms and also determines the degree of excess weight.",
"   </p>",
"   <p>",
"    &nbsp;BMI = body weight (in kg) &divide; height (in meters) squared",
"   </p>",
"   <p>",
"    Using the BMI, obesity is then classified as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Overweight",
"      </strong>",
"      &ndash; BMI &ge;25.0 to 29.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"     <li>",
"      <strong>",
"       Class I obesity",
"      </strong>",
"      &ndash; BMI of 30.0 to 34.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"     <li>",
"      <strong>",
"       Class II obesity (formerly known as morbid obesity)",
"      </strong>",
"      &ndash; BMI of 35.0 to 39.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"     </li>",
"     <li>",
"      <strong>",
"       Class III obesity (formerly known as severe obesity)",
"      </strong>",
"      &ndash; BMI &ge;40",
"      <span class=\"nowrap\">",
"       kg/m2.",
"      </span>",
"      This type of obesity is also referred to as severe or extreme obesity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physiologic and anatomic changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of obesity is discussed in detail separately. Aspects of obesity of particular relevance to airway management are reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=see_link&amp;anchor=H15#H15\">",
"     \"Pathogenesis of obesity\", section on 'Physiologic basis for obesity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several physiologic and anatomic changes occur in obese patients that are important for airway management. Both oxygen consumption and carbon dioxide production are increased. These increases result from metabolic activity in excess adipose tissue and from the increased work required of supportive tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/5\">",
"     5",
"    </a>",
"    ]. As a consequence, desaturation time and thus, the \"safe apnea period\" during rapid sequence intubation, are decreased. The attached figure illustrates time to desaturation for obese patients compared with others (",
"    <a class=\"graphic graphic_figure graphicRef56716 \" href=\"UTD.htm?2/58/2976\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Morbidly obese patients have increased airway resistance, an abnormally elevated diaphragm, and increased work of breathing secondary to abnormal chest wall elasticity and resistance to caudad excursion of the diaphragm. These alterations result in shallow, rapid breathing and limited ventilatory capacity and are more pronounced when the patient is supine [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/2,5,6\">",
"     2,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obesity alters upper airway anatomy. Increased fat deposition in pharyngeal tissues increases the likelihood of pharyngeal wall collapse, which can complicate the performance of rapid sequence intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obesity contributes to the development of many diseases and increases not only the morbidity and mortality from such diseases, but also the incidence of complications from managing them [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/2,8-10\">",
"     2,8-10",
"    </a>",
"    ]. Obesity plays a significant role in atherosclerosis, hypertension, diabetes, cardiomyopathy, and arrhythmias, such as bradycardia, second-degree heart block, and ventricular arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/1\">",
"     1",
"    </a>",
"    ]. Obese patients are also at increased risk of aspiration pneumonitis secondary to an excess volume of gastric acid and increased intraabdominal pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/5,11\">",
"     5,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The metabolism and pharmacokinetics of commonly used drugs are altered by the physiologic changes of obesity. Lipophilic drugs have a larger volume of distribution (Vd), since the Vd is dependent upon the amount of adipose tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/6\">",
"     6",
"    </a>",
"    ]. Obese patients are known to have higher glomerular filtration rates, and renally excreted drugs may have shorter half-lives since their elimination is directly proportional to creatinine clearance. Obesity does not generally affect the clearance of drugs that are metabolized by the liver. Because of the complexity of obesity-related pharmacokinetic changes and because detailed data are lacking for many drugs, individual drug dosing for obese patients remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Drugs that depress the central nervous system, such as opioids, benzodiazepines, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    , can both depress respiratory drive and increase the tendency for collapse of the pharyngeal wall [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     AIRWAY ASSESSMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Obesity and airway difficulty",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of airway assessment is to identify clinical features that predict difficulty in any of the following areas of emergency airway management:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ventilation with bag-mask or extraglottic device",
"     </li>",
"     <li>",
"      Laryngoscopy and endotracheal intubation",
"     </li>",
"     <li>",
"      Surgical airway performance",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obesity may complicate the performance of any of these tasks, and therefore, airway management in obese patients should always be considered potentially difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/14\">",
"     14",
"    </a>",
"    ]. However, obese patients are also subject to the same risk factors for difficult airway management as nonobese patients, and whenever possible, a careful evaluation for such factors should be conducted before undertaking airway management.",
"   </p>",
"   <p>",
"    After assessing the patient, the clinician must decide whether to use an awake approach or to proceed with rapid sequence intubation (RSI). Airway assessment and the approach to the difficult airway are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .) Aspects of particular relevance to obesity are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Bag-mask ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity makes bag-mask ventilation more difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/1,2,9,10,15\">",
"     1,2,9,10,15",
"    </a>",
"    ]. Redundant upper airway soft tissue coupled with increased body mass results in increased airway resistance. Higher pressures are required to ventilate effectively, and this can lead to difficulty maintaining a mask seal. Oxygen consumption is increased in obese patients, and target oxygen saturations may be difficult to achieve or maintain. Other predictors of difficult bag-mask ventilation are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef73627 \" href=\"UTD.htm?0/39/635\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Physiologic and anatomic changes'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tracheal intubation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laryngoscopy and tracheal tube placement can be difficult in obese patients. Such patients may have altered upper airway anatomy resulting in a poor view of the glottis despite optimal laryngoscopic technique. In addition, short, thick necks may limit mobility and make it difficult to place the patient in the optimal sniffing position. General indicators of difficult intubation are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef64336 \" href=\"UTD.htm?0/46/747\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Studies assessing emergency airway management in obese patients are scarce. Nevertheless, a few studies in the emergency setting and multiple studies performed in the operating room have found an association between obesity and difficult laryngoscopy and endotracheal intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/3,4,17-23\">",
"     3,4,17-23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large retrospective study using the Danish Anesthesia Database found that patients with a BMI above 35 were more likely to be difficult to intubate compared with those with a lower BMI [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/19\">",
"       19",
"      </a>",
"      ]. When controlling for other risk factors, researchers found the odds ratio for the obese patients to be 1.34 (95% CI 1.19-1.51).",
"     </li>",
"     <li>",
"      One observational study compared the incidence of difficult endotracheal intubation in consecutive obese (n = 129) and lean (n = 134) patients undergoing elective surgery using a validated difficulty score (The Intubation Difficulty Scale, or IDS) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/20\">",
"       20",
"      </a>",
"      ]. The rate of difficult intubation was 15 percent for obese patients versus 2 percent for lean patients. In obese patients, a Mallampati score of III or IV was the only independent risk factor for difficult intubation (OR 12.51; 95% CI 2.01-77.81) (",
"      <a class=\"graphic graphic_figure graphicRef75229 \" href=\"UTD.htm?2/36/2626\">",
"       figure 2",
"      </a>",
"      ). Hypoxemia occurred more frequently in obese patients despite preoxygenation.",
"     </li>",
"     <li>",
"      Another study using the IDS to assess 204 elective surgery patients found endotracheal intubation to be more difficult in obese patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/21\">",
"       21",
"      </a>",
"      ]; a study examining 100 consecutive morbidly obese surgical patients arrived at a similar conclusion [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/22\">",
"       22",
"      </a>",
"      ]. The researchers of the latter study found that large neck circumference and high Mallampati score were the only predictors of difficult intubation in this population.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Surgical airway",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excessive soft tissue in the anterior neck limits access to the cricothyroid membrane and makes it difficult to identify the anatomic landmarks needed to perform a cricothyrotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/24\">",
"     24",
"    </a>",
"    ]. Therefore, surgical airways can be extremely difficult in morbidly obese patients. Other limitations to performing a cricothyrotomy are described in the accompanying table (",
"    <a class=\"graphic graphic_table graphicRef67468 \" href=\"UTD.htm?2/49/2843\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     AIRWAY MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Bag-mask ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best method for bag-mask ventilation in obese patients is the two-person technique with oropharyngeal and nasopharyngeal airways in place, unless these airway adjuncts are contraindicated. This approach allows for better patient positioning and mask seal. The performance of bag-mask ventilation, including the two-person technique, is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If possible, the hospital bed is angled with the head up and foot down (reverse Trendelenburg position) to reduce pressure from the abdominal contents on the diaphragm and to shift the weight of the chest wall inferiorly, thereby improving chest wall and diaphragm excursion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Tracheal intubation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;In preparation for intubation, the obese patient should be placed in an upright or semi-upright position (eg, reverse Trendelenburg), depending upon the degree of respiratory distress. An upright position improves respiratory function by allowing the diaphragm to fall downward and reducing the weight on the chest wall. Even in trauma patients requiring cervical spine stabilization, the stretcher can be tilted with the head elevated to improve breathing while preparations are made for intubation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=see_link&amp;anchor=H9#H9\">",
"     \"Direct laryngoscopy and tracheal intubation in adults\", section on 'Laryngoscopy Technique'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If there is no contraindication (eg, cervical spine precautions), the obese patient should be placed in a ramped or head-elevated position for direct laryngoscopy. In the ramped position, blankets or commercially available beds are used to elevate the head and torso such that the external auditory meatus and the sternal notch are horizontally aligned (",
"    <a class=\"graphic graphic_picture graphicRef72755 \" href=\"UTD.htm?20/50/21285\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sniffing position has traditionally been recommended to optimize glottic visualization during direct laryngoscopy, but the ramped position appears to be more effective in the obese patient [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Several studies have compared the positions used to optimize the glottic view:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a blinded, randomized trial, 60 morbidly obese patients were assigned to either the ramped or to the sniffing position (7 cm head elevation) for direct laryngoscopy and endotracheal intubation prior to surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/26\">",
"       26",
"      </a>",
"      ]. The authors reported that the ramped position provided a significant improvement in the glottic view.",
"     </li>",
"     <li>",
"      A randomized trial of direct laryngoscopy in 40 anesthetized patients found that the glottic view improved by over 50 percent when the head-elevated position was used compared with supine positioning [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study using fresh cadavers found significant improvement in the glottic view during direct laryngoscopy with the head in a fully elevated position compared with either a supine or partially elevated position [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Preoxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoxygenation is an essential aspect of rapid sequence intubation (RSI). The significance and techniques of preoxygenation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link&amp;anchor=H7#H7\">",
"     \"Rapid sequence intubation in adults\", section on 'Preoxygenation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It can be difficult to achieve and maintain adequate oxygenation in morbidly obese patients. Furthermore, oxygen saturation levels fall faster in the obese during RSI [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/30\">",
"     30",
"    </a>",
"    ]. Thus, it is important to preoxygenate as well as possible. Techniques to optimize preoxygenation include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Administer the highest possible concentration of oxygen via the best available means.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Remember that the traditional non-rebreather mask provides about 70 percent oxygen.",
"     </li>",
"     <li>",
"      A properly configured bag-valve-mask unit can provide 90 to 100 percent oxygen during active breathing, even without bag assist.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Place the obese patient in an upright position whenever possible.",
"     </li>",
"     <li>",
"      Use lubricated, bilateral nasal trumpets to assist with oxygenation when needed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Oxygen reserves can generally be maximized by administering high-flow oxygen for three to five minutes while the patient breathes their normal tidal volumes. Patients should be allowed to breathe spontaneously without assistance unless adequate oxygen saturation cannot be achieved.",
"   </p>",
"   <p>",
"    When time allows, noninvasive positive pressure ventilation can be used to improve preoxygenation in the morbidly obese [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. This approach is best suited to patients who do not achieve adequate oxygen saturation with standard techniques and are judged capable of tolerating positive pressure support. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=see_link&amp;anchor=H2#H2\">",
"     \"Noninvasive positive pressure ventilation in acute respiratory failure in adults\", section on 'Patient selection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A systematic review concluded that preoxygenation in morbidly obese adults is more effective when performed with the patient in the head-up position rather than a supine position [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/33\">",
"     33",
"    </a>",
"    ]. Among several studies that have investigated the effects of positioning on preoxygenation, one assessed the time necessary for desaturation to occur in 40 obese patients undergoing elective surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/34\">",
"     34",
"    </a>",
"    ]. After preoxygenation, induction, and intubation, patients were left apneic until their SpO2 dropped to 90 percent. Preoxygenation in the sitting position increased the mean time needed to desaturate to 90 percent by almost one minute. Other studies have reported similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The angle of head elevation that enables optimal preoxygenation while still permitting a good intubating position remains unclear. One option is to preoxygenate with the patient positioned as close to 90 degrees as possible (ie, sitting upright) and then to intubate in the ramped position once induction and paralysis are complete. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Positioning'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Providing oxygen by nasal cannula during the apneic phase of RSI may improve oxygenation in obese patients. In a small randomized trial, patients (n = 15) provided with oxygen at 5",
"    <span class=\"nowrap\">",
"     L/minute",
"    </span>",
"    by nasal cannula maintained an SpO2 above 95 percent for a mean of 5.29 minutes compared to 3.49 minutes for those not given oxygen [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/36\">",
"     36",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Medication dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal dosing for many drugs in the obese patient remains controversial. Obesity alters the pharmacokinetics and pharmacodynamics of many medications, including some of those used for rapid sequence intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/5,12,13\">",
"     5,12,13",
"    </a>",
"    ]. The mechanisms by which obesity alters the effects of drugs are described above. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Physiologic and anatomic changes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Evidence supporting the use of any particular calculation of body weight to determine the dosing of induction or neuromuscular blocking agents (NMBAs) is limited and our approach is based primarily upon clinical experience and pharmacologic considerations, although there is stronger evidence in the case of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    . In summary, we suggest using dosing based upon lean body weight (LBW) for induction agents, ideal body weight (IBW) for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"     rocuronium",
"    </a>",
"    (and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15079?source=see_link\">",
"     vecuronium",
"    </a>",
"    ), and total body weight (TBW) for succinylcholine.",
"   </p>",
"   <p>",
"    We believe the use of LBW for induction agents provides the best trade-off between insufficient sedation, which may occur with dosing based upon IBW, and excessive sedation (possibly leading to hemodynamic compromise), which may occur with dosing based upon TBW. Furthermore, in emergency circumstances, it can be difficult to recall which drugs should be dosed according to which body weight. For this reason as well, we suggest using LBW for all induction agents, unless there is time available to determine the best approach for a particular drug.",
"   </p>",
"   <p>",
"    Commonly used formulas to calculate LBW that rely on height and sex underestimate actual non-adipose tissue mass in the severely obese (Class II or III) and may be difficult to use in emergencies [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/13,37\">",
"     13,37",
"    </a>",
"    ]. Clinicians can use the attached table or calculators to rapidly estimate LBW and calculate emergent drug doses in the severely obese (",
"    <a class=\"graphic graphic_table graphicRef66098 \" href=\"UTD.htm?17/27/17852\">",
"     table 4",
"    </a>",
"    ) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?28/26/29089?source=see_link\">",
"     calculator 1",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?28/21/29009?source=see_link\">",
"     calculator 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The characteristics of particular induction agents may also affect dosing [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/9\">",
"     9",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/63/1015?source=see_link\">",
"     Thiopental",
"    </a>",
"    and benzodiazepines may have prolonged effects in obese patients due to their lipophilicity and large volumes of distribution. Dosing for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    and opioids is generally similar for obese and nonobese patients. Data evaluating",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/34/15908?source=see_link\">",
"     etomidate",
"    </a>",
"    dosing in the obese is scant.",
"   </p>",
"   <p>",
"    Both depolarizing and nondepolarizing NMBAs have been used successfully for the intubation of morbidly obese patients. Dosing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    by TBW appears to give better results. In one randomized trial, excellent intubating conditions and full paralysis were achieved in all obese patients dosed by TBW while poor intubating conditions were found in one third of patients dosed by IBW [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/38\">",
"     38",
"    </a>",
"    ]. Succinylcholine demonstrated equivalent activity in obese and nonobese adolescents when dosed by TBW [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Few studies have evaluated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"     rocuronium",
"    </a>",
"    use in the morbidly obese. Early reports suggest the duration of action is prolonged in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. A small randomized trial found that recovery time (ie, time to muscle twitch recovery) was doubled in patients dosed according to TBW compared with IBW, while the time to onset of muscle relaxation was not significantly different (TBW group 77 seconds and IBW group 87 seconds) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/42\">",
"     42",
"    </a>",
"    ]. A calculator to determine IBW is provided (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?2/41/2706?source=see_link\">",
"     calculator 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Rapid sequence intubation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway management in the obese patient is always potentially difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/14\">",
"     14",
"    </a>",
"    ]. Based upon an assessment of the patient's airway, the clinician may decide it is prudent to take an \"awake look\" to determine if rapid sequence intubation (RSI) is appropriate. The clinician can proceed with RSI if the vocal cords are well visualized during the awake look [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/43\">",
"     43",
"    </a>",
"    ]. If the patient is combative or otherwise uncooperative due to respiratory distress and hypoxia, an awake look may not be possible and RSI may provide the best approach for securing the airway [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/44\">",
"     44",
"    </a>",
"    ]. Assessment of the airway for signs of potential difficulty and the awake look are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .) Awake intubation in the obese patient is discussed below. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Awake intubation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    When performing direct laryngoscopy in the obese patient, specific pieces of equipment may make management easier. A short laryngoscope handle may be easier to insert. Larger laryngoscope blades, such as a size four Macintosh or Grandview&trade;, can help to control excess soft tissue and improve the glottic view. An endotracheal tube introducer may be extremely helpful in cases of a limited view despite optimal technique and is discussed immediately below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Devices for airway management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Below is a brief description of airway adjuncts that can be employed when managing a difficult airway in an obese patient, particularly a \"can't intubate, can ventilate\" scenario, in which bag-mask ventilation is successful, but the vocal cords cannot be adequately visualized using direct laryngoscopy to place an endotracheal tube. These devices are discussed in greater detail separately; techniques and evidence concerning their use in the obese are described here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=see_link\">",
"     \"Devices for difficult emergency airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Optical and video laryngoscopes",
"      </strong>",
"      &ndash; Preliminary studies suggest that optical and video laryngoscopes are useful for intubating the morbidly obese patient and have advantages over standard laryngoscopes (",
"      <a class=\"graphic graphic_picture graphicRef57154 \" href=\"UTD.htm?27/3/27700\">",
"       picture 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/45-48\">",
"       45-48",
"      </a>",
"      ]. In two small randomized trials of bariatric surgery patients, a video laryngoscope consistently provided a superior view of the glottis and led to fewer difficult intubations compared to direct laryngoscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/45,49\">",
"       45,49",
"      </a>",
"      ]. These devices can also be used for awake intubation [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/50\">",
"       50",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Awake intubation'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      In two randomized trials performed in bariatric surgery patients, the Airtraq, a novel optical laryngoscope (",
"      <a class=\"graphic graphic_picture graphicRef72818 \" href=\"UTD.htm?14/32/14863\">",
"       picture 3",
"      </a>",
"      ), provided a better view of the glottis and allowed for more successful and faster tracheal intubation than the Macintosh laryngoscope [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]. Differences in the glottic view and speed of intubation achieved statistical significance in both studies.",
"     </li>",
"     <li>",
"      <strong>",
"       Laryngeal mask airway (LMA) and laryngeal tubes",
"      </strong>",
"      &ndash; LMAs and laryngeal tubes are supraglottic devices, placed blindly, for use in difficult airways and in failed airways as a temporizing measure before cricothyrotomy. They are easy to place, have high ventilation success rates, and have been used effectively in obese patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/53\">",
"       53",
"      </a>",
"      ]. They are not definitive airways and likely do not protect against aspiration (",
"      <a class=\"graphic graphic_picture graphicRef81776 \" href=\"UTD.htm?5/36/5697\">",
"       picture 4",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      When using the LMA, patient positioning may be important as excessive resistance to ventilation in the obese may overcome the seal pressure of the LMA cuff, reducing the effectiveness of ventilation. Proper positioning is identical to that used for bag-mask ventilation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Bag-mask ventilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Intubating LMAs",
"      </strong>",
"      &ndash; The intubating LMA (ILMA) is a laryngeal mask modified to facilitate intubation directly through the mask. Prospective trials suggest it is effective for intubating morbidly obese patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/28,54\">",
"       28,54",
"      </a>",
"      ]. The LMA C-Trach&trade; is a modified ILMA that allows for video laryngoscopy. Preliminary studies suggest it may be effective in obese patients, but less so than the ILMA [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]. In a randomized trial of 80 patients with a BMI &gt;40, the C-Trach required significantly more time and more adjustments than the ILMA, and the video component did not work in 7 of 40 cases [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Combitube&trade;",
"      </strong>",
"      &ndash; The Combitube&trade; is a double-lumen rescue device for blind insertion in patients who cannot be intubated. It is an easy to learn technique for untrained medical personnel providing temporary airway support. There are several case reports of its successful use in obese patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/57,58\">",
"       57,58",
"      </a>",
"      ]. The pressure required to break the seal of the Combitube&trade; is felt to be higher than for the LMA.",
"     </li>",
"     <li>",
"      <strong>",
"       Endotracheal tube introducer (ETTI)",
"      </strong>",
"      &ndash; The endotracheal tube introducer (often referred to as a gum elastic bougie or bougie) is a plastic, semirigid stylet that can be useful when intubating difficult airways and should be available during any attempt to intubate a morbidly obese patient. In the event of a class III vocal cord view, the clinician may be able to place the introducer into the trachea and then insert the endotracheal tube over it (",
"      <a class=\"graphic graphic_figure graphicRef63503 \" href=\"UTD.htm?20/24/20864\">",
"       figure 3",
"      </a>",
"      ). Use of the introducer is described separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=see_link&amp;anchor=H3#H3\">",
"       \"Devices for difficult emergency airway management in adults\", section on 'Endotracheal tube introducers (gum elastic bougie)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Lighted stylets",
"      </strong>",
"      &ndash; A light guided stylet transilluminates the soft tissues in the anterior neck and facilitates blind insertion of an endotracheal tube. It can be a useful adjunct in patients with anatomical abnormalities of the airway. However, in morbidly obese patients, transillumination is often hindered due to the extra subcutaneous tissue, particularly in patients with heavily pigmented skin.",
"     </li>",
"     <li>",
"      <strong>",
"       Fiberoptic stylets",
"      </strong>",
"      &ndash; Fiberoptic stylets incorporate a fiberoptic viewing element into the distal end of a metal stylet. There are case reports of their successful use in obese patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/44,59\">",
"       44,59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Flexible fiberoptic laryngoscopes",
"      </strong>",
"      &ndash; Flexible fiberoptic laryngoscopy with light sedation and topical anesthesia is the mainstay of \"awake\" intubation for the obese patient. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Awake intubation'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Awake intubation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of an awake approach to intubation is prudent when traits associated with difficult bag-mask ventilation or endotracheal intubation is identified in the morbidly obese patient. The awake approach is described separately; issues related to its performance in obese patients are reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients considered poor candidates for rapid sequence intubation (RSI) because of difficult airway attributes (including obesity itself), awake intubation, using flexible fiberoptic laryngoscopy via the nasal or oral route, often is the best approach, provided time and the necessary equipment and expertise are available. Awake intubation offers superior visualization without the time pressure inherent in the use of neuromuscular blockade, and intubation can be accomplished while the patient continues to maintain respiratory drive and protective airway reflexes.",
"   </p>",
"   <p>",
"    An awake approach usually requires sedation and topical anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/60\">",
"     60",
"    </a>",
"    ]. If time permits, topical anesthesia is preceded (by 10 minutes or so) by administration of a mucosal drying agent, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/20/11591?source=see_link\">",
"     glycopyrrolate",
"    </a>",
"    (0.004",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IM or IV; usual adult dose 0.4 to 0.8 mg), to reduce mucosal moisture, enhance effectiveness of topical anesthetics, and minimize blockage of the fiberoptic lens by secretions. Light to moderate systemic sedation is then given, followed by inspection of the airway using video or direct laryngoscopy or fiberoptic instruments.",
"   </p>",
"   <p>",
"    Failure to obtain an adequate view of the glottis using direct or video laryngoscopy despite excellent technique and effective sedation and topical anesthesia argues against RSI and in favor of switching to a flexible fiberoptic method if possible [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/17\">",
"     17",
"    </a>",
"    ]. When a flexible fiberoptic laryngoscope is used, the procedure continues until the glottis is traversed and the endotracheal tube is introduced over the endoscope into the trachea. If the vocal cords are adequately visualized during the \"awake look,\" the operator may opt to proceed with intubation during awake laryngoscopy or to perform RSI. Immediate intubation may be best in dynamic situations where the airway may degenerate quickly (eg, neck trauma, thermal burns).",
"   </p>",
"   <p>",
"    Awake intubation requires careful use of medications because obese patients, particularly those with obstructive sleep apnea, have an increased risk of upper airway obstruction precipitated by opioids or sedatives, particularly when these are used in combination [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/1\">",
"     1",
"    </a>",
"    ]. When performing awake intubation in the obese, physicians should use medications with which they are familiar and titrate them to achieve a level of sedation similar to that needed for a painful procedure. The medication chosen should be given in reduced doses, typically 25 to 50 percent of the normal dose (based upon lean body weight), and titrated to the desired effect using small aliquots. Commonly used drugs include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/34/15908?source=see_link\">",
"     etomidate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/59,61\">",
"     59,61",
"    </a>",
"    ]. These are often accompanied by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    for analgesia.",
"   </p>",
"   <p>",
"    In more urgent circumstances when time is short or the airway of a combative patient must be assessed,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    (doses of 2 to 10 mg IV) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    (doses of 10 to 20 mg IV) may enable the physician to take an awake look while the patient maintains airway reflexes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cricothyrotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cricothyrotomy is the technique of choice to secure a failed airway. However, the procedure can be difficult to perform in obese patients, particularly those with a large amount of soft tissue in the anterior neck. If the clinician must perform the procedure in an obese patient, it may be necessary to have an assistant retract redundant soft tissue and to make a generous vertical midline incision [",
"    <a class=\"abstract\" href=\"UTD.htm?19/54/20329/abstract/16\">",
"     16",
"    </a>",
"    ]. The physician should also be prepared to place an endotracheal tube, rather than a standard cricothyrotomy tube, in case the latter is too short. The performance of cricothyrotomy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=see_link\">",
"     \"Emergent surgical cricothyrotomy (cricothyroidotomy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Mechanical ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Providing adequate ventilation and oxygenation to the intubated obese patient can be difficult. Tidal volumes are calculated based upon the patient's ideal body weight (obesity does",
"    <strong>",
"     not",
"    </strong>",
"    change underlying lung volumes) and then adjusted according to the clinical response, using airway pressures, oxygen saturation, and blood gas results. Oxygenation and ventilation can be improved in the morbidly obese by placing them in a more upright position (eg, reverse Trendelenburg). Management of mechanical ventilation in the emergency department is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=see_link\">",
"     \"Mechanical ventilation of adults in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obesity leads to a number of anatomic and physiologic changes that increase the difficulty of airway management and alter the pharmacology of many medications used for rapid sequence intubation (RSI) and awake intubation. Of note, obese patients desaturate quickly. Bag-mask ventilation, laryngoscopy and intubation, and cricothyrotomy are all more likely to be difficult in such patients. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physiologic and anatomic changes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Airway assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The best method for bag-mask ventilation in obese patients is the two-person technique with oropharyngeal and nasopharyngeal airways in place, unless these airway adjuncts are contraindicated.",
"     </li>",
"     <li>",
"      Techniques for improving intubation in obese patients include preoxygenating the patient in an upright or semi-upright position and placing the patient in the ramp position (align the external auditory meatus and sternal notch) if cervical spine precautions are not necessary (",
"      <a class=\"graphic graphic_picture graphicRef72755 \" href=\"UTD.htm?20/50/21285\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Positioning'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Preoxygenation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When performing RSI in the obese patient, we use the following approach to medication dosing: We suggest using the lean body weight (LBW) to determine the dose of the induction agent (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); we suggest using the ideal body weight (IBW) to determine the dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"       rocuronium",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); and we suggest the use of the total body weight (TBW) to determine the dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"       succinylcholine",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Based upon the clinical circumstances and the characteristics of the airway, the clinician may decide it is prudent to manage the obese patient's airway using an \"awake approach.\" This approach is described in the text. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Rapid sequence intubation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Awake intubation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of airway adjuncts can be employed when managing a difficult airway in the obese patient. These are described in the text. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Devices for airway management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DISCLOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calvin A. Brown, III, MD, an author of this topic review, has received research support from Karl Storz Endoscopy.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/1\">",
"      Benumof JL. Obstructive sleep apnea in the adult obese patient: implications for airway management. Anesthesiol Clin North America 2002; 20:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/2\">",
"      Levi D, Goodman ER, Patel M, Savransky Y. Critical care of the obese and bariatric surgical patient. Crit Care Clin 2003; 19:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/3\">",
"      Rocke DA, Murray WB, Rout CC, Gouws E. Relative risk analysis of factors associated with difficult intubation in obstetric anesthesia. Anesthesiology 1992; 77:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/4\">",
"      Rose DK, Cohen MM. The airway: problems and predictions in 18,500 patients. Can J Anaesth 1994; 41:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/5\">",
"      Ogunnaike, BO, Whitten, CW. Anesthetic management of morbidly obese patients. Semin Anesth 2002; 21:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/6\">",
"      Varon J, Marik P. Management of the obese critically ill patient. Crit Care Clin 2001; 17:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/7\">",
"      Behringer EC. Approaches to managing the upper airway. Anesthesiol Clin North America 2002; 20:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/8\">",
"      Bercault N, Boulain T, Kuteifan K, et al. Obesity-related excess mortality rate in an adult intensive care unit: A risk-adjusted matched cohort study. Crit Care Med 2004; 32:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/9\">",
"      O'Brien JM Jr, Phillips GS, Ali NA, et al. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med 2006; 34:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/10\">",
"      Ray DE, Matchett SC, Baker K, et al. The effect of body mass index on patient outcomes in a medical ICU. Chest 2005; 127:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/11\">",
"      Passannante AN, Rock P. Anesthetic management of patients with obesity and sleep apnea. Anesthesiol Clin North America 2005; 23:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/12\">",
"      Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci 1999; 88:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/13\">",
"      Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000; 39:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/14\">",
"      Butler KH, Clyne B. Management of the difficult airway: alternative airway techniques and adjuncts. Emerg Med Clin North Am 2003; 21:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/15\">",
"      Langeron O, Masso E, Huraux C, et al. Prediction of difficult mask ventilation. Anesthesiology 2000; 92:1229.",
"     </a>",
"    </li>",
"    <li>",
"     Murphy, MF, Walls, RM. Identification of the difficult and failed airway. In: Manual of emergency airway management, 3rd ed, Walls, RM (Eds), Lippincott, Williams and Wilkins, Philadelphia 2008. p.82.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/17\">",
"      Grant P, Newcombe M. Emergency management of the morbidly obese. Emerg Med Australas 2004; 16:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/18\">",
"      Voyagis GS, Kyriakis KP, Dimitriou V, Vrettou I. Value of oropharyngeal Mallampati classification in predicting difficult laryngoscopy among obese patients. Eur J Anaesthesiol 1998; 15:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/19\">",
"      Lundstr&oslash;m LH, M&oslash;ller AM, Rosenstock C, et al. High body mass index is a weak predictor for difficult and failed tracheal intubation: a cohort study of 91,332 consecutive patients scheduled for direct laryngoscopy registered in the Danish Anesthesia Database. Anesthesiology 2009; 110:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/20\">",
"      Juvin P, Lavaut E, Dupont H, et al. Difficult tracheal intubation is more common in obese than in lean patients. Anesth Analg 2003; 97:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/21\">",
"      Lavi R, Segal D, Ziser A. Predicting difficult airways using the intubation difficulty scale: a study comparing obese and non-obese patients. J Clin Anesth 2009; 21:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/22\">",
"      Brodsky JB, Lemmens HJ, Brock-Utne JG, et al. Morbid obesity and tracheal intubation. Anesth Analg 2002; 94:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/23\">",
"      Holmberg TJ, Bowman SM, Warner KJ, et al. The association between obesity and difficult prehospital tracheal intubation. Anesth Analg 2011; 112:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/24\">",
"      Aslani A, Ng SC, Hurley M, et al. Accuracy of identification of the cricothyroid membrane in female subjects using palpation: an observational study. Anesth Analg 2012; 114:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/25\">",
"      Rao SL, Kunselman AR, Schuler HG, DesHarnais S. Laryngoscopy and tracheal intubation in the head-elevated position in obese patients: a randomized, controlled, equivalence trial. Anesth Analg 2008; 107:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/26\">",
"      Collins JS, Lemmens HJ, Brodsky JB, et al. Laryngoscopy and morbid obesity: a comparison of the \"sniff\" and \"ramped\" positions. Obes Surg 2004; 14:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/27\">",
"      Lee BJ, Kang JM, Kim DO. Laryngeal exposure during laryngoscopy is better in the 25 degrees back-up position than in the supine position. Br J Anaesth 2007; 99:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/28\">",
"      Frappier J, Guenoun T, Journois D, et al. Airway management using the intubating laryngeal mask airway for the morbidly obese patient. Anesth Analg 2003; 96:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/29\">",
"      Neligan PJ, Porter S, Max B, et al. Obstructive sleep apnea is not a risk factor for difficult intubation in morbidly obese patients. Anesth Analg 2009; 109:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/30\">",
"      Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 1997; 87:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/31\">",
"      Delay JM, Sebbane M, Jung B, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008; 107:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/32\">",
"      El-Khatib MF, Kanazi G, Baraka AS. Noninvasive bilevel positive airway pressure for preoxygenation of the critically ill morbidly obese patient. Can J Anaesth 2007; 54:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/33\">",
"      Solis A, Baillard C. [Effectiveness of preoxygenation using the head-up position and noninvasive ventilation to reduce hypoxaemia during intubation]. Ann Fr Anesth Reanim 2008; 27:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/34\">",
"      Altermatt FR, Mu&ntilde;oz HR, Delfino AE, Cort&iacute;nez LI. Pre-oxygenation in the obese patient: effects of position on tolerance to apnoea. Br J Anaesth 2005; 95:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/35\">",
"      Dixon BJ, Dixon JB, Carden JR, et al. Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology 2005; 102:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/36\">",
"      Ramachandran SK, Cosnowski A, Shanks A, Turner CR. Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration. J Clin Anesth 2010; 22:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/37\">",
"      Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010; 49:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/38\">",
"      Lemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg 2006; 102:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/39\">",
"      Rose JB, Theroux MC, Katz MS. The potency of succinylcholine in obese adolescents. Anesth Analg 2000; 90:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/40\">",
"      P&uuml;hringer FK, Keller C, Kleinsasser A, et al. Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesthesiol 1999; 16:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/41\">",
"      P&uuml;hringer FK, Khuenl-Brady KS, Mitterschiffthaler G. Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients. Eur J Anaesthesiol Suppl 1995; 11:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/42\">",
"      Leykin Y, Pellis T, Lucca M, et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004; 99:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/43\">",
"      Levitan RM. Patient safety in emergency airway management and rapid sequence intubation: metaphorical lessons from skydiving. Ann Emerg Med 2003; 42:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/44\">",
"      Levitan RM, Chudnofsky C, Sapre N. Emergency airway management in a morbidly obese, noncooperative, rapidly deteriorating patient. Am J Emerg Med 2006; 24:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/45\">",
"      Marrel J, Blanc C, Frascarolo P, Magnusson L. Videolaryngoscopy improves intubation condition in morbidly obese patients. Eur J Anaesthesiol 2007; 24:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/46\">",
"      Dhonneur G, Abdi W, Ndoko SK, et al. Video-assisted versus conventional tracheal intubation in morbidly obese patients. Obes Surg 2009; 19:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/47\">",
"      Maassen R, Lee R, Hermans B, et al. A comparison of three videolaryngoscopes: the Macintosh laryngoscope blade reduces, but does not replace, routine stylet use for intubation in morbidly obese patients. Anesth Analg 2009; 109:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/48\">",
"      Abdelmalak BB, Bernstein E, Egan C, et al. GlideScope&reg; vs flexible fibreoptic scope for elective intubation in obese patients. Anaesthesia 2011; 66:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/49\">",
"      Andersen LH, Rovsing L, Olsen KS. GlideScope videolaryngoscope vs. Macintosh direct laryngoscope for intubation of morbidly obese patients: a randomized trial. Acta Anaesthesiol Scand 2011; 55:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/50\">",
"      Moore AR, Schricker T, Court O. Awake videolaryngoscopy-assisted tracheal intubation of the morbidly obese. Anaesthesia 2012; 67:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/51\">",
"      Ndoko SK, Amathieu R, Tual L, et al. Tracheal intubation of morbidly obese patients: a randomized trial comparing performance of Macintosh and Airtraq laryngoscopes. Br J Anaesth 2008; 100:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/52\">",
"      Ranieri D Jr, Filho SM, Batista S, do Nascimento P Jr. Comparison of Macintosh and Airtraq&trade; laryngoscopes in obese patients placed in the ramped position. Anaesthesia 2012; 67:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/53\">",
"      Zoremba M, Aust H, Eberhart L, et al. Comparison between intubation and the laryngeal mask airway in moderately obese adults. Acta Anaesthesiol Scand 2009; 53:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/54\">",
"      Combes X, Sauvat S, Leroux B, et al. Intubating laryngeal mask airway in morbidly obese and lean patients: a comparative study. Anesthesiology 2005; 102:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/55\">",
"      Dhonneur G, Ndoko SK, Yavchitz A, et al. Tracheal intubation of morbidly obese patients: LMA CTrach vs direct laryngoscopy. Br J Anaesth 2006; 97:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/56\">",
"      Arslan ZI, &Ouml;zdamar D, Yildiz TS, et al. Tracheal intubation in morbidly obese patients: a comparison of the Intubating Laryngeal Mask Airway&trade; and Laryngeal Mask Airway CTrach&trade;. Anaesthesia 2012; 67:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/57\">",
"      Della Puppa A, Pittoni G, Frass M. Tracheal esophageal combitube: a useful airway for morbidly obese patients who cannot intubate or ventilate. Acta Anaesthesiol Scand 2002; 46:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/58\">",
"      Banyai M, Falger S, R&ouml;ggla M, et al. Emergency intubation with the Combitube in a grossly obese patient with bull neck. Resuscitation 1993; 26:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/59\">",
"      Kovacs G, Law AJ, Petrie D. Awake fiberoptic intubation using an optical stylet in an anticipated difficult airway. Ann Emerg Med 2007; 49:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/54/20329/abstract/60\">",
"      Wieczorek PM, Schricker T, Vinet B, Backman SB. Airway topicalisation in morbidly obese patients using atomised lidocaine: 2% compared with 4%. Anaesthesia 2007; 62:984.",
"     </a>",
"    </li>",
"    <li>",
"     Murphy, MF. Sedation and anesthesia for awake intubation. In: Manual of emergency airway management, 3rd ed, Walls, RM (Eds), Lippincott, Williams and Wilkins, Philadelphia 2008. p.82.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 283 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-213.131.41.98-64F77B4D5B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20329=[""].join("\n");
var outline_f19_54_20329=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OBESITY'S EFFECTS ON THE AIRWAY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physiologic and anatomic changes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      AIRWAY ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Obesity and airway difficulty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Bag-mask ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tracheal intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Surgical airway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      AIRWAY MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Bag-mask ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Tracheal intubation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Positioning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Preoxygenation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Medication dosing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Rapid sequence intubation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Devices for airway management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Awake intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cricothyrotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DISCLOSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/283\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/283|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/58/2976\" title=\"figure 1\">",
"      Time to oxygen desaturation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/36/2626\" title=\"figure 2\">",
"      Modified Mallampati airway classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/24/20864\" title=\"figure 3\">",
"      SunMed bougie",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/283|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/50/21285\" title=\"picture 1\">",
"      RAMP position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/3/27700\" title=\"picture 2\">",
"      Storz C Mac video laryngoscope",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/32/14863\" title=\"picture 3\">",
"      Airtraq device",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/36/5697\" title=\"picture 4\">",
"      Laryngeal mask airway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/283|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/39/635\" title=\"table 1\">",
"      MOANS mnemonic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/46/747\" title=\"table 2\">",
"      LEMON mnemonic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/49/2843\" title=\"table 3\">",
"      SMART mnemonic for difficult cricothyrotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/27/17852\" title=\"table 4\">",
"      Ideal body weight lean body weight approximation table",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?28/26/29089?source=related_link\" title=\"calculator 1\">",
"      Calculator: Lean body weight (adult female)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?28/21/29009?source=related_link\" title=\"calculator 2\">",
"      Calculator: Lean body weight (adult male)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?2/41/2706?source=related_link\" title=\"calculator 3\">",
"      Calculator: Ideal body weight (method of Devine) and dosing weight for adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=related_link\">",
"      Advanced emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=related_link\">",
"      Devices for difficult emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=related_link\">",
"      Direct laryngoscopy and tracheal intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=related_link\">",
"      Emergent surgical cricothyrotomy (cricothyroidotomy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=related_link\">",
"      Mechanical ventilation of adults in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=related_link\">",
"      Noninvasive positive pressure ventilation in acute respiratory failure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=related_link\">",
"      Pathogenesis of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=related_link\">",
"      Screening for and clinical evaluation of obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_54_20330="Mediastinal seminoma I Low";
var content_f19_54_20330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66422%7EPULM%2F54661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66422%7EPULM%2F54661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mediastinal seminoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph shows discohesive cells with abundant cytoplasm, vesicular nuclei, and prominent nucleoli surrounded by numerous lymphocytes. (Hematoxylin and eosin, magnification 50x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic mediastinal seminoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows a multilocular thymic cyst containing tumor cells of seminoma in the cystic wall. (Hematoxylin and eosin, magnification 10x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20330=[""].join("\n");
var outline_f19_54_20330=null;
var title_f19_54_20331="Romiplostim in chronic ITP";
var content_f19_54_20331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F55815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F55815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Romiplostim increases the platelet count response in adult patients with chronic immune thrombocytopenia (ITP)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Treatment",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Overall platelet response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Splenectomized (63)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Non-splenectomized (62)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Total (125)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placebo",
"       </td>",
"       <td>",
"        0.0 percent (21)",
"       </td>",
"       <td>",
"        14.3 percent (21)",
"       </td>",
"       <td>",
"        7.1 percent (42)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Romiplostim",
"       </td>",
"       <td>",
"        78.6 percent (42)*",
"       </td>",
"       <td>",
"        87.8 percent (41)*",
"       </td>",
"       <td>",
"        83.1 percent (83)*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Splenectomized and non-splenectomized adult patients with chronic ITP were treated for 24 weeks in a blinded, controlled study with romiplostim (AMG-531) or placebo. The overall platelet response (weekly platelet count &gt;50x10",
"    <sup>",
"     9",
"    </sup>",
"    /L for four or more of the 24 weeks of the study) is shown in this table. Numbers of patients in each group are shown in parentheses.",
"    <div class=\"footnotes\">",
"     * All comparisons were statistically significant, with p&lt;0.0001.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008; 371:395.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20331=[""].join("\n");
var outline_f19_54_20331=null;
var title_f19_54_20332="Prognosis after MI men women";
var content_f19_54_20332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Six-year prognosis following myocardial infarction: Framingham study, 44-year follow-up for cohort and 20-year follow-up for offspring",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Men",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Percent",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"1\">",
"        Risk ratio",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Risk ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Recognized",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        9.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angina pectoris",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        4.1",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiac failure",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        5.4",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        15.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke/transient ischemic attack",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\" rowspan=\"1\">",
"        Unrecognized",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myocardial infarction",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        3.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angina pectoris",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        3.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiac failure",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        5.3",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        6.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke/transient ischemic attack",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20332=[""].join("\n");
var outline_f19_54_20332=null;
var title_f19_54_20333="Rx strep PVE II";
var content_f19_54_20333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71412&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested regimens for therapy of prosthetic valve endocarditis due to strains of viridans streptococci and Streptococcus bovis relatively or fully resistant to penicillin G (minimum inhibitory concentration &gt;0.12 &micro;g/mL)*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"       American Heart Association",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       European Society of Cardiology",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Adult (for patients with normal renal function)",
"      </td>",
"      <td class=\"subtitle2\">",
"       Pediatric (not to exceed dose of normal adult)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        <strong>",
"         Either",
"        </strong>",
"        aqueous penicillin G 24 million units per 24 h IV either continuously or in 4 or 6 equally divided doses for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Ceftriaxone&bull; 2 g/24 h IV or IM in 1 dose for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Delta; 3 mg/kg per 24 h IV or IM in 1 dose for 6 wks (see text)",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Single drug treatment",
"       </p>",
"       <p>",
"        Vancomycin&loz; 30 mg/kg per 24 h IV in 2 equally divided doses for 6 wks; not to exceed 2 g/24 h unless concentrations in serum are inappropriately low",
"       </p>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        <strong>",
"         Either",
"        </strong>",
"        aqueous penicillin G 300,000 units/kg per 24 h IV in 4 or 6 equally divided doses for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Ceftriaxone&bull; 100 mg/kg per 24 h IV or IM in 1 dose for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Delta; 3 mg/kg per 24 h IV or IM in 1 dose or in 3 equally divided doses for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Single drug treatment",
"       </p>",
"       <p>",
"        Vancomycin&loz; 40 mg/kg per 24 h IV in 2 or 3 equally divided doses for 6 wks",
"       </p>",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        <strong>",
"         Either",
"        </strong>",
"        aqueous penicillin G 24 million units per 24 h IV in 6 equally divided doses for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Amoxicillin 200 mg/kg per 24 h IV in 4 to 6 equally divided doses for 6 wks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Ampicillin 12 g per 24 h (or 200 mg/kg per 24 h) in 6 equally divided doses for 6 weeks",
"       </p>",
"       <p>",
"        <strong>",
"         or",
"        </strong>",
"       </p>",
"       <p>",
"        Vancomycin&loz; 30 mg/kg per 24 h IV in 2 doses for 4 wks",
"       </p>",
"       <p>",
"        <strong>",
"         plus",
"        </strong>",
"       </p>",
"       <p>",
"        Gentamicin&Delta; 3 mg/kg per 24 h IV or IM in 1 dose for first 2 wks (see text)",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenously; IM: intramuscularly; h: hours; wks: weeks",
"     <br>",
"      * European society of cardiology (ESC) guideline recommendations are applicable to strains having penicillin MIC 0.125 &micro;g/mL up to 2 &micro;g/mL.",
"      <br>",
"       &bull; Alternative in patients with non-immediate penicillin allergy; preferred for outpatient therapy; IM administration is painful.",
"       <br>",
"        &Delta; In adults aminoglycosides are dosed based on ideal body weight. Renal function and serum gentamicin concentrations should be monitored at least once per week. When given in a single daily dose, pre-dose (trough) concentrations should be &lt; 1 &micro;g/mL.",
"        <br>",
"         &loz; Vancomycin therapy only recommended for patients allergic to penicillin and cephalosporins. In adults vancomycin is dosed based on actual body weight. The dose should be adjusted for peak serum concentrations (1 h after infusion) of 30-45 &micro;g/mL and trough concentration of 15-20&nbsp;&micro;g/mL. The dose may need to be increased beyond 30 mg/kg actual body weight and frequency may need to be increased to 3 equally divided doses.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      1. Baddour, LM, Wilson, WR, Bayer, AS, et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association--executive summary: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:3167.",
"      <br>",
"       2. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30:2369.",
"       <br>",
"        3. Liu, Catherine et al Clinical Practice guidelines by the Infectious Disease Society of America for the Treatment of Methicillin- Resistant Staphylococcus aureus Infections in Adults and Children. CID 2011; 52; 285-292.",
"       </br>",
"      </br>",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20333=[""].join("\n");
var outline_f19_54_20333=null;
var title_f19_54_20334="Topical hemostatic agents used in surgery";
var content_f19_54_20334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F71852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F71852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Topical hemostatic agents used in surgery",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Source",
"       </td>",
"       <td class=\"subtitle1\">",
"        How supplied",
"       </td>",
"       <td class=\"subtitle1\">",
"        US Tradenames",
"       </td>",
"       <td class=\"subtitle1\">",
"        Absorption time",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adverse effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Relative expense*",
"        <sup>",
"         [1,2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Physical agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"7\">",
"        Wax-based",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Bone wax",
"       </td>",
"       <td>",
"        Beeswax",
"       </td>",
"       <td>",
"        Stick form",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        Indefinite",
"       </td>",
"       <td>",
"        Impaired bone healing",
"       </td>",
"       <td>",
"        &cent;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ostene",
"       </td>",
"       <td>",
"        Synthetic alkaline oxide copolymer",
"       </td>",
"       <td>",
"        Stick form",
"       </td>",
"       <td>",
"        Ostene",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        48 hours",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &cent;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"7\">",
"        Dry matrix",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Gelatin matrix",
"       </td>",
"       <td>",
"        Porcine",
"       </td>",
"       <td>",
"        Sponge, powder",
"       </td>",
"       <td>",
"        <p>",
"         Gelfilm",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Gelfoam",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Surgifoam",
"         <sup>",
"          &reg;",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        4 to 6 weeks",
"       </td>",
"       <td>",
"        Infection, abscess or granuloma formation, fibrosis, clot disruption if sponge is removed",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        $",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Oxidized regenerated cellulose",
"       </td>",
"       <td>",
"        Plant",
"       </td>",
"       <td>",
"        Mesh",
"       </td>",
"       <td>",
"        Surgicel",
"        <sup>",
"         &reg;",
"        </sup>",
"        (Nu-Knit",
"        <sup>",
"         &reg;",
"        </sup>",
"        , Fibrillar",
"        <sup>",
"         &reg;",
"        </sup>",
"        , SNoW",
"        <sup>",
"         &reg;",
"        </sup>",
"        )",
"       </td>",
"       <td>",
"        1 to 2 weeks",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Foreign body reaction, infection, adhesions",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        $",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\" rowspan=\"2\">",
"        Microfibrillar collagen (collagen hemostat)",
"       </td>",
"       <td rowspan=\"2\">",
"        Bovine",
"       </td>",
"       <td>",
"        Sheets",
"       </td>",
"       <td>",
"        <p>",
"         Avitene&trade; (Ultrafoam&trade;, Ultrawrap&trade;), EndoAvitene&trade;, Instat MCH",
"         <sup>",
"          &reg;,",
"         </sup>",
"         Helistat",
"         <sup>",
"          &reg;,",
"         </sup>",
"         SyringeAvitene&trade;",
"        </p>",
"       </td>",
"       <td rowspan=\"2\">",
"        &gt;8 weeks",
"       </td>",
"       <td rowspan=\"2\">",
"        Granuloma formation, allergenic",
"       </td>",
"       <td rowspan=\"2\">",
"        $$",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Powder",
"       </td>",
"       <td>",
"        Avitene&trade; Flour",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Microporous polysaccharide hemospheres (MPH",
"        <sup>",
"         &reg;",
"        </sup>",
"        )",
"       </td>",
"       <td>",
"        Synthetic",
"       </td>",
"       <td>",
"        Powder",
"       </td>",
"       <td>",
"        Arista&trade;",
"       </td>",
"       <td>",
"        24 to 48 hours",
"       </td>",
"       <td>",
"        None reported",
"       </td>",
"       <td>",
"        $",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"7\">",
"        External agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Chitosan",
"       </td>",
"       <td>",
"        Biodegradable complex carbohydrate derived from chitin",
"       </td>",
"       <td>",
"        Adhesive dressing",
"       </td>",
"       <td>",
"        HemCon",
"        <sup>",
"         &reg;",
"        </sup>",
"        bandage (Chitoflex",
"        <sup>",
"         &reg;)",
"        </sup>",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        Training needed to ensure proper application",
"       </td>",
"       <td>",
"        &cent;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Zeolite",
"       </td>",
"       <td>",
"        Calcium-loaded aluminosilicate mineral",
"       </td>",
"       <td>",
"        Very low moisture granule",
"       </td>",
"       <td>",
"        Quikclot",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        Potential for thermal injury",
"       </td>",
"       <td>",
"        &cent;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Biologically active agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Topical thrombin",
"       </td>",
"       <td>",
"        <p>",
"         Bovine",
"        </p>",
"        <p>",
"         Human",
"        </p>",
"        <p>",
"         Recombinant (preliminary data only)",
"        </p>",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"       <td>",
"        <p>",
"         Evithrom",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Recothrom",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Thrombi-Gel",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Thrombi-Pad",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Thrombin-JMI",
"         <sup>",
"          &reg;",
"         </sup>",
"         ,",
"        </p>",
"       </td>",
"       <td>",
"        Not applicable",
"       </td>",
"       <td>",
"        <p>",
"         Intravascular application leads to thrombosis",
"        </p>",
"        <p>",
"         Antibody formation against bovine thrombin can inhibit coagulation and prolong prothrombin time/INR",
"        </p>",
"       </td>",
"       <td>",
"        $$",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fibrin sealant",
"       </td>",
"       <td>",
"        Human (some preparations contain bovine aprotinin)",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"       <td>",
"        <p>",
"         Artiss, Tisseel, Evicel&trade;, Proceed&trade;, Hemaseel APR&trade;, Crosseal&trade;",
"        </p>",
"       </td>",
"       <td>",
"        Immediate",
"       </td>",
"       <td>",
"        Potential exposure to blood-borne viruses",
"       </td>",
"       <td>",
"        $$$",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dry Fibrin Sealant Dressing (DFSD)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Freeze dried fibrinogen and thrombin applied to gauze substrate",
"       </td>",
"       <td>",
"        Dressing",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        $$$$",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bovine albumin-glutaraldehyde tissue adhesive",
"       </td>",
"       <td>",
"        Bovine",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"       <td>",
"        Bioglue",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Antibody formation against bovine thrombin can inhibit coagulation and prolong prothrombin time/INR",
"       </td>",
"       <td>",
"        $$$$",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Combination preparations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thrombin/gelatin",
"       </td>",
"       <td>",
"        Bovine",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"       <td>",
"        <p>",
"         Floseal&trade;, Surgiflo",
"         <sup>",
"          &reg;",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        6 to 8 weeks",
"       </td>",
"       <td>",
"        Antibody formation against bovine thrombin can inhibit coagulation and prolong prothrombin time/INR",
"       </td>",
"       <td>",
"        $$$",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thrombin/collagen",
"       </td>",
"       <td>",
"        Bovine",
"       </td>",
"       <td>",
"        Liquid",
"       </td>",
"       <td>",
"        <p>",
"         Costasis",
"         <sup>",
"          &reg;",
"         </sup>",
"         , Vitagel&trade;",
"        </p>",
"       </td>",
"       <td>",
"        4 weeks",
"       </td>",
"       <td>",
"        Antibody formation against bovine thrombin can inhibit coagulation and prolong prothrombin time/INR",
"       </td>",
"       <td>",
"        $$$",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     INR: international normalized ratio; NA: not applicable.",
"     <br>",
"      * Price range (US dollars): &cent;: less than 50 dollars; $: 50-100 dollars; $$: 101-300 dollars; $$$: 301-500 dollars; $$$$: 501 to 750 dollars.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       The low pH of the oxidized regenerated cellulose can inhibit proteases and elastase which can delay resorption for more than two weeks.",
"       <br>",
"        &Delta; Investigational.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Duenas-Garcia OF, Goldberg JM. Obstet Gynecol Surv 2008; 63:389.",
"       </li>",
"       <li>",
"        Hong YM, Loughlin KR. J Urol 2006; 176:2367.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20334=[""].join("\n");
var outline_f19_54_20334=null;
var title_f19_54_20335="Incision inguinal node dissection";
var content_f19_54_20335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68359&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68359&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inguinal node dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Line of incision and pertinent landmarks.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_54_20335=[""].join("\n");
var outline_f19_54_20335=null;
